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Abstract 
This thesis investigates the possibility of using ambient ionisation and surface mass 
spectrometry for the detection and quantification of drugs of abuse in latent fingerprints. The 
use of fingerprints for drug testing in lieu of blood, oral fluid or urine reduces the biological 
hazard associated with these types of samples. The sample collection procedure is non-
invasive, can be monitored to prevent cheating (submitting samples from a drug free 
individual) and the identity of the donor is embedded in the fingerprint ridge detail. In this 
thesis, three techniques – desorption electrospray ionisation (DESI), liquid extraction surface 
analysis (LESA) and paper spray mass spectrometry, were evaluated for their ability to 
provide a rapid drug test from a fingerprint. 
Paper spray-mass spectrometry was chosen for further development due to the ease of set-
up, rapid nature of the analysis and potential to provide quantitative results. The final 
optimised method included full scan mass spectrometry measurements (quantitative) 
followed by tandem mass spectrometry (MS/MS) scans (qualitative) for the detection of 
cocaine, benzoylecgonine (BZE) and ecgonine methyl ester (EME). Limits of detection 
(LOD) were calculated to be 1 ng/mL, 2 ng/mL and 31 ng/mL for cocaine, BZE and EME, 
respectively.  
Using the optimised method of analysis, 159 individual fingerprint samples (collected from 
individuals seeking treatment for substance abuse) were analysed with a 99% true positive 
rate through the detection of either cocaine, BZE or EME. The detection of these substances 
was corroborated by a positive oral fluid result from samples collected from the same 
individuals. Analysis of fingerprint samples collected from the non-drug users (n=80) 
indicated <2.5% false positive rate. 
The significance of detecting the parent drug or metabolite in fingerprint samples was 
determined through the analysis of samples after contact with seized cocaine from Forensic 
Science Ireland. Cocaine, BZE and EME were found in fingerprints produced by contact, 
showing that the presence of a cocaine metabolite in a fingerprint is not enough to show that 
a suspect has taken a drug. Furthermore, secondary transfer scenarios showed that cocaine 
could be transferred through handshakes. None of the hand cleaning methods employed in 
this research were sufficient to remove all traces of cocaine from contact residues.  
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Finally, the possibility of visualising the fingerprint ridge detail prior to analysis was tested 
and the presence of the analytes was qualitatively confirmed in fingerprint samples after 
application of silver nitrate. This is an important step that allows for sample traceability, 
whilst still providing high throughput analysis and sensitivity. 
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1. Introduction 
1.1. Motivation 
The abuse of illicit substances is cause for concern in the United Kingdom (UK), with the 
government estimating that drug trafficking costs approximately £10.7 billion each year. 
Substances such as cocaine (crack and powder cocaine), opiates (diamorphine) and ecstasy are 
the most consumed substances and are easily attainable in the UK (National Crime Agency, 
2016). Treating substance addiction will improve general public health by preventing infection 
and reducing the spread of disease (Public Health England, 2016). It is estimated that 45% of 
all acquisitive offences are committed by offenders under the influence of illicit substances. As 
a result, in the recently published “Modern Crime Prevention Strategy” (Home Office, 2016), 
the Home Office outlined an approach to reduce the number of drug users through treatment, 
prevention and enforcement. Monitoring of substance abuse costs the National Health Service 
(NHS) around £488 million per year, and the aim is to help heavy drug users rebuild their lives, 
deter the younger generation from experimenting with drugs and use law enforcement to 
monitor critical zones in the UK. Another key area where drug testing is on the rise is workplace 
drug testing (Ironmonger, 2014). This has been supported by reports in the literature that 
suggest that regular testing led to improved productivity and attendance (Carpenter, 2007, 
Fortner et al., 2011). 
The use of fingerprint samples as a drug testing matrix is novel and has considerable advantages 
over other more conventional matrices (e.g. urine and blood). Fingerprint samples reduce the 
biohazards associated with blood and consequently the cost associated with this type of sample 
transport and storage. Sample collection is also fast and easy, unlike urine, which must be 
carried out in privacy and can therefore be falsified by submitting samples from a drug-free 
individual. Most significantly, deposition of a fingerprint sample is a secure route for drug 
testing because the identity of the donor is encapsulated within the sample. In this thesis, an 
investigation into the feasibility of using surface ambient ionisation mass spectrometry (AIMS) 
techniques to provide a high throughput and cost effective method for drug testing based on a 
fingerprint is carried out. This can be used by the NHS, probation services, courts and police 
officers for road-side testing. The implementation of such a test can also be applied to work 
place screening, which may become a major market for a fingerprint based drug test. 
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A fingerprint-based drug-screening test may be a practical replacement for the commonly 
applied immunoassay screening tests. Furthermore, the use of portable mass spectrometers may 
allow for onsite testing, ultimately resulting in a cost and time saving process. The adaptation 
of such a test requires full validation and comparison to the standard qualitative and quantitative 
methods currently available for drug testing, using other matrices mentioned previously. A 
good example is the European funded project, ROSITA-2, which integrated six European 
countries and four North American states to evaluate several available devices for onsite drug 
detection in oral fluid against confirmatory methods (chromatography-mass spectrometry 
techniques). Study outcomes suggested that none of the commercially available devices 
produced reliable results, although it was found that random roadside testing discouraged drug-
driving (Verstraete et al., 2006).  
The further development of a quantitative drug test based on a single fingerprint will enhance 
the value of the test and may be a suitable replacement for confirmatory blood/urine testing. 
The European Laboratory Guidelines for Legally Defensible Workplace Drug Testing 
(European Workplace Drug Testing Society, 2002), outlines the minimum requirements for an 
urine based confirmatory test. Requirements include a system suitability check (prior to 
analysis), a calibration curve that must include at least three data points and a blank, an internal 
standard must be used (isotopically labelled internal standards, when available) and a control 
sample with a concentration close to the cut-off limit (defined as the point that differentiates 
between a negative and a positive result) (Alere, 2016a). All of these requirements can be met 
with fingerprint samples. The integration of a fingerprint pattern visualisation step will add on 
to an effective chain of custody and ensure that the sample was obtained from the intended 
person. 
1.2. Drugs of Abuse & Drug Testing 
1.2.1. Cocaine 
According to the National Statistics, powder cocaine is the one of most consumed illicit drug 
in England and Wales by adults aged 16 to 59 (2.3%), and the second most consumed substance 
between young adults aged 16 and 24 (4.8%) (National Statistics, 2015). Cocaine is a stimulant 
extracted from coca leaves found in South America. Figure 1-1 describes the traditional 
procedure for the illicit production of natural free base cocaine using the solvent extraction 
method. This method, depending on how carefully the steps are followed, yields a product that 
contains 30-80% cocaine. Illicitly produced cocaine will inevitably contain impurities resulting 
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from the extraction method and these will includes solvents, processing chemicals and other 
coca-related compounds including the two major metabolites – benzoylecgonine (BZE) and 
ecgonine methyl ester (EME) (Casale J.F., 1993).  
Cocaine works by increasing the amount of dopamine in the brain by blocking dopamine 
receptors, which consequently heightens the senses and produces an effect of happiness and 
mental alertness. Although cocaine has some medicinal use (local anaesthetic) it is classified in 
the UK as a Schedule 2 (Class A) drug as per the Misuse of Drugs Act 1971 (National Institute 
on Drug Abuse, 2016). 
 
Figure 1-1 – Illicit production of natural cocaine using the solvent extraction method (Casale 
J.F., 1993). 
The administration of cocaine is through snorting through the nose, oral ingestion, intravenous 
injection or smoking. The latter requires the powder to be processed into a free base cocaine to 
produce “crack cocaine”, which has a lower melting point (98 °C) than the cocaine salt (192 
°C) (Jatlow, 1988). The lipophilicity of cocaine free base enables the drug to easily filter 
through the fat tissue in the organs, and most importantly the brain, causing strong 
pharmacological effects. Smoking has a good bioavailability (57%) but intravenous 
administration gives a more reliable dose and perfect bioavailability (100%).  Injecting or 
smoking cocaine produces a quicker but shorter high (5-10 minutes) than snorting (15-30 
minutes). Snorting cocaine powder (hydrochloride salt) requires the drug to be absorbed into 
the blood stream through the nasal tissues and results in 80% bioavailability. Finally, oral 
1. Ground coca 
leaves
2. Add inorganic 
base (e.g. lime)
3. Add minimal 
amount of water
4. Place in large 
volume container
5. Add water 
imiscible container 
(e.g. kerosene)
6. Mix and allow to 
stand
7. Remove kerose 
and add dilute 
sulphuric acid to 
the organic layer
8. Mix thoroughly 
9. Collect cocaine 
containing aqueous 
layer
10. Add excess of 
base (e.g. lime) and 
stir
11. Cocaine free 
base precipitates
12. Filter and dry 
the cocain epaste
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administration of cocaine (33% bioavailability) causes a delayed sense of high as it can only be 
detected 30 minutes after the dose due to the difficulty in absorbing cocaine (present in its 
ionised form at the stomach’s pH) through the  fat tissue of the stomach.(Jatlow, 1988, Baselt 
et al., 1990, Joan M. Lakoski, 1991, Cone et al., 1994, Preston et al., 1999, Kidwell et al., 2003, 
Liberty et al., 2004, Kolbrich et al., 2006, Huestis et al., 2007, National Institute on Drug 
Abuse, 2016). 
Metabolism and Pharmacokinetics of Cocaine 
Cocaine metabolism is extremely fast once it is in the body, with a half-life of approximately 
one hour and a clearance rate of 2 litres per minute (Jatlow, 1988). However, the drug 
metabolism, psychotropic effects and elimination profile has been found to vary between 
individuals (30 to 120 minutes difference). The metabolic path of cocaine (Figure 1-2) is 
through the enzymatic hydrolysis to ecgonine methyl ester (EME) and the non-enzymatic 
hydrolysis to benzoylecgonine (BZE). The dose of cocaine administered results in different 
amounts of these metabolites being produced. A cocaine concentration in the blood above 1000 
ng/mL will preferentially produce mostly BZE whilst a dose around 100 ng/mL will produce 
mostly EME. These two metabolites, both biologically inactive, will further hydrolyse to yield 
ecgonine (Joan M. Lakoski, 1991). Co-ingestion of cocaine and alcohol leads to the formation 
of cocaethylene (Handbook of Analytical Separations, 2008). Metabolism of cocaine in the 
liver (hepatic metabolism) is very small and produces norcocaine, the only active metabolite 
(Jatlow, 1988). 
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Figure 1-2 – Major metabolic pathway of cocaine (Kolbrich et al., 2006, Handbook of Analytical 
Separations, 2008). 
Levels of cocaine in blood varies with the form of administration; smoking or intravenous (IV) 
injection result in almost immediate peak plasma levels, hence why the sense of a “high” is 
almost instantaneous too. Snorting leads to absorption of the parent drug into the blood stream 
soon after administration, but plasma peak levels are not seen until at least one hour later. Oral 
administration of cocaine, although rare, is detectable in plasma 30 minutes after ingestion. 
From the administered dose, 85-90% appears in urine, 1-5% belonging cocaine and 75-90% to 
BZE and EME – the two main metabolites. Cocaine is quickly metabolised and excreted in 
urine. Both BZE and EME have much slower elimination rates and half-lives of five and eight 
hours, respectively. These substances can be detected in urine up to 48 hours after ingestion, 
but the detection window will vary with the amount of parent drug taken and the individual 
rates of metabolism. Disadvantageously, the levels of metabolites in urine cannot be related to 
the level of impairment of the user (Cone et al., 1988, Jatlow, 1988, Jones, 1997, Cone et al., 
1998, Huestis et al., 2007). 
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The detection of cocaine in oral fluid after controlled administration (subcutaneous injection), 
showed that cocaine appeared approximately 5-20 minutes after administration and was 
eliminated within 1.1-3.8 hours. BZE and EME were detected 5-60 minutes after dosage and 
had 13.8 and 2.4-15.5 hours half-lives, respectively (Cone et al., 1988, Scheidweiler et al., 
2010).  
Chemistry of Cocaine 
Cocaine is available as a free base or as cocaine salt (crystalline cocaine). The chemical 
properties of the two forms vary slightly, namely in their volatility. Cocaine is a tertiary amine 
with a pKa of 8.6 (weak base) and at a higher pH, the freebase form predominates whilst lower 
pH encourages the formation of the cocaine salt – cocaine hydrochloride. As mentioned 
previously, cocaine metabolises to yield BZE and EME. Figure 1-3 shows the molecular 
structures of the three analytes.  
In mass spectrometry, identification of analytes is achieved through the molecular ion or 
through the characteristic fragmentation pattern. Different mass spectrometry methods will lead 
to the formation of different forms (like the formation of adducts with sodium) of cocaine, BZE 
and EME. However, in the ambit of this report, protonated molecular ions [M+H]+ are most 
commonly found. Further fragmentation of the protonated molecular ion results in the 
formation of characteristic fragment ions (see Figure 1-3). Fragmentation of the molecular ions 
results in the following transitions m/z 304>182, 290>168 and 200>182 for cocaine, BZE and 
EME respectively.  
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Figure 1-3 - Main fragments of cocaine, benzoylecgonine (BZE) and ecgonine methyl ester 
(EME) (Muddiman et al., 1996, Smith, 1997). 
1.2.2. Drug Testing Matrices 
Drug testing can use different types of matrices – blood, urine, oral fluid, sweat and hair. Each 
of the matrices provide with advantages in ease of sample collection, biohazards and detection 
windows. Blood and oral fluid are known to have shorter detection windows than urine and 
hair. Blood is considered to relate most directly to the level of impairment of an individual 
(Karch, 2008).  Urine has the next widest detection window (1-3 days depending on the drug 
and dosage) and is therefore typically tested for metabolites. Sweat analysis can be used to 
detect drug use within a few hours of ingestion (2-8 hours). Hair is often used for long-term 
drug detection and is thought to present with a similar distribution of drugs and respective 
metabolites (ratio of parent drug and metabolites) as sweat. Thus, in summary, the detection 
window of drugs in the different available matrices increases as blood < oral fluid < urine < 
sweat < hair as shown in Figure 1-4.  
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Figure 1-4 – Approximate detection window of drugs of abuse in the different biological 
matrices. Detection windows are highly dependent of the substance and the dosage (Karch, 
2008). 
Current methods for drug detection in human biological matrices use blood, urine or oral fluid 
analysis. Testing is typically carried out in two stages, with a first presumptive screening tested 
followed by a confirmation test to confirm the presence of analytes detected by the screening 
stage. The initial screening test offers a rapid method of distinguishing negative samples from 
the “non-negative” samples (Darwish, 2006). Immunoassays are most commonly used for 
screening tests, and these rely on the binding of antibodies (specific to the target analyte) to an 
antigen (the analyte). The antibody is labelled (using a radioactive or fluorescent tag, for 
example) and different methods of detection (based on the type of label) are used to detect 
relevant analytes in a sample. However, immunoassays require a confirmatory test due to non-
specific binding of the antibodies that can lead to false-positive results (Darwish, 2006). “Non-
negative” samples are taken for further confirmatory testing. Confirmatory tests typically use a 
chromatographic method coupled with mass spectrometry (e.g. liquid chromatography-mass 
spectrometry (LC-MS) or gas chromatography-mass spectrometry (GC-MS)). Confirmatory 
tests are quantitative and will report the concentration of each of the substances detected in 
ng/mL (LGC, 2014, Claritest, 2015).  
Table 1-1 summarises the analytical methods used by commercial providers for the detection 
of cocaine and benzoylecgonine in oral fluid, urine and hair samples.  
-100 -80 -60 -40 -20 0
Blood
Oral Fluid
Urine
Sweat
Hair
Days
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Table 1-1 – Oral fluid screening and quantitative methods used for oral fluid, urine and hair 
analysis at LGC Forensics and Claritest (LGC, 2014, Claritest, 2015). LC-MS/MS = liquid 
chromatography tandem mass spectrometry; GC-MS = gas chromatography mass spectrometry. 
Provider Matrix 
Screening Quantitation 
Method Cut-Off Method Cut-Off 
LGC 
Forensics 
Oral 
Fluid 
Immunoassay 
Cocaine = 30 ng/mL 
BZE = 30 ng/mL 
GC-MS 
Cocaine = 8 ng/mL 
BZE = 8 ng/mL 
Urine Immunoassay BZE = 150 ng/mL GC-MS BZE = 150 ng/mL 
Hair LC-MS/MS Cocaine = 500 pg/mg LC-MS/MS 
Cocaine = 500 pg/mg 
BZE = 50 pg/mg 
Claritest 
Oral 
Fluid 
Immunoassay BZE = 20 ng/mL LC-MS/MS 
Cocaine = 8 ng/mL 
BZE = 8 ng/mL 
Urine Immunoassay BZE = 300 ng/mL LC-MS/MS 
Cocaine = 150 ng/mL 
BZE = 150 ng/mL 
Hair N/A N/A LC-MS/MS 
Cocaine = 0.5 ng/mg 
BZE = 0.5 ng/mg 
 
1.3. Fingerprints 
1.3.1. What is a fingerprint? 
The skin of the fingertips, palms of the hands, soles of the feet and toes is characterized by the 
presence of friction ridges, which are arranged in distinct patterns and can be used for personal 
identification. The excretion of sweat through the pores at the fingertips leads to an 
accumulation of sweat materials on the skin, which will transfer to any surface the skin touches 
with a pattern that mirrors the ridge arrangement (Weyermann et al., 2011, Hazarika et al., 
2012). A more in-depth characterization of a fingerprint may be achieved through chemical 
profiling of fingerprint residues (Asano et al., 2002, Archer et al., 2005, Croxton et al., 2006, 
Mountfort et al., 2007, Ricci et al., 2007, Ifa et al., 2008a, Kante, 2009, Antoine et al., 2010, 
Croxton et al., 2010, Weyermann et al., 2011, Bailey et al., 2012, van Dam et al., 2013, M. de 
Puit et al., 2014). 
1.3.2. Composition of fingerprint residues 
Sweat and sebum have been extensively studied for dermatological research purposes. The 
composition of a fingermark left on a surface will be typically a mixture of endogenous 
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substances excreted from various parts of the body as well as exogenous substances which are 
picked up through contact (Girod et al., 2012, Girod et al., 2014, Cadd et al., 2015).   
Endogenous substances are those secreted by the sweat/sebum glands and there are three main 
secretory glands in the human body – eccrine, apocrine and sebaceous (Freinkel et al., 2001, 
Cadd et al., 2015). Eccrine glands are present all over the body but can be found at the highest 
concentration on the friction ridge skin, such as hands and feet.  The composition of sweat 
excreted through eccrine glands has been shown to vary with level of hydration, state of health, 
exercise and area of the body but it is mostly composed of water (98.5-99.5%) and 
inorganic/organic substances (0.5-1.5%) as shown in Table 1-2. Apocrine glands develop 
during the foetal stage but are not active until puberty. They can be found on the breasts, 
genitals, inguinal and axillary regions. Apocrine sweat has a milky appearance, is mainly 
composed of proteins, lipids and steroids and open into hair follicles, similarly to sebaceous 
glands. Sebaceous glands are present all over the body except for the hands. Sebum has been 
found to be predominantly composed of fatty acids, glycerides, wax esters, squalene, 
cholesterols and hydrocarbons. (Freinkel et al., 2001, Wilke et al., 2007, Hazarika et al., 2012, 
M. de Puit et al., 2014, Cadd et al., 2015, Huynh et al., 2016, Kent, 2016).  
Only eccrine glands are present in the palms of the hands and fingertips. However, fingermarks 
will typically include materials from all three due to contact between the hands/fingertips and 
other parts of the body, for example the face (Croxton et al., 2006).  
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Table 1-2 - Most common constituents found in human sweat and sebum (Cadd et al., Freinkel et 
al., 2001, Archer et al., 2005, Croxton et al., 2006, Weyermann et al., 2011, Girod et al., 2012, 
Hazarika et al., 2012, Cadd et al., 2015, Huynh et al., 2016, Kent, 2016). 
Source Inorganic Constituents Organic Constituents 
Eccrine Glands 
Chloride 
Metal Ions 
Ammonia 
Sulfate 
Phosphate 
Sodium 
Potassium 
Magnesium 
Amino Acids 
Urea 
Lactic Acid 
Creatinine 
Choline 
Uric Acid 
Proteins 
Peptides 
Apocrine Glands  
Proteins 
Lipids 
Steroids 
Sebaceous Glands Iron 
Fatty Acids 
Glycerides 
Hydrocarbons 
Alcohols 
Proteins 
Carbohydrates 
Cholesterol 
Wax Esters 
Squalene 
 
Exogenous substances are those foreign to the body (not naturally excreted) such as compounds 
picked up by contact (Hazarika et al., 2012). Drugs of abuse and respective metabolites are 
known to also known to be excreted through sweat (Cone et al., 1994, Kidwell et al., 1998, 
Huestis et al., 1999, Preston et al., 1999, Samyn et al., 2002, Kidwell et al., 2003, Pichini et 
al., 2003, de la Torre et al., 2004, Liberty et al., 2004, Saito et al., 2004, Chawarski et al., 2007) 
but these substances are not naturally secreted by the body and are therefore have been 
previously classified as semi-exogenous substances (Francese et al., 2013). 
Despite the fact that the chemical composition of fingerprint has been studied by many, there 
is no definitive model of the typical composition of a finger residue. This is due to the large 
degree of variability encountered between fingerprint samples (Weyermann et al., 2011). 
Studies have shown that the composition varies between donors (inter-variability) but also 
within donors (intra-variability) because different materials are excreted at different times. In 
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spite of this, some authors have suggested that fingerprint composition may be useful for donor 
profiling (gender, age, ethnicity) (Croxton et al., 2010, Weyermann et al., 2011, Ferguson et 
al., 2012, Girod et al., 2012, M. de Puit et al., 2014).  The idea of donor profiling through 
fingerprint residues would be a great advancement from a forensic perspective. However, large 
scale studies are required to obtain representative population profiles. Furthermore, gender 
identification, which may rely on amino acid distribution (M. de Puit et al., 2014) and/or levels 
of hormones, may lead to misleading donor profiling, particularly in the case of people 
undergoing gender reassigning procedures or with hormone imbalance conditions. 
The detection of drugs of abuse and metabolites in finger depositions has been reported in the 
literature (Day et al., 2004a, Day et al., 2004b, Leggett et al., 2007a, Hazarika et al., 2008, 
Jacob et al., 2008, Goucher et al., 2009, Szynkowska et al., 2010, Bailey et al., 2015, Bailey et 
al., 2016) using various different analytical techniques (see Section 1.3.3). The advantages of 
fingerprints as a drug testing medium (see Table 1-3) comes from the elimination of the 
biological hazards encountered with blood, the easiness and rapidity of the collection procedure 
and the fact that the identity of the donor is encapsulated in the ridge detail (Kidwell et al., 
1998, Bailey et al., 2015). The amount of sample, and consequently of analyte present in a 
finger deposition, is much smaller than other matrices and there are no known strategies for 
quantification. In parallel, advances in mass spectrometry ionisation sources has led to the 
development of techniques that provide surface mass spectrometry under ambient conditions. 
The techniques allow high throughput analysis of samples and lend themselves well to 
fingerprint samples, which are thin layers (Bailey et al., 2015, Bailey et al., 2016).  
Table 1-3 – Comparison of the different biological matrices available for drug testing (Kidwell et 
al., 1998, Bailey et al., 2015). 
 Fingerprints Blood Urine Oral Fluid 
Bio hazardous 
(threat to human 
health)? 
No Yes Yes No 
Requires trained 
staff? 
No Yes No No 
Privacy concerns? No No Yes No 
Speed of collection A few seconds Minutes Minutes Minutes 
Volume of sample Small (few µL) 5-20 mL >50 mL 1-5 mL 
Traceability 
Potential 
Ridge detail DNA (expensive) DNA (expensive) DNA (expensive) 
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1.3.3. Techniques applied for drug testing using fingerprints 
1.3.3.3. Mass spectrometry methods 
Several mass spectrometry methods have been applied to the detection of semi-exogenous 
substances in fingerprints including chromatography, surface imaging and ambient ionisation 
methods. 
Chromatography 
Liquid chromatography-mass spectrometry (LC-MS) has been applied for the detection of 
methadone, lorazepam (and respective metabolites) and caffeine after administration of the 
substances (Jacob et al., 2008, Goucher et al., 2009, Kuwayama et al., 2013). For the methadone 
study, eight patients on a daily prescription of methadone provided with a single fingerprint 
sample from the index finger. To remove any traces of methadone from contact, the finger was 
wiped with an ethanol wipe and the finger was rubbed over the forehead and face. A methadone 
metabolite, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), was only detected in 
two of the patients that had comparatively high levels of methadone in their fingerprint samples. 
The levels of methadone detected varied even if the donors were prescribed the same dose of 
methadone and this could be the result of different metabolism. Results obtained from different 
fingers of the same donor also showed variability which was thought to be due to the variations 
in size of the fingertip and the amount of sweat excreted (Jacob et al., 2008). Similarly, Goucher 
et al. (2009) reported the detection of lorazepam and lorazepam-3-O-glucuronide in fingerprint 
samples after controlled administration of 2 mg of lorazepam. To avoid the variability seen by 
Jacob et al. (2008), creatinine (a naturally secreted endogenous substance) was used to 
normalise the levels of parent drug in metabolite detected in the fingerprint samples and it was 
found that this helped smooth the elimination profile of the analytes. The two substances could 
only be detected when all 10 fingerprint samples from one donor were combined and the 
measured concentration of the glucuronide always surpassed that of the parent drug (Goucher 
et al., 2009).  
 Surface Mass Spectrometry 
The use of imaging mass spectrometry techniques such as matrix assisted laser desorption 
ionisation (MALDI) enables the generation of images of the sample surface whilst still 
providing molecular speciation. MALDI has been extensively tested for its applicability to 
fingerprint analysis (Wolstenholme et al., 2009, Ferguson et al., 2011, Bailey et al., 2012, 
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Bradshaw et al., 2012, Ferguson et al., 2012, Bradshaw et al., 2013a, Bradshaw et al., 2013b, 
Ferguson et al., 2013, Bradshaw et al., 2014, Deininger et al., 2016) and has also been applied 
to the detection of drugs of abuse in fingerprints. Cocaine was detected in fingerprint samples 
after contact with a solution of the drug (Francese et al., 2013). The method is useful for 
determination of contact residues but represents a different scenario to the detection of drug 
ingestion, metabolism and excretion. Several other controlled substances (including 
amphetamines, cocaine, diamorphine, cannabis and respective metabolites) were detected and 
quantified in fingerprints by spiking solution of the drugs on top the fingerprint and producing 
spiked fingerprints with physiologically relevant levels of the drugs (Groeneveld et al., 2015). 
In a more representative approach, fingerprint samples collected from patients seeking 
treatment at a drug rehabilitation clinic, were analysed with MALDI coupled with ion mobility 
tandem mass spectrometry (IMS-MS/MS) for added selectivity (Bailey et al., 2015). The main 
cocaine metabolite, benzoylecgonine (BZE), was detected in the sample and assignment was 
confirmed through tandem MS measurements that detected the main BZE fragment ion at m/z 
168 (290>168), as well as the ion mobility drift time.  
Time-of-flight secondary ion mass spectrometry (ToF-SIMS), is a very surface sensitive 
technique which enabled the detection of drugs of abuse (amphetamine, methamphetamine and 
ecstasy) after contact and chemical mapping of the fingerprint ridge pattern on several different 
surfaces (steel, aluminium, brass and glass) (Szynkowska et al., 2009, Szynkowska et al., 2010, 
Muramoto et al., 2015). When ToF-SIMS was used to analyse cocaine in fingerprints collected 
from drug users, only the fragment at m/z 82 could be detected due to the high levels of 
fragmentation caused by the technique (Bailey et al., 2015). This prevents the parent drug from 
being distinguished from the metabolite. 
The ToF-SIMS and MALDI instruments described above, typically operate under ultra-high 
vacuum conditions, which reduces their capacity to provide high throughput analysis of large 
batches of samples. Additionally, the instrumentation cost is high, costing upwards of £400,000 
and are not typically used in forensic or drug testing laboratories, meaning the cost of entry for 
new laboratories is high. More recently, ambient ionisation mass spectrometry (AIMS) methods 
have been investigated by several authors for the chemical analysis of fingerprints and the 
detection of drugs of abuse. AIMS offers the advantage of providing analysis under ambient 
conditions (unlike MALDI and ToF-SIMS) and with minimal or no sample preparation (unlike 
LC-MS). Furthermore, because these are mass spectrometry techniques, the sensitivity and 
selectivity are superior compared to spectroscopy methods (Raman and FTIR). 
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Recent work by Bailey et al. (2015) showed that desorption electrospray ionisation (DESI), an 
AIMS technique, was capable of detecting cocaine (in 5 out 5 different donors whose oral fluid 
tested positive for the presence of cocaine), BZE (in 5 out of 5 of those same samples) and 
ecgonine methyl ester (EME) (in 5 out of the 5 fingerprint samples analysed). Peak assignment 
was also confirmed through tandem MS measurements. Analysis of a control sample collected 
from a non-drug user was negative for the presence of the three substances named above, 
showing some selectivity (Bailey et al., 2015). The procedure was touted as a rapid alternative 
to chromatography approaches due to the ability to analyse the sample is less than 2 minutes 
without any sample preparation. Like MALDI, DESI can be used to map analytes in a 
fingerprint, as described by Ifa et al. (2008) Additionally, the DESI technique has been used to 
detect cocaine after exposing the fingers to a cocaine solution (Ifa et al., 2008a). 
Liquid extraction surface analysis mass spectrometry (LESA-MS) enabled the successful 
detection of cocaine, BZE, diamorphine and 6-monoacetyl morphine (6-MAM) in four points 
analysed from one single fingerprint collected from a drug user (Bailey et al., 2016). EME, a 
secondary metabolite of cocaine, was detected in 3 out of the 4 areas analysed. The detection 
of these substances was corroborated by oral fluid analysis, which revealed the presence of 
cocaine and opiates. Peak assignments were confirmed by tandem MS measurements. This data 
will be fully explored later in Section 6.3. 
DESI, which can be used to analyse several small areas in one fingerprint, showed the 
variability encountered with the finger depositions. In Bailey et al. (2015), metabolites of 
cocaine were not consistently detected in all areas/samples analysed which may suggest the 
non-spatial uniformity of the excreted sweat over the area of the fingerprint. This is particularly 
significant for a technique that consumes only a small area of the fingerprint rather than sample. 
The parent drug was systematically detected and since the samples used for cocaine detection 
in fingerprints previously took fingerprints “as presented”, this may be the result of contact 
residues rather than excretion after ingestion. To ensure the fingerprint samples relates as 
closely as possible to ingestion rather than contact, the fingerprint collection procedure should 
be optimised to remove contact residue (hand washing or wiping). The detection of the parent 
drug may not necessarily indicate that illicit activities have taken place, as substances like 
cocaine have been identified in 11% of the UK banknotes (Travis, 2011). Thus, it has been 
proposed that the presence of drug metabolites in fingerprint samples may be a better indication 
that the substances have been consumed and excreted through the sweat pores (Leggett et al., 
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2007b).  There is currently no data on the significance of finding a drug or its metabolite in a 
fingerprint sample.  
1.4. Aim & Objectives 
There is substantial evidence that drugs of abuse and respective metabolites are excreted and 
can therefore be detected in fingerprint residues (Section 1.3.3). However, much of the work 
published in the literature reports the detection of drugs of abuse through contact with the 
substances rather than ingestion. Additionally, no large cohorts of patients have been monitored 
through their fingerprints. 
In this thesis, the detection of drugs and metabolites in fingerprints is further studied using 
ambient ionisation mass spectrometry (AIMS) methods. Although more established techniques 
such as chromatographic-mass spectrometry methods may offer superior selectivity and 
sensitivity, the extensive sample preparation methods reduces the sample throughput and may 
not be well suited to a fingerprint, which is in essence, a surface deposit. AIMS techniques, on 
the other hand, require minimal or no sample preparation. Several AIMS methods are available, 
but it is unknown, which is most suited to the chemical analysis of fingerprint residues.  
In terms of the sample matrix, little is known regarding the feasibility of fingerprint residues as 
a drug-testing medium and the potential to produce quantitative results. The stability of the 
samples and of the illicit drugs in the sample is largely unknown. Cocaine is known to be a 
common contaminant on bank notes and it is not known if it is transferred onto the fingertips. 
No data has yet been published on whether this transfer can produce detectable quantities of 
cocaine in a fingerprint or on the possibility of cocaine metabolising on the fingertip and 
producing metabolites. Thus, the significance of the detection of these substances in fingerprint 
residues is unknown and yet to be explored. Consequently, the collection procedures that are 
implemented for fingerprint testing should eliminate the presence of contact residues whilst 
also stimulating the secretion of parent drug and metabolites. Once again, no reports in the 
literature have explored these two parameters. 
One other particular advantage of fingerprint samples over other matrices is the fingerprint 
ridge pattern, which can be used for donor identification without the need for deoxyribonucleic 
acid (DNA) extraction. The coupling of chemical analysis with fingerprint visualisation 
methods helps build a chain of custody and reduce the possibility of cheating the drug test. 
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The aim of this work is to develop a confirmatory test for the detection and quantification of 
drugs of abuse and their metabolites in latent fingerprints based on AIMS methods, using 
cocaine as a starting point. To achieve the aim of this project, the following objectives have 
been set: 
(1) Evaluate the applicability of ambient ionisation mass spectrometry for the detection of 
cocaine in natural fingerprints. 
(2) Select a method from (1) and develop a procedure for the application of this method to 
latent fingerprints. 
(3) Investigate the fingerprint sample collection procedure. 
(4) Evaluate the quantitative capacity of the technique compared with oral fluid testing 
(5) Investigate the significance of drug detection within a fingerprint and the validity of 
fingerprints as drug testing media.  
(6) Integrate the developed method in (2) with a fingerprint visualisation procedure. 
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2. Experimental Techniques 
2.1. Introduction 
In this chapter, ambient ionisation techniques and the different types of mass spectrometers 
explored in this thesis are briefly introduced (Sections 2.2 and 2.3, respectively). Two types of 
mass spectrometers have been explored – quadrupole time-of-flight (QToF) and Orbitrap. 
These mass spectrometers (MS) were used in combination with different ambient ionisation 
techniques such as desorption electrospray ionisation (DESI), liquid extraction surface analysis 
(LESA) and paper spray.  
2.2. Ambient Ionisation Techniques 
For a compound to be detected by a mass spectrometer, it is necessary for the molecule to be in 
its ionised form (Hoffmann et al., 2007). Thus, several pre-detection methods (ionisation 
sources) are used to ensure that the analytes are suitable for mass spectrometry (MS) detection. 
Well-known examples of ionisation sources are electrospray ionisation (ESI), atmospheric 
pressure chemical ionisation (APCI), chemical ionisation (CI) and electron ionisation (EI). The 
first two – ESI and APCI – are commonly used to couple liquid chromatography (LC) with 
mass spectrometry (LC-MS). These two ionisation methods offer the possibility of ionisation 
under ambient conditions and aid the transition from ambient (in the chromatography step) to 
vacuum (the mass spectrometer). The latter two – CI and EI – are most commonly found with 
gas chromatography instruments (GC-MS) and work under vacuum conditions (Hoffmann et 
al., 2007, G. Kaklamanos et al., 2016). New trends in the field have led to the development of 
ambient ionisation mass spectrometry (AIMS) techniques that enable the removal and 
ionisation of the analytes under ambient conditions with minimal sample preparation before 
detection under vacuum (see Section 2.2) (Ambient Ionization Mass Spectrometry, 2014).  
The necessity for new and improved methods of analysis comes from the demand for analytical 
laboratories to have high sample throughput systems, automated instrumentation (reducing the 
workload) and cost effective procedures. AIMS techniques have met some of these needs by 
offering the possibility of qualitative and quantitative analysis of samples previously not 
agreeable with conventional mass spectrometry methods, direct analysis of samples in-situ and 
minimal sample preparation (Ambient Ionization Mass Spectrometry, 2014).  
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There is some disagreement in what makes an ionisation technique ambient. However, 
according to a recent publication (Ambient Ionization Mass Spectrometry, 2014), AIMS 
techniques must possess the following four characteristics: 
• Ionisation under open air (allows for samples or varying shapes and sizes to be analysed) 
• Direct surface analysis (minimal sample preparation) 
• No modification of the mass spectrometer ion optics of vacuum system (unless with the 
intent of protecting the vacuum system from gas overload) 
• Soft-ionisation (minimal fragmentation) 
There are a large number of ionisation techniques reported in the literature but for the scope of 
this report, only three have been explored for their applicability to fingerprint analysis. 
Desorption electrospray ionisation (DESI) and liquid extraction surface analysis (LESA) have 
been explored due to their surface nature, high throughput, their ability to preserve much of the 
fingerprint ridge detail and their commercial availability (described in Sections 2.2.1 and 2.2.2). 
Paper spray mass spectrometry described in detail in Section 2.2.3, has recently emerged as a 
high throughput method for testing drugs in blood and is therefore considered for fingerprint 
drug testing. Although paper spray enables analysis under ambient conditions, it is not a surface 
analysis technique such as the other two. As a result, it has been characterised as a direct 
ionisation (DI) technique (Ambient Ionization Mass Spectrometry, 2014). 
2.2.1. Desorption electrospray ionisation mass spectrometry (DESI-MS) 
Desorption electrospray ionisation (DESI) was first reported in 2004 (Takáts et al., 2004) and 
has been described an extension to electrospray ionisation (ESI) by allowing analysis of 
samples in the solid state. DESI uses charged droplets to perform sample extraction (desorption) 
and ionisation simultaneously (Ambient Ionization Mass Spectrometry, 2014). DESI sources 
are commercially available (Prosolia, 2015) and all analyses described later in this report 
(Chapter 6) used a DESI 2D Source (Prosolia, Indiana, US) that comprises of a 2 dimensional 
sampling stage, video monitoring of the analysis and a light-emitting diode (LED) light source 
(Prosolia, 2015). The two-dimensional sampling stage is software controlled and allows for 
imaging of the surface of a sample, consequently enabling spatially resolved information to be 
obtained (Ambient Ionization Mass Spectrometry, 2014). 
A schematic representation of a typical DESI experiment is shown in Figure 2-1. The 
electrospray is composed of a solvent with a flow rate of 0.5-5 µL/min, a nebulising gas 
(typically nitrogen) and a direct current potential between 2-5kV. The charged droplets formed 
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by the DESI head impact the surface, creating secondary droplets that contain the analytes and 
are electrically charged. The electrical charge leads to a Coulomb explosion that leads to the 
creation of smaller droplets, which are desolvated before entering the mass spectrometer 
capillary (Takáts et al., 2004, Takáts et al., 2005, Badu-Tawiah et al., 2013, Ambient Ionization 
Mass Spectrometry, 2014).  
 
Figure 2-1 – Schematic of a DESI experiment. Sample desorption and ionisation is accomplished 
under ambient conditions using an electrospray aimed at the sample at an angle. Ions formed 
are then extracted onto the mass spectrometer through a capillary inlet (Takáts et al., 2004). 
DESI parameters such as angle of spray emitter, angle of collection, distance to the sample, 
applied capillary voltage, spray composition and flow rate can be optimised to specific analytes 
to give the best sensitivity and reproducibility. The efficiency of the technique relies heavily on 
the ability of the spray solvent to solubilise the sample molecules. Reports in the literature have 
looked at the effect on desorption and spatial resolution of using different solvents and additives 
for DESI measurements. Green et al. (2010) studied the effects of substrate wettability, 
solubility and solvent composition on the erosion diameter (spot size of the electrospray) and 
DESI efficiency (intensity of the protonated molecular ion per unit of erosion area). The authors 
noted that the higher the fraction of organic solvent (methanol and acetonitrile for example) the 
smaller the erosion area due to the smaller electrospray droplets formed. The DESI efficiency, 
E, is directly related to the solubility of the analyte in the spray (Green et al., 2010). The addition 
of formic acid (FA) to the electrospray is known to promote protonation of the ionic species in 
the positive ion mode (Zhou et al., 2000, García-Reyes et al., 2008) and is commonly added to 
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the DESI spray at concentrations of 0.1%. In another report by Green et al. (2009), the study of 
the effect of the solvent flow rates suggested that higher flow rates (>2.0 μL/min) generate 
higher molecular ion intensities although this results in a loss of spatial resolution due to the 
larger erosion area (Green et al., 2009).  
One of the limitations of AIMS techniques such as DESI is the unavoidable presence of 
contaminants picked up from the surrounding atmosphere, solvents and from the sample 
substrate. The use of high resolution mass spectrometry and tandem MS measurements can help 
to separate samples analyse from the background. However, because no sample preparation 
steps are carried out to “clean the sample”, matrix effects can affect the ionisation (ionisation 
suppression/enhancement) and this limits the quantitative power of the technique (Ambient 
Ionization Mass Spectrometry, 2014).  
DESI has found numerous of applications from small (Ifa et al., 2008b) to large molecules 
(Douglass et al., 2013) , from homeland security (Cotte-Rodríguez et al., 2005) to forensics 
applications (Morelato et al., 2013, Ambient Ionization Mass Spectrometry, 2014). In this 
thesis, the applicability of DESI to the analysis of drugs and metabolites in fingerprints and its 
quantitative potential is explored (Section 6.2). 
2.2.2. Liquid extracted surface assisted mass spectrometry (LESA-MS) 
The first report on liquid extraction surface analysis (LESA) dates back to 2009 (Kertesz et al., 
2010) under the name of liquid microjunction surface sampling probe (LMJ-SSP). The original 
instrumentation used an Advion NanomateTM chip-based infusion nanoelectrospray ionisation 
system for sample introduction to the mass spectrometer. At present, LESA is commercially 
available from Advion and is sold as the TriVersa-NanomateTM (Advion, 2014). Figure 2-2 
shows a schematic representation of a typical LESA experiment. 
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Figure 2-2 – Schematic representation of a LESA experiment. (a) tip is picked by the robot and 
(b) extraction solvent is withdrawn from the contained; (c)-(d) tip is brought to a pre-selected 
area of the sample to (e) dispense the liquid, forming a microjunction, (f) before re-aspirating 
the liquid and (g) engaging with a nanoelectrospray chip for sample ionisation (Walworth et al., 
2011). 
The commercially available LESA system includes a robot that is responsible for picking up 
conductive sampling tips (one at a time), fill them with a pre-selected amount of solvent (1-2 
µL), move the loaded tip to a pre-determined position (with a 50 µm precision) above the 
sample, lower the tip close enough to the surface and dispense the solvent. A liquid 
microjunction (LMJ) is kept between the sampling tip and the sample, where the sample 
extraction takes places. Successively, the extracted sample is carried to a nanoelectrospray (n-
ESI) chip for ionisation. The sampling tip engages with a single nanospray emitter in the chip 
(out of a possible 400 single use emitter nozzles) and a voltage is applied, causing the generation 
of ions, which are pulled into the mass spectrometer for analysis. The volume of solvent 
dispensed, time spent sampling, volume of sample aspirated and number of dispense/aspirate 
cycles are optimisable and influence the efficiency of extraction and consequently the 
sensitivity of the method (Kertesz et al., 2010, Ellis et al., 2013, Ambient Ionization Mass 
Spectrometry, 2014).  
The sensitivity of the LESA comes from the ability to dissolve the sample in such a small 
volume of solvent (1-2 µL). Much like DESI, the solvent composition can be optimised to yield 
the best sample extraction achievable, whilst still being compatible with the nanoelectrospray 
and enabling the production of stable and long sprays for the required mass spectrometry 
measurements. The choice of solvent will influence the spot size of the measurements (currently 
limited to 400 µm). Despite the low volumes of sample available, nanoelectrosprays can last 
for as long as 4-5 minutes which provides with enough time to carry out different MS scans 
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(full scan and multiple MS/MS measurements) in positive and negative polarities (Ellis et al., 
2013, Ambient Ionization Mass Spectrometry, 2014).   
LESA-MS has been widely applied for tissue imaging and drug mapping in tissue sections 
(Eikel et al., 2011) and more recently, the LESA extract was injected into a nano-liquid 
chromatography (LC) column (Almeida, 2011). This increases both the sensitivity and 
selectivity of the method by concentrating the analyte and removing matrix effects from the 
sample. However, the addition of the chromatography step adds to the analysis time, drastically 
reducing the throughput of samples (Ambient Ionization Mass Spectrometry, 2014).  
In this report, LESA is explored for its ability for drug detection in urine, oral fluid and 
fingerprint samples collected from individuals seeking treatment at a drug rehabilitation centre 
(Section 6.3) (Bailey et al., 2016). 
2.2.3. Paper Spray Mass Spectrometry (PS-MS) 
Paper spray was first mentioned in the literature in 2010 (Liu et al., 2010) and is a very 
simplistic method for ambient analysis using a pre-cut piece of paper to load the sample, extract 
and ionise (Ambient Ionization Mass Spectrometry, 2014). The fundamental principles of 
operation (see Figure 2-3) relies on the application of a voltage to a pre-loaded (with sample) 
and pre-wetted (with a spray solvent) triangular piece of paper (with areas averaging 0.5 cm2). 
The voltage creates an electric field at the tip of the paper, resulting in the formation of charged 
droplets through a Taylor cone. The formed droplets, containing the ions, travel through air 
suffering desolvation before entering the mass spectrometer for analysis. The ionisation 
mechanism of paper spray has been found to be similar to that of nano-ESI and has therefore 
been characterised as a soft ionisation technique (ionisation of the molecules leads to minimal 
fragmentation of the parent ions). 
Paper spray involves high voltages (>2 kV), and a macroscopically sharp tip is required for 
effective sample transportation through the paper or due the necessity of a high electric field at 
the tip of the paper for ionisation to occur (Liu et al., 2010, Wang et al., 2010, Espy et al., 2012, 
Shen et al., 2013). The angle at the tip of the paper is required to be between 45-90° degrees, 
with the highest ion currents being measured at 90° degrees. Studies on the shape of the paper 
have been carried out by Espy (2014) and it was shown that there is a moderate backwards flow 
(towards the base of the triangle) that can be attenuated by cutting off the sharp edges to form 
a tear drop shaped piece of paper. This leads to a higher ion current and consequently higher 
sensitivity.  
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Figure 2-3 – Schematic representation of the paper spray experimental set up. The sample is 
loaded onto a triangular piece of paper and the spray solvent (solution) is added to the paper 
before applying a high voltage (kV). The electric field leads to the creation of the ions that travel 
towards the mass spectrometer inlet (Liu et al., 2010).  
Whatman grade 1 chromatography paper (thickness 0.18 mm, flow rate 130 mm/30 minutes) is 
the most commonly used substrate for paper spray analysis. However, the choice of substrate 
is highly dependent on the type of sample being analysed and for more viscous samples, such 
as blood, high porosity substrates (Whatman Grade 31ET chromatography paper (thickness 
0.508 mm, flow rate 225 mm/30 minutes)) are required to prevent blockage. Functionalised 
cellulose paper (ion exchange papers and Whatman DMPK paper) have been tested as paper 
spray substrates but these resulted in high background signals. Treatment of paper with 0.1% 
hydrochloric acid (HCl) and methanol/water rinse, was shown to remove any unwanted 
background (Espy, 2014).  
Paper spray has been used qualitative and quantitatively in many applications areas from the 
detection of drugs in blood (Manicke et al., 2011, Su et al., 2013, Espy et al., 2014), to reaction 
monitoring (Yan et al., 2013, Himmelsbach et al., 2014, Bag et al., 2015) and food analysis 
(Zhang et al., 2012, Deng et al., 2013, Li et al., 2013, Taverna et al., 2013, Evard et al., 2015). 
The use of paper spray for the detection of drugs of abuse in dried blood spots led to the 
manufacture of a commercial instrument by Prosolia, called Velox 360 (Prosolia, 2016). Blood 
samples are collected and analysed in a pre-assembled cartridge, containing a sample zone 
(where a few microliters of blood sample is introduced) and solvent zone (where the spray 
solvent is introduced). Loaded cartridges are placed in a carousel auto-sampler where an 
infrared (IR) tag reader is used for sample tracking. Solvent is added to the sample and through 
the solvent zone window to encourage analyte elution from the matrix. A high voltage is applied 
to the paper through a ball bearing pre-installed in the cartridge and the acquisition is started. 
Using this method, eight drugs of abuse (amphetamine, methamphetamine, 
methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-methamphetamine (MDMA), 3,4-
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methylenedioxy-N-ethylamphetamine (MDEA), tetrahydrocannabinol (THC), morphine and 
cocaine) have been quantified in dried whole blood spots with relative standard deviations 
(RSD) between 1-5% and limits of detection below physiological levels and between 0.03-12 
ng/mL (Espy et al., 2014). 
The work by Espy et al. (2014) showed the quantitative potential of paper spray for drugs of 
abuse testing in complex matrices. The cartridges that have been commercialised for paper 
spray mass spectrometry are not amenable to fingerprint analysis due to the size of the paper, 8 
mm2, which is too small to collect an entire fingerprint. However, it is possible that the paper 
spray, with alterations to the paper shape and size, may be relevant for the detection and 
quantification of drugs of abuse in latent fingerprints and this is explored in Chapter 4. 
2.3. Mass Spectrometry 
Mass spectrometry is a well-established analytical technique that enables the measurement of 
the mass-to-charge (m/z) ratio of single molecules or atoms in their ionised state (both positive 
and negative). Figure 2-4 shows an example of a mass spectrum obtained with paper spray on 
a QToF mass spectrometer. Depending on the type of mass spectrometer (MS) and ionisation 
source, fragmentation of the analytes can take place, which can provide more in-depth 
knowledge of the structure of compounds (especially important if the compound is unknown) 
and/or confirm the assignment based on the characteristic fragmentation pattern of the molecule 
through tandem mass spectrometry (MS/MS). During MS/MS measurements, the parent ion is 
fragmented in a controlled manner, leading to the formation of characteristic fragmentation 
peaks (Hoffmann et al., 2007).  
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Figure 2-4 – Example of a mass spectrum obtained for a quality control sample using paper 
spray with a QToF mass spectrometer. 
Time-of-flight (ToF), quadrupoles, ion traps and Fourier transform ion cyclotron resonance 
(FTICR) are examples of mass analysers that separate the ions before detection and after the 
ionisation step. Some mass spectrometers are hybrids of some of the mass analysers listed above 
such as triple quadrupoles (QQQ), quadrupole time-of-flight (QToF) and quadrupole ion traps 
(QIT) (G. Kaklamanos et al., 2016). Each type of mass analyser offer different benefits in terms 
of limits of detection (LOD, the lowest concentration that can be detected and that yields an 
instrument response meaningfully higher than the background) (Miller et al., 2005), mass 
resolution (ability to differentiate between ions with similar m/z) and mass range 
(Chernushevich et al., 2001). QToF and Orbitrap (a type of ion trap) mass spectrometers were 
used throughout the research described in this report and are described in Section 2.3.1. Table 
2-1 shows the main characteristics of five different types of mass analysers.  
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Table 2-1 – Characteristic of different types of mass analysers (Hoffmann et al., 2007) 
 Quadrupole Ion Trap 
Time-of-
Flight 
Orbitrap FT-ICR 
m/z range >3,000 >20,000 
Virtually no 
limit 
>6,000 (unless 
extended mass 
range) 
>30,000 
Mass Accuracy >100 ppm <30 ppm 5-100 ppm <1-2 ppm <0.6 ppm 
Mass 
Resolution 
(FWHM) 
<3,000 <5,000 5,000-40,000 >100,000 2.5 x 106 
Quantification Good Poor Medium Medium Medium 
 
The relative mass accuracy (W), calculated as per Equation 2-1, is defined as the difference 
between the measured peak mass and the theoretical calculated monoisotopic mass over the 
theoretical monoisotopic mass (times one million, for W in ppm).  
𝑊 (𝑝𝑝𝑚) =  
𝑚𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 − 𝑚𝑡ℎ𝑒𝑜𝑟𝑒𝑡𝑖𝑐𝑎𝑙
𝑚𝑡ℎ𝑒𝑜𝑟𝑒𝑡𝑖𝑐𝑎𝑙
∙  106 
Equation 2-1 –Relative mass accuracy (W) calculation in parts per million (ppm); mmeasured is the 
measured peak mass and mtheoretical the calculated theoretical monoisotopic mass (Green et al., 
2006). 
The mass resolution, calculated as per Equation 2-2, where 𝑚  is the mass of the peak of interest 
and ∆𝑚 is the full peak width at half maximum (FWHM) describes the ability of the instrument 
to resolve peaks with the same nominal mass (Chernushevich et al., 2001). 
𝑅𝐹𝑊𝐻𝑀 =  
𝑚
∆𝑚
 
Equation 2-2 – Calculation of the mass resolution of a QToF instrument; m is the mass of the 
peak of interest, Δm is the full peak width at half maximum (FWHM). 
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2.3.1. Detectors 
Quadrupole time-of-flight (QToF) 
Quadrupole time-of-flight mass spectrometers are known for their high sensitivity, mass 
resolution and accuracy. Although the quantitation potential is reduced in comparison other 
types of mass analysers such as QQQ due to the short linear dynamic range, QToF offers a 
better signal-to-noise (S/N) ratio and therefore greater sensitivity in full scan mode 
(Chernushevich et al., 2001).  
The QToF available at the University of Surrey is a Micromass QToF 2 mass spectrometer 
(Waters, Hertfordsire). The mass resolution of these instruments is typically around 10 000 and 
it can be calculated using Equation 2-2. The configuration of the instrument is shown in Figure 
2-5. The inlet to the MS, when used with an ESI source (probe), creates a “z-spray” where the 
ions produced in the electrospray are fired perpendicularly to the outer cone (z-spray ion 
source). The ESI source requires the sample to be introduced in solution (preferably in a polar 
solvent) which is infused, under ambient conditions, into the ionisation source through a thin 
capillary. A high voltage (3-5 kV) is applied to the capillary, resulting in nebulisation 
(formation of charged droplets) of the solution being infused. These droplets are desolvated 
with the aid of nitrogen gas, resulting in the formation of ions in the gas phase. Ions are pulled 
into the MS through a cone inlet. Inlet parameters such as cone voltage (voltage applied to the 
sampling cone) and extraction voltage (voltage applied to the extraction lens) are typically 
optimised for specific analytes to ensure optimal ion recovery from the ionisation source. 
Extracted ions are then injected into the first set of radio frequency (RF) lens. The function of 
the RF lens is to offer collisional cooling and focussing that reduces the energy and spread of 
the incoming ions. This results in better transmission into the quadrupole. In full scan 
measurements, there is only an RF voltage applied to the quadrupole, which enlarges the 
transmission window meaning that many ions are allowed to pass through (band pass filter). To 
ensure maximum transmission, an MS profile can be set to scan from the lowest mass of interest 
to the highest mass of interest. In tandem MS (MS/MS) measurements, both a direct current 
(DC) and RF voltages are applied to the quadrupole and only the pre-selected masses (parent 
ions) are allowed to pass on to the collision cell.  
In the collision cell (or hexapole) controlled fragmentation takes place through collision-
induced dissociation (CID) with a neutral gas (argon). The collision energy set in the MS tune 
page determines the energy of the ions entering the collision cell and in full scan experiments 
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it is typically set to 10 eV to produce little fragmentation. The collision cell is only used for 
MS/MS measurements, although manufacturers often advise the collision gas to be on during 
full scan measurements to cool down the ions and ultimately increase the peak resolution.  
Before entering the flight tube, ions are accelerated (20-200 eV) and focussed by passing 
through a series of ion optics (hexapole transfer lens). Ions are then injected into the pusher unit 
that accelerates the ions down the flight tube. The time-of-flight (ToF) tube is a field free drift 
space and this is where ions separate based on their mass, lighter ions are faster and therefore 
travel quicker down the tube. The QToF 2 instrument has an orthogonal ToF and at the bottom 
of the flight tube, a reflectron reflects the ions back up the flight tube for detection. The 
reflectron acts like a mirror and provides compensation for the initial energy and spreading of 
the ion beam.  
The multi-channel plate (MCP) detects the incoming ions, creating a pulse of electrons which 
is amplified and triggers a timing pulse that is sent to the time-to-digital converter (TDC). The 
TDC registers the arrival time (from start of ToF pulse in the pusher unit) of the ions and 
converts the data into m/z spectra. Regardless of the mode of operation (full scan or MS/MS), 
ions are always recorded in the ToF analyser which maintains the mass resolution, accuracy 
and calibration. In MS/MS experiments, the ion counts are several orders of magnitude lower 
than in full scan but this is balanced out by the selectivity of the MS/MS experiments, which 
produce virtually no background (1-3 counts/s). As a result, fragment peaks that would easily 
be lost to noise using a QQQ can be confidently identified with a QToF (Micromass, 2000, 
Chernushevich et al., 2001, El-Aneed et al., 2009). 
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Figure 2-5 – Schematic representation of the Micromass Q-ToF 2 mass spectrometer available at 
the University of Surrey (Micromass, 2000). 
Orbitrap 
Drug testing requires high sensitivity and selectivity whilst also demanding precise and accurate 
quantitative results. This need can be met with the development of faster, more efficient and 
robust mass spectrometers. Linear ion trap Fourier transform ion cyclotron (LIT/FTICR) mass 
spectrometers provide the best known selectivity due to the high mass resolution (Perry et al., 
2008). However, the size, complexity and cost, this type of MS restricts the type of laboratory 
where it can be set-up. The LTQ-Orbitrap (linear trap quadrupole) was developed as an 
instrument of comparable performance to the LIT/FTICR but more compact, less costly and 
easier to run and maintain. Orbitrap MS are known for their high mass resolution (>100,000) 
and excellent mass accuracy (~2-5 ppm) (Perry et al., 2008), and are therefore becoming widely 
adapted for ambient analysis where it is necessary to separate ambient and analyte signals.  
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Analysis carried out in this work at the National Physical Laboratory (NPL) used an LTQ 
Orbitrap Velos™ mass spectrometer. Figure 2-6 shows a schematic of the instrument. Similarly 
to the QToF, Orbitrap instruments can be coupled with a wide variety of ionisation techniques 
like ESI, for example. The ions generated by the source are extracted onto the MS and passed 
through a series of lenses (S-, “square quadrupole” and octopole lenses) for ion beam focussing 
and cooling purposes. The ions are then injected into the mass analyser, which contains two 
linear ion traps (LIT) in series – one high pressure cell (high pressure of gas for collision cooling 
and ion packet focussing) and one low pressure cell (where the ions are ejected into the 
detector). Each LIT consists of square arrangement of hyperbolic rods which have three sections 
and a slot each. The LTQ Orbitrap Velos can be used in “ion trap” or “Orbitrap” mode, although 
the latter offers higher sensitivity and mass resolution.  
In “ion trap” mode, ions are selectively ejected out of the low-pressure cell and into the detector 
by an increase in the RF voltage applied to the low pressure cell. Lighter ions require less 
voltage and therefore are the first to be ejected. The ion detection system for the linear ion trap 
uses a conversion dynode – a concave metal surface that is placed at a right angle to the ion 
beam direction – and an electron multiplier. The conversion dynode stands at a polarity that is 
opposite of that of the ions being detected. Sequentially, impact of ions with the dynode produce 
multiple secondary particles. The secondary particles are focussed (because of the concavity of 
the dynode) and accelerated into the electron multiplier for detection.  
 In Orbitrap mode, ions are transferred from the linear trap through an RF-only octopole 
(vacuum atmosphere), into a curved linear trap (C-trap), which can store, select, and excite ions 
(using a collision gas) before injection of these ions into the Orbitrap mass analyser. Voltages 
are applied at either end of the C-trap to prevent the ions from leaving the trap. Once these 
voltages are switched off and extraction voltages are applied to the electrodes, ions are pushed 
out of the C-trap and injected into the Orbitrap (in a position that is offset from the middle point 
of the Orbitrap cell). The Orbitrap cell contains a spindle-like electrode encased in barrel-like 
electrodes. A voltage is applied to the electrodes, creating an electric field that captures the ions. 
Ions are injected from the C-trap as small ion packets and start oscillating around the spindle 
without the necessity for more excitation. This results in stable ion trajectories (along with 
harmonic oscillations) around the spindle, where the frequency of these oscillations are 
dependent on the m/z of the ions. The two split halves of the outer electrode detect the image 
current produced by the oscillating ions. Fast Fourier Transformation (FTT) is used on the 
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amplified image current to obtain the frequencies of the oscillation and consequently the m/z of 
the ions.  
Fragmentation of the trapped ions happens using high energy collisional dissociation (HCD) 
where ions are accelerated (collision energy) from the C-trap into the HCD collision cell for 
collision induced dissociation. Fragmented ions are passed back to the C-trap ready for injection 
into the Orbitrap for mass analysis and detection (Perry et al., 2008, Thermo Scientific, 2009a, 
Thermo Scientific, 2009b). 
 
Figure 2-6 - Schematic representation of the LTQ Orbitrap Velos™ mass spectrometer available 
at the National Physical Laboratory (Thermo Scientific, 2009a). 
2.4. Summary 
Mass spectrometry is a well-established analytical technique that offers superior sensitivity, 
selectivity and versatility, with a large number of ionisation sources available, compared with 
spectroscopy, for example. Ambient ionisation mass spectrometry (AIMS) techniques have 
found a wide variety of applications and have complementary features. DESI, LESA and paper 
spray are described above and offer key advantages such as high sample throughput and 
minimal sample preparation. On the other hand, these techniques lack a chromatography step 
to separate analytes from the matrix. Thus, a high-resolution mass spectrometer is required for 
selective detection of the analytes, in addition to tandem MS measurements for confirmation 
through the characteristic fragmentation pattern. Two types of mass spectrometers – QToF and 
Orbitrap – have been used for the work later described in this thesis and are briefly described 
in this chapter.  
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3. Method Development 
3.1. Introduction 
This chapter describes the steps taken to optimise the paper spray procedure in order to increase 
the sensitivity of the method towards cocaine, benzoylecgonine (BZE) and ecgonine methyl 
ester (EME) in fingerprints.  
Drug standards (cocaine, BZE, EME, cocaine-D3, benzoylecgonine-D3 (BZE-D3) and ecgonine 
methyl ester-D3 (EME-D3)) were prepared from certified reference materials (Cerilliant, Sigma, 
Dorset). LC-MS grade solvents (methanol (MeOH), acetonitrile (ACN) and water (H2O)) were 
used to prepare all solutions and solvent mixtures (Fischer, Leicestershire). Formic acid 
(Fischer, Leicestershire) was added to every spray solvent at 0.1% v/v. Reagent grade 
dichloromethane (DCM, Fischer, Leicestershire) was also used as spray solvent Paper washing 
solution consisted of 0.1% (v/v) hydrochloric acid (HCl) was prepared from a 27% (v/v) HCl 
solution (Fischer, Leicestershire). Paper washing procedure included the immersion of the 
paper in 0.1% hydrochloric acid followed by 50:50 MeOH:H2O and allowing the paper to dry 
before being used for analysis as suggested in the literature (Espy, 2014). Artificial sweat was 
purchased from Pickering Labs (Mountain View, CA, US). Whatman Grade I chromatography 
paper was used as a substrate for the analysis. The paper spray source was built at the University 
of Surrey and was coupled with a Waters Micromass QToF 2 mass spectrometer (Waters, 
Hertfordsire).  
Fingerprint and oral fluid samples were collected from individuals seeking treatment at a drug 
rehabilitation centre. This study received a favourable opinion from the National Research 
Ethics Service (NRES) (REC reference: 14/LO/0346). Oral fluid samples were collected using 
a QuantisalTM collection device and sent to LGC Forensics or Claritest for drug 
screening/confirmatory testing.  
3.2. Early work with paper spray  
Paper spray (PS) found its application in dried blood spot analysis (Manicke et al., 2011, Espy 
et al., 2014). Paper spray is commercially available (Prosolia, 2016) as the Velox 360. However, 
it has been specifically commercialised for the rapid analysis of blood spots. Consequently, the 
cartridges provided are small and cannot be used for fingerprint analysis. Thus, a paper spray 
source was built in-house and adapted to enable the analysis of fingerprint samples.   
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A paper spray source was designed and built at the University of Surrey by Dr Vladimir Palitsin 
(Ion Beam Centre, University of Surrey). The initial paper spray set-up, as shown in Figure 3-8, 
used a capillary (with a 35° bend) as a mass spectrometer inlet and the tip of the paper was 
aligned by eye with the end of the capillary. The paper was cut into a triangular shape (1.5cm 
height x 2.4cm base) with a macroscopically sharp tip and placed on top of a cut glass slide and 
below a strip of aluminium foil to avoid carry over effects and contamination of the source. No 
carry over effects were observed for cocaine, BZE or EME in the range between 50-1000 ng/mL 
regardless of the paper spray method employed. The geometric positioning of the paper in 
relation to the inlet was optimised by pipetting 40µL of 100% ACN (with 0.1% formic acid) 
onto washed paper (Whatman grade 1 chromatographic paper) and applying a 3.5 kV voltage. 
Table 3-1 shows the experimental parameters followed during the initial optimisation work with 
paper spray. A Waters Micromass 2 (Waters, Hertfordsire, UK) quadrupole time of flight 
(QToF) mass spectrometer was used in full scan mode in the 50-500 m/z range. 
Table 3-1 – Experimental parameters for the optimisation of paper spray coupled to a QToF mass 
spectrometer for the detection of cocaine, benzoylecgonine (BZE) and ecgonine methyl ester 
(EME). 
Experimental Parameters 
Mass Spectrometer Waters QToF 2 
Analyser Quadrupole-Time of Flight 
Cone Voltage (V) 36 
Multi-Channel Plate Voltage (V) 2200 
Voltage Applied (kV) Experiment dependant 
Capillary Temperature (oC) 150 
Source Temperature (oC) 150 
Solvent Experiment dependant 
Acquisition Time (min) 2 (unless otherwise stated) 
Computer Software Micromass MassLynx 4.0 
Ion Mode Positive Ion Mode 
 
The total ion chromatogram (TIC) was used to determine the optimum geometry. No analytes 
were considered individually as a flat total ion chromatogram was the desired outcome. The 
paper spray stage was moved in the x,y,z directions and the optimum distances were found to 
be 3 mm on the x-axis (horizontal distance between the end of the capillary and the tip of the 
paper) and 1 mm on the z-axis (vertical distance between the end of the capillary and the tip of 
the paper). The y-axis was positioned so that the tip of the paper was always aligned with the 
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capillary inlet. Distances were measured using a 15c m ruler and therefore there is an associated 
uncertainty with the measurements, approximated at ± 0.5 mm. 
Using the configuration described above, source parameters such as solvent spray composition 
and addition of internal standard were optimised to increase the sensitivity to cocaine, 
benzoylecgonine (BZE) and ecgonine methyl ester (EME). Table 3-2 shows the compositions 
of spray solvents tested. 
Table 3-2 – Composition of the different spray solvents tested with paper spray for the analysis of 
cocaine, benzoylecgonine (BZE) and ecgonine methyl ester (EME) 
Solvent Composition 
1 80% methanol (MeOH)/20% dichloromethane (DCM)/0.1% formic acid (FA) 
2 35% acetonitrile (ACN)/35% methanol (MeOH)/30% water (H2O)/0.1% formic acid (FA) 
3 100% ethanol (EtOH)/0.1% formic acid (FA) 
4 
35% methanol (MeOH)/35% acetonitrile (ACN)/30% dichloromethane (DCM)/0.1% formic acid 
(FA) 
 
Standards were prepared using artificial sweat (Pickering Labs, Mountain View, CA, US) 
spiked with 250 ng/mL of cocaine-D3, BZE-D3 and EME-D3. The sweat standard was pipetted 
(10 µL) onto the paper and allowed to air dry for 5 minutes. The loaded paper was placed on 
top of a glass slide, below a strip of aluminium foil and positioned on the paper spray source 
under the high voltage clip as shown in Figure 3-1. The spray solvent was then pipetted onto 
the loaded paper (50 µL) and a 4.5 kV voltage was applied to the paper. Acquisition of mass 
spectra in full scan mode was then started. Table 3-1 shows the mass spectrometer parameters 
used for this experiment. Spectra for each spray solvent were taken in triplicate. 
 
Figure 3-1 – Positioning of the paper on top of a glass slide and below a piece of folded 
aluminium foil. 
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Figure 3-2 displays the average measured peak intensity for cocaine-D3 (monoisotopic mass = 
307.17), BZE-D3 (monoisotopic mass = 293.16) and EME-D3 (monoisotopic mass = 203.15) 
as a function of the spray solvent. Solvent 1 (80:20 (%v/v) MeOH:DCM) produced the highest 
peak intensities for cocaine and EME with RSD% of 22% and 29%, respectively. Solvents 2 
and 3 yielded the next highest peak intensities, with RSD% also above 20%. The measured 
intensities for BZE were consistently lower than for the other two analytes and the variability 
associated with the repeat measurements was greater than the variability between different 
solvents. Solvent 1 was therefore chosen for further optimisation work. This was consistent 
with reports in the literature (Espy et al., 2014) in which this solvent composition was used to 
detect seven drugs of abuse in dried blood spots. 
 
Figure 3-2 – Plot of the average (n=3) measured peak intensity for cocaine-D3, BZE-D3 and 
EME-D3 (250 ng/mL) in artificial sweat using paper spray and different solvent composition see 
Table 3-2).  
Using the same paper spray method as described above and Solvent 1, the effect of the voltage 
applied to the paper on the signal intensity for cocaine-D3, BZE-D3 and EME-D3 was 
observed.  
Figure 3-3 shows the average (n=3) peak intensities for cocaine-D3, BZE-D3 and EME-D3 in 
artificial sweat using paper spray at different applied voltages. A voltage of 3.5 kV yielded the 
highest peak intensities for both cocaine-D3 and BZE-D3 but, due to the variability between the 
three repeat measurements, the choice of the optimised voltage was based on that which 
produced the lowest variability and permitted all three analytes to be detected. Therefore, a 
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voltage of 3.5 kV was selected as the best voltage for the detection of cocaine-D3, BZE-D3 and 
EME-D3. 
 
Figure 3-3 - Plot of the average (n=3) measured peak intensity for cocaine-D3, BZE-D3 and 
EME-D3 (250ng/mL) in artificial sweat using paper spray and different applied voltages (3.0kV, 
3.5kV, 4.0kV, 4.5kV). 
The treatment of the paper substrate was investigated for its potential to influence the sensitivity 
to the analytes of interest. The sweat standard solution (250 ng/mL of each cocaine-D3, BZE-
D3 and EME-D3 was spotted (10 µL) onto washed and unwashed (as presented) paper, air dried 
for 5 minutes and placed on the paper spray source. To the paper, 50 µL of  Solvent 1 was 
pipetted onto the paper, a voltage of 3.5 kV was applied and acquisition was started.  
Figure 3-4 displays the average (n=3) measured peak intensity of cocaine-D3, BZE-D3 and EME-D3 
when washed and unwashed paper were used as sample substrates. Treated paper clearly 
yielded higher peak intensities, possibly because the washing process removes impurities from 
the paper that can cause ionisation suppression effects. 
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Figure 3-4 - Plot of the average (n=3) measured peak intensity for cocaine-D3, BZE-D3 and 
EME-D3 (250 ng/mL) in artificial sweat using paper spray and different paper treatments. 
Based on the optimisation work described above, a series of calibration standards were analysed 
using washed paper with an applied voltage of 3.5 kV and 50 µL of Solvent 1 spiked with 
internal standard (250 ng/mL of each of cocaine-D3, BZE-D3 and EME-D3). Mass spectra were 
acquired for 2 minutes using the experimental parameters described in Table 3-1 and the method 
defined in 
 
Figure 3-5. 
 
Figure 3-5 –Paper spray method applied to the analysis of calibration standards. Spray solvent 
was spiked with 250ng/mL of cocaine-D3, BZE-D3 and EME-D3. 
Calibration standards were prepared in artificial sweat with concentrations between 0 and 1000 
ng/mL of cocaine, benzoylecgonine (BZE) and ecgonine methyl ester (EME) from certified 
reference standards (1 mg/mL) purchased from Cerilliant, Sigma Aldrich (Dorset, UK). Each 
standard was analysed in triplicate.  
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Peak intensities were measured for cocaine monoisotopic mass = 304.15), BZE ([M+H]+ 
monoisotopic mass = 200.13) and EME ([M+H]+ monoisotopic mass = 290.14) and respective 
internal standards – cocaine-D3, BZE-D3 and EME-D3 – and extracted from the resulting spectra 
(over the 2-minute acquisition time). The peak intensity of the analytes of interest was 
normalised to the peak intensity of the corresponding internal standard. Normalised peak 
intensity was also blank corrected by subtracting the signal from the normalised average blank 
signal from the normalised peak intensity of the analyte of interest. Table 3-3 shows the average 
normalised intensities for cocaine, BZE and EME in the calibration standards analysed with 
paper spray and the method described above. The limit of detection (LOD) for each analyte was 
calculated as three times the standard deviation of the average normalised blank signal (δBlank) 
plus the average normalised blank signal (?̅?𝐵𝑙𝑎𝑛𝑘). LOD was calculated to be (in normalised 
peak intensity) 0.65, 1.27 and 1.23 for cocaine, BZE and EME in spiked artificial sweat. 
Highlighted cells in Table 3-3 indicate measurements that these are below the LOD, and 
therefore BZE could only be detected when present at 1000 ng/mL. As for cocaine and EME, 
the linear dynamic range was found to be between 100 and 600 ng/mL for cocaine and between 
200 and 600 ng/mL for EME. Consequently, a calibration curve could not be constructed for 
EME as only 3 standards were suitable for the calibration curve.  
Table 3-3 – Average (n=3) of normalised peak intensities of cocaine, BZE and EME in the 
calibration standards analysed with paper spray. Cells highlighted in red indicate that the 
response for this standard was below the limit of detection (LOD).  
 Standard Concentration 
 (ng/mL) 
100 200 400 600 800 1000 
Cocaine 0.75 1.23 1.77 3.94 4.21 4.15 
BZE 0.26 0.27 0.43 0.91 0.74 1.29 
EME 0.95 1.39 2.41 5.02 5.54 4.66 
 
The resulting calibration curve for cocaine is shown in Figure 3-6. The correlation between the 
concentration and the normalised peak intensity (ratio of cocaine to cocaine-D3) is poor and this 
is shown by the correlation factor, R2. Furthermore, the standard deviation of the repeated 
measurements (shown as 1 sigma error bars) were quite high. Using the linear regression 
equation (𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 = 0.0056 ∙ 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 + 0.0687), the LOD of cocaine in artificial 
sweat was calculated to be 104 ng/mL. This limit of detection in ng/mL indicates that for the 
100 ng/mL standard, cocaine was not detected. However, the difference is probably within the 
error of the measurement.  
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Figure 3-6 – Calibration curve of the ratio between cocaine and cocaine-D3 (normalised peak 
intensity) against the concentration of cocaine in artificial sweat standards analysed with paper 
spray. 
The sensitivity of the paper spray method described this far is too poor for cocaine, BZE and 
EME for drug testing purposes, where detection below 10 ng/mL is necessary.  
The proof of concept for the paper spray method was tested through the analysis of fingerprint 
samples collected from two individuals seeking treatment at a drug rehabilitation clinic. 
Fingerprint samples were collected using a collection kits such as the one shown in Figure 3-7; 
the treated chromatography paper (Whatman grade 1) was cut into a triangular shape (1.5 cm 
height x 2.1 cm base) with a rectangular extension so that the paper could be attached to a glass 
slide for ease of collection. The fingerprint samples were collected as presented using kitchen 
scales to apply a pressure between 800-1200 g. Immediately before collection, the triangular 
piece of paper containing the sample was cut along the base of the triangle and placed in the 
paper spray source (along with the glass slide under the paper and a strip of aluminium foil on 
top of the paper). The method described in Figure 3-5 was applied. MS spectra were acquired 
for 2 minutes in full scan mode in the m/z 50-500 range. 
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Figure 3-7 – Collection kit used to collect fingerprints for analysis with paper spray. 
Oral fluid samples were collected from the same two individuals using a QuantisalTM collection 
kit (Allere Toxicology, UK) and sent to LGC Forensics for immunoassay screening. Table 3-4 
shows the immunoassay results for the oral fluid fingerprint analysis. There is a good agreement 
between the two tests; the positive detection of the parent drug or at least one of the metabolites 
was matched with a positive oral fluid result for the drug in the immunoassay-screening test. 
Positive identification of cocaine, BZE and EME detected from the fingerprints was based on 
the mass resolution of the instrument (set at 8500 FWHM) which allows for a ±118 ppm mass 
deviation from the calculated monoisotopic mass (see Section 2.3 for more information on the 
mass spectrometer). Blank measurements were taken before the analysis of the fingerprint 
samples and the limit of detection (in normalised counts – ratio of the analyte to internal 
standard, A/IS) was calculated for cocaine, BZE and EME. The ratio of A/IS was above the 
calculated limit of detection for all three analytes. 
Oral fluid immunoassay testing provided by LGC Forensics detects the presence of cocaine and 
BZE for cocaine screening (LGC, 2014). However, the detection window of drugs and 
metabolites in fingerprint residues is unknown, which means that the correlation between 
fingerprints and oral fluid is also unknown. For Donor 1, BZE was not consistently detected in 
both fingers analysed and this indicates either poor distribution of the analytes between 
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fingerprints or lack of sensitivity of the analysis method. The spray solvent composition used 
for these analyses did not enable the detection of fingerprint endogenous substances.  
Table 3-4 – Oral fluid (immunoassay drug testing, LGC Forensics) and fingerprint results 
(analysed by paper spay) for samples collected from individuals seeking treatment at a drug 
rehabilitation centre. √ = detected; N/D = not detected. 
  
  
  
Donor 1 Donor 2 
Oral Fluid 
Result 
Fingerprint Results Oral 
Fluid 
Result 
Fingerprint Results 
Left Thumb Left Index Left Thumb 
Cocaine 
√ 
√ √ 
√ 
√ 
BZE N/D √ N/D 
EME N/D N/D √ 
 
The sensitivity of paper spray has been explored for other drug testing matrices such as blood 
(Espy et al., 2014) and was found to be in the low ng/mL range. In the work described above, 
the Surrey paper spray method was adapted for fingerprint analysis.  Although the sensitivity 
was significantly worse than observed using a standard paper spray set up, the technique was 
successfully applied to the detection of drugs of abuse from a single fingerprint. A preliminary 
analysis of the quantitative potential of the technique showed significant scope for 
improvement.  
3.3. Optimisation of the mass spectrometer settings 
Optimisation of the Waters QToF 2 mass spectrometer parameters was performed using an 
electrospray ionization (ESI) source. Optimisation solution was introduced into the ESI source 
through a syringe pump (kd Scientific, model KDS-100-CE) fitted with a 2.5mL Hamilton 
(Gastight #1002), pumping with a flow rate of 3 mL/h and a desolvation temperature of 400 ºC. 
Source temperature was kept at 100 ºC and a capillary voltage of 3.5 kV was applied to the ESI 
capillary. All analyses were carried out in positive ion mode. 
The optimization solution consisted of a mixture of cocaine, EME and BZE at a concentration 
of 500 ng/mL in 70:30 MeOH:H2O. Optimal parameters were selected based on the settings 
that resulted in the highest measured counts for each of the three analytes over a 30 second 
acquisition time. Table 3-5 describes the final optimised settings. Data was acquired over a 
mass range of m/z 50-500 with a scan time of 1 second and an inter-scan delay of 0.1 seconds 
in continuum mode. 
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Table 3-5 - Optimised settings for the analysis of cocaine, benzoylecgonine (BZE) and ecgonine 
methyl ester (EME) in 70:30 MeOH:H2O using the Waters QToF 2 mass spectrometer with an 
electrospray ionisation (ESI) source. (*unless otherwise specified) 
 Parameter Optimized Settings 
Function Parameters 
Scan Time  1* 
Inter-Scan Delay 0.1* 
Mass range (u) 50-500 
ES+ Source 
Cone (V) 25 
Extractor (V) 5 
RF Lens (V) 0.05 
MS (Quadrupole) 
Multiplier (V) 550 
Multi-channel plate (V) 2000 
LM Res 10 
HM Res 15 
Collision energy 10 
Ion energy 4 
Steering -2 
Entrance -55.0 
Pre-filter 10.8 
MS 2 (Time-of-Flight) 
Transport 4 
Aperture 2 3.0 
AccV 200 
Focus 0 
Tube Lens 135 
Offset 1 -0.2 
Offset 2 0 
Pusher 980 
TOF (V) 9.10 
Reflectron 35 
 
3.4. Optimisation of the mass spectrometer inlet for paper spray 
The initial paper spray configuration included the use of a capillary bent at 35º and the 
geometric arrangement shown in Figure 3-8; d1 = distance between the capillary and tip of the 
paper in the x-axis; d2 = diagonal distance between the capillary and tip of the paper; d3 = 
distance between the capillary and tip of the paper in the z-axis. Distances were measured using 
a 15 cm (± 0.5cm) ruler. 
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All of the analysis carried out for the optimisation of the mass spectrometer inlet used a 
triangular piece of Whatman grade I chromatography paper (1.6 cm base, 2.1 cm height) that 
was submitted to a wash process. The substrate employed for dried blood spot analysis using 
the commercially available paper spray source uses a tear drop shaped paper (Whatman 
chromatography paper, grade 31ET-Ch) with an area of 8 mm2. In this work, the area of the 
analysis substrate was increased to 168 mm2 to accommodate a larger area of a fingerprint. 
Additionally, grade I chromatography paper was chosen as fingerprint residues are not as 
viscous as blood and therefore do not require larger paper pore sizes (Espy, 2014).  
 
Figure 3-8 - Schematic representation of the positioning of the paper spray source relatively to 
the capillary inlet of the mass spectrometer. 
As concluded in Section 3.2, the paper spray method used for the analysis of natural fingerprints 
and spiked sweat standards was not optimised and required further improvement to achieve the 
required sensitivity. The volume of spiked sweat standard loaded onto the paper was increased 
from 10 µL to 20 µL to increase the mass of analytes on the paper, and consequently allow for 
higher counting statistics and thereby a sharper optimisation. The spray solvent composition 
was modified from 80:20 (%v/v) MeOH:DCM to 70:30 MeOH:H2O. This change was made 
due to the more stable and longer sprays produced by the second solvent mixture.  The volume 
of spray solvent pipetted onto the paper was also increased from 50 µL to 60 µL to prolong the 
duration of the spray – longer spray time meant more time for acquisition and consequently 
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better sensitivity and the possibility of including tandem MS measurements. Finally, the voltage 
applied to the paper was raised from 3.5 kV to 4.5 kV. Test samples were composed of artificial 
sweat spiked with cocaine, BZE and EME and isotopically labelled internal standards (IS) – 
cocaine-D3, BZE-D3 and EME-D3 at a concentration of 500 ng/mL. The spiked sweat samples 
were spotted onto the paper (20 µL) and allowed to air dry for 5 minutes before being placed 
on the paper spray source. Paper was placed on top of a glass slide to prevent contamination of 
the source (and consequently memory effects) and below folded aluminium foil, to aid the 
charge transfer from the clip to the paper and prevent contamination of the clip. Lastly, spray 
solvent was pipetted onto the paper, voltage applied and the acquisition was started for 2 
minutes in full scan mode. 
 
Figure 3-9 shows a schematic representation of the method used for optimisation of the mass 
spectrometer inlet for paper spray analysis. 
 
Figure 3-9 – Method for paper spray analysis of spiked artificial sweat: 20 µL of spiked artificial 
sweat pipetted onto the paper and allowed to air dry for 5 minutes; pre-loaded paper placed on 
the source (aluminium foil on top and glass under) and 60 µL of spray solvent (70:30 
MeOH:H2O) added before applying a 4.5 kV to the paper and starting data acquisition. 
The data acquired with this configuration showed very low counts (see Figure 3-11) for the 
analytes of interest. This might be due to poor ion transmission through the capillary as reports 
in the literature describe the use of a short and unbent capillary (Liu et al., 2010). As a result, 
the capillary was substituted by the standard ESI cones and the paper spray source was placed 
directly in front of the inlet, as shown in Figure 3-10.  The paper was positioned 0.4 cm away 
from the cone. The same method of analysis as shown in 
 
Figure 3-9 was applied, using the same standards and spray solvent as described above. 
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Figure 3-10 – Schematic representation of the positioning of the paper spray source relatively to 
the mass spectrometer using a cone as an inlet. 
The replacement of the capillary with the cones resulted in an increase of the number of ions 
detected, namely for EME which was not detected when a capillary was used. BZE was not 
detected using the cone. Figure 3-11 shows a comparison of the average ion counts of three 
replicate measurements of the same spiked sweat sample (containing cocaine, cocaine-D3 EME, 
EME-D3, BZE and BZE-D3 at 500 ng/mL) using a capillary and a cone. Such findings are 
consistent with reports in the literature which have studied the effect of capillary dimensions 
and temperature on the transmission and ionisation efficiencies. Results suggest that a decrease 
on the length of the capillary results in a more efficient ion transmission process (Page et al., 
2009). This leads to a decrease in the ionization efficiency due to the less effective desolvation 
process. Regarding the temperature of the inlet, it was found that higher temperatures increase 
the ionisation efficiency but decrease the transmission efficiency (likely due to diffusion to the 
walls of the capillary).  However, the improvement gained from shorter capillaries outweighs 
the loss in transmission efficiency (Page et al., 2009). Thus, when the capillary (which was not 
heated), was substituted by a cone (which was heated to 100 ºC), the ion gain was increased 
due to an increase of ion transmission and ionisation. 
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Figure 3-11 – Plot of the average (n=3) peak intensity of a spiked sweat sample containing 
cocaine, cocaine-D3 EME, EME-D3, BZE and BZE-D3 at 500 ng/mL using a capillary and a cone 
and a cone with a ‘z-spray’ configuration as inlets to the mass spectrometer using paper spray. 
Data was acquired using 60μL of 70:30 MeOH:H2O as a spray solvent and an applied voltage of 
4.5 kV. 
Although this configuration showed an improvement of the number of ions being detected, it 
caused the accumulation of dried material around the inner cone, which subsequently caused 
arcing between the tip of the paper and the inlet. Thus, the configuration was changed to a ‘z-
spray’ configuration, where the paper was placed perpendicularly to the inlet, as shown in 
Figure 3-12.  
 
Figure 3-12 – Schematic representation of the paper spray set-up using a ‘z-configuration’ 
whereby the ion beam generated by the source is perpendicular to the inlet. 
Using the ‘z-spray’ configuration, all the analytes were detected in the spiked artificial sweat 
(see Figure 3-11); a significant improvement on the use of a capillary inlet. Furthermore, this 
configuration eliminated the build-up of dirt on the cone that could potentially lead to cross-
contamination.  
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3.5. Optimisation of the paper spray parameters 
Optimisation of the paper spray method using the ‘z-spray’ configuration included optimisation 
of the composition of the spray solvent, the volume of spray solvent, the voltage applied to the 
paper and the paper treatment prior to analysis. Optimisation was carried out using artificial 
sweat spiked with a mixture of cocaine, BZE and EME at a concentration of 500 ng/mL, unless 
otherwise specified. Internal standard (500ng/mL of cocaine-D3, BZE-D3 and EME-D3) was 
prepared in 100% ACN. The sweat standard was added to the paper (20 µL), followed by the 
internal standard (20 µL). The internal standard was removed from the sweat standard to best 
replicate the scenario with fingerprints where the internal cannot be easily mixed with the 
sample. The loaded paper was allowed to air dry for 10 minutes before being placed between a 
folded piece of aluminium foil and the glass slide. A voltage of 4.0 kV (lower than previously 
to reduce the risk of arching) was applied to the paper and acquisition started for 2 minutes. MS 
tune file settings are described in Table 3-5. 
3.5.1. Solvent composition and volume 
The solvent spray composition was optimised to yield the best ratio (1:1) of the analytes 
(cocaine, BZE and EME) to the internal standard (cocaine-D3, BZE-D3 and EME-D3) in the 
artificial sweat standards. The role of the spray solvent is to aid the extraction of the analytes 
from the paper and facilitate the production of an electrospray at the tip of the paper (Su et al., 
2013). Reports in the literature described the use of a combination of different solvents such as 
MeOH, ACN, DCM and H2O for the analysis of drugs of abuse in other biological matrices, 
such blood (Espy et al., 2014). For this work, three different solvent mixtures were tested: 70:30 
(%v/v) MeOH:H2O, 90:10 (%v/v) ACN:H2O and 80:20 (%v/v) MeOH:DCM. Formic acid was 
added to the spray solvent (0.1% v/v) to promote the protonation of the molecular species to 
form [M+H]+. The volume of spray solvent added to the sample was tested simultaneously with 
the solvent composition by testing the three different solvent mixtures at three different 
volumes: 60, 80 and 100 μL.  
Figure 3-13 shows the ratios of analytes (A) to internal standard (IS) obtained for each solvent 
composition at each different volume. The MeOH:DCM mixture produced the best ratios for 
cocaine and EME at the cost of poor repeatability, as shown by the error bars. Furthermore, this 
solvent mix also produced unstable sprays over the 2 minutes of acquisition, likely due to the 
volatility of dichloromethane. Figure 3-14 shows the total ion chromatograms obtained using 
60 µL of (A) 70:30 (%v/v) MeOH:H2O and (B) 80:20 (%v/v) MeOH:DCM on blank paper. For 
these reasons, 80:20 (%v/v) MeOH:DCM was discarded as a viable spray solvent for this 
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application. The remaining two spray solvents produced similar results in terms of ratios and 
repeatability.  
 
Figure 3-13 – Plot of the average (n=3) of the ratios of analytes (A) to internal standard (IS) 
using three different solvents (70:30 MeOH:H2O, 90:10 ACN:H2O and 80:20 MeOH:DCM), 
each at three different volumes (60, 80 and 100 μL). Data was acquired with an applied voltage 
of 4.0 kV. 
 
Figure 3-14 – Example of total ion chromatograms (TIC) obtained using (A) 60 µL of 70:30 
MeOH:H2O and (B) 60 µL of 80:20 MeOH:DCM under the same paper spray experimental 
conditions on blank paper. 
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Figure 3-15 shows the plot of the average (n=3) peak intensity for cocaine, BZE and EME in 
artificial sweat when 70:30 (%v/v) MeOH:H2O and 90:10 (%v/v) ACN: H2O were used at three 
different volumes. Taking in consideration the variability associated with the repeated 
measurements, none of the spray compositions or volumes were found to make a noticeable 
difference to the measured intensities for any of the analytes. 
 
Figure 3-15 – Average (n=3) peak intensity for cocaine, BZE and EME in spiked artificial 
(500ng/mL) sweat using two different solvent compositions at three different volumes each; data 
was obtained using paper spray with an applied voltage of 4.0kV. 
The solvent chosen for this application should also be able to promote the extraction and 
ionization of endogenous substances found in artificial sweat and natural fingerprints, for 
example amino acids. This was of particular interest at one point in the study since it was 
hypothesised that quantification could be improved through normalisation to endogenous 
compounds, as discussed later in Sections 6.2 and 6.3 for LESA and DESI.   
Section 9.1 – Appendix I, shows examples of spectra obtained using paper spray around the 
masses of ornithine (m/z 133.0977), histidine (m/z 156.0773) and arginine (m/z 175.1195) using 
70:30 (%v/v) MeOH:H2O and 90:10 (%v/v) ACN:H2O as spray solvents in spiked sweat 
standards (A and B), in blank sweat (C and D) and on blank paper (E and F). The blank paper 
should not contain amino acids and therefore the reported mass accuracy corresponds to the 
nearest detected peak. The mass accuracies calculated for the three analytes in sweat 
(irrespective of the spray solvent) were much smaller than those calculated for the blank paper. 
Thus, the detected signals are likely to belong to the three amino acids. Figure 3-16 shows a 
plot of the amino acid signals detected in the artificial sweat. The MeOH:H2O mixture yielded 
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higher peak intensities for four out of the six amino acids monitored, with the exception of 
methionine, which could only be detected with the ACN:H2O mixture. For this reason, the 
70:30 (%v/v) MeOH:H2O mixture was found to be the optimal spray solvent mixture as it 
enabled the detection of the analytes of interest, amino acids and produced very stable sprays 
over the 2 minutes of acquisition time. 
 
Figure 3-16 - Plot of the average (n=3) peak intensity for amino acids using two different 
solvents (70:30 MeOH:H2O and 90:10 ACN:H2O), each at three different volumes (60, 80 and 
100 μL). Data was acquired with an applied voltage of 4.0 kV. 
The volume of the spray solvent added to the sample was found to cause no significant 
differences in the ratios of A/IS. However, the total ion chromatograms showed that 60 μL 
produced very irregular sprays, and 80 and 100 μL produced stable sprays over the 2 minutes 
acquisition time, as shown in Figure 3-17. The drawback of using larger volumes such as 100 
μL is the overloading of the paper substrate, which may contaminated the paper spray source. 
Therefore, 80 μL was found to be the optimal volume of spray solvent to be pipetted onto the 
sample. 
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Figure 3-17 – Total ion chromatograms obtained when pipetting (A) 60 μL, (B) 80 μL and (C) 
100 μL of 70:30 MeOH:H2O onto an artificial sweat standard pre-loaded onto the paper and an 
applied voltage of 4.0 kV. 
3.5.2. Applied voltage 
The voltage applied to the paper has an impact on the efficiency of the ionization process as 
well as on the velocity of the droplets formed on the electrospray (Liu et al., 2010). Figure 3-18 
shows the plot of the average measured peak intensities for cocaine, BZE and EME as a function 
of the applied voltage (3.5 kV, 4.0 kV and 4.5 kV). The highest measured intensities for all 
three analytes was recorded at 4.0 kV, and therefore this voltage was chosen as the optimal 
voltage for paper spray analysis of spiked artificial sweat, using a ‘z-spray’ geometry and a 
cone inlet.  
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Figure 3-18 - Plot of the average (n=3) peak intensity for cocaine, BZE and EME at 3.5 kV, 4.0 
kV and 4.5 kV applied voltages. Data was acquired using 80 μL of 70:30 MeOH:H2O. 
3.5.3. Paper treatment 
To observe the effect of treating the paper, spiked artificial sweat (20 µL of 500 ng/mL of 
cocaine, BZE and EME) was analysed on both washed and unwashed paper. Washed paper 
refers to paper triangles that were submitted to a wash process as described previously, whilst 
unwashed paper refers to paper triangles that were cut and used without any other treatment. 
To the spiked artificial sweat, 20 µL of internal standard (500 ng/mL of cocaine-D3, BZE-D3 
and EME-D3) was added, followed by 80 µL of 70:30 MeOH:H2O and a voltage of 4.0 kV. 
Figure 3-19 shows the plot of the average (n=3) peak intensities for the on washed and 
unwashed paper. Although the ratios are higher when unwashed paper is used, when the error 
of the measurements are considered, it becomes clear that there is no significant difference. 
Although data shows that there is no added benefit of washing the paper in terms of the ratios 
obtained, paper will still be washed in future experiments. The washing process will eliminate 
any major contamination to the paper during the cutting process.  
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Figure 3-19 - Plot of the average (n=3) peak intensity measured for cocaine, BZE, EME and 
respective internal standards using washed and unwashed paper. Data was acquired using 80 μL 
of 70:30 MeOH:H2O and an applied voltage of 4.0 kV. 
The method developed (described in Figure 3-20) for the analysis of cocaine and metabolites 
in artificial sweat included the addition of 20 μL of spiked sweat standard and 20 μL of the 
internal standard (containing a mixture of cocaine-D3, BZE- D3 and EME- D3 at 500 ng/mL in 
100% ACN) to the pre-cut and washed chromatography grade 1 paper. The paper containing 
the sample and internal standard was allowed to air dry for 10 minutes in an open atmosphere, 
before being placed between folded aluminium foil and a glass slide and on the paper spray 
source. The paper was positioned perpendicularly to the cone inlet at a distance of 3x3 mm (see 
Figure 3-12). To the paper, 80 μL of spray solvent (70:30 MeOH:H2O) was added and a voltage 
of 4.0 kV was applied.  
 
Figure 3-20 – Paper spray method developed for the analysis of cocaine, BZE and EME in 
spiked artificial sweat. 
3.6.  Method performance 
Using the paper spray method developed above (Figure 3-20), a calibration curve was 
constructed for cocaine, BZE and EME by running spiked sweat standards with concentrations 
varying between 0-800 ng/mL.  This calibration curve range was chosen as it is presumed that 
the concentration of drugs in a fingerprint would fall within this range. Each standard and blanks 
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(non-spiked synthetic sweat) were analysed in triplicate. The peak intensity of the analyte of 
interest was normalised to the peak intensity of the deuterated analogue (Equation 3-1), 
followed by blank correction to the normalised average blank intensity (Equation 3-2). An 
average was taken for the three replicate measurements and plotted against the concentration to 
produce a calibration curve. 
𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑠𝑒𝑑 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 (𝐴/𝐼) =  
𝑃𝑒𝑎𝑘 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝐴𝑛𝑎𝑙𝑦𝑡𝑒 (𝐴)
𝑃𝑒𝑎𝑘 𝐼𝑛𝑡𝑒𝑟𝑛𝑠𝑖𝑡𝑦  𝑜𝑓 𝐼𝑛𝑡𝑒𝑟𝑛𝑎𝑙 𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑 (𝐼)
 
Equation 3-1 – Normalised intensity (A/I) calculation; peak intensity of cocaine, benzoylecgonine 
or ecgonine methyl ester (A) over the peak intensity of cocaine-D3, benzoylecgonine-D3 or 
ecgonine methyl ester-D3 (I), respectively. Same calculation was applied to both blanks and 
standards. 
𝐵𝑙𝑎𝑛𝑘 𝐶𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑠𝑒𝑑 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 = 𝐴/𝐼 − ?̅?𝑏𝑙𝑎𝑛𝑘 
Equation 3-2 – Blank corrected normalised intensity calculation; normalised intensity (A/I) 
minus the average normalised blank intensity (?̅?𝒃𝒍𝒂𝒏𝒌). 
For cocaine and BZE the response between the concentration and measured intensity was found 
to be linear in the range 0-400 ng/mL and between 0-600 ng/mL for EME. The limits of 
detection (LOD) in normalised counts were calculated as three times the standard deviation of 
the blank measurements plus the average signal from the blank (LOD = ?̅?𝑏𝑙𝑎𝑛𝑘 + (3 ∙ 𝜎𝑏𝑙𝑎𝑛𝑘)). 
The LOD in ng/mL was calculated using the linear regression equations. Table 3-6 shows the 
average (n=3) of normalised and blank corrected signals and LOD for cocaine, BZE and EME 
in artificial sweat. Figure 3-21 shows the calibration curves plotted for cocaine and EME. 
Table 3-6 – Normalised and blank corrected peak intensities for cocaine, BZE and EME over a 0-
800 ng/mL range and calculated limits of detection. 
 Average (n=3) of normalised and blank corrected signals 
Concentration (ng/mL) Cocaine BZE EME 
0 0.00 0.00 0.00 
50 0.07 0.01 0.11 
100 0.12 0.06 0.15 
200 0.37 0.34 0.46 
400 0.72 0.55 0.85 
600 0.62 0.34 1.16 
800 0.50 0.27 1.05 
 
LOD (normalised intensity) 0.02 0.14 0.13 
LOD (in ng/mL) 21 - 61 
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The limit of detection for cocaine was calculated to be 21 ng/mL which meant that cocaine 
could be detected in all standards analysed. The linearity of the results was also good as shown 
by a correlation factor (R2) of 0.9929. The calibration curve for cocaine in shown in Figure 3-21 
(A). The limit of detection for benzoylecgonine was calculated to be 0.14 (normalised intensity) 
and therefore it was only detected in standards of concentration 200 ng/mL and above. 
However, due to the short linear dynamic range, a calibration curve could not be plotted and 
the limit of detection in ng/mL could not be calculated. The limit of detection for EME was 
calculated to be 61 ng/mL and it was detected in every standard with a concentration of 100 
ng/mL and higher. Figure 3-21 (B) shows the calibration curve obtained for EME, where the 
linearity of the curve (R2=0.9892) is poorer in comparison to cocaine (R2=0.9929). 
83 
 
 
 
Figure 3-21 – Calibration curve for (A) cocaine and (B) EME in spiked artificial sweat and 
analysed using paper spray mass spectrometry. Data was acquired using 80 μL of 70:30 
MeOH:H2O and an applied voltage of 4.0 kV. 
Results described above are an improvement on the paper spray method described in Section 
3.2, where the LOD for cocaine was calculated to be 104 ng/mL.  
The technique and method developed are capable of producing quantitative results for cocaine, 
EME and BZE in spiked sweat standards. However, the method developed will be required to 
confirm the identity of all three analytes and distinguish between isobaric species (i.e. 
compounds that are not cocaine, detected at the same mass) (Armstrong et al., 1987, Melchert 
et al., 1992). This is usually achieved either by high mass resolution detectors (limited by the 
mass spectrometer available), chromatographic separation or tandem mass spectrometry.    
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As explained previously, QToF mass spectrometers are high-resolution instruments  with mass 
resolutions typically around 10,000 FWHM (Chernushevich et al., 2001). This is higher than 
other instruments such as triple quadrupoles (QQQ). However, the resolution will be influenced 
by other factors such as maintenance of the instrument. Chromatographic separation requires a 
chromatography instrument which is not compatible with paper spray. Finally, tandem mass 
spectrometry enables confirmation of the peak assignment based on fragment identification 
from the parent ion. Monoisotopic masses for the parent ions (protonated) and respective 
fragments is shown in Section 9.2 – Appendix II.    
3.6.1. Development of an MS/MS Method 
A new mass spectrometer method that included full scan and tandem MS (MS/MS) 
measurements was investigated. Full scan measurements can be used for quantitation and 
MS/MS scans for the qualitative identification of the substances. The MS method developed 
(Figure 3-22) comprised of 6 individual functions lasting for 0.5 minutes each. Function 1 
consisted of a full scan measurement over the m/z 50-500 range and it was used to monitor the 
stability of the spray at the start of the analysis. Functions 2 to 6 consisted of tandem MS 
measurements for each of the analytes (cocaine, BZE and EME) and internal standards (BZE-
D3 and EME-D3). Collision induced dissociation (CID) was used for fragmentation of the parent 
ion and the collision energy was set at 25 eV. The acquisition time was extended to 3 minutes. 
Functions for each internal standard were preceded by the respective analyte, with the exception 
of cocaine given that at the time of the experiment cocaine-D3 was unavailable due to drug 
licensing issues.  
 
Figure 3-22 – Mass spectrometer method including full scan and tandem MS measurements for 
the analysis of spiked sweat standards using paper spray. The method was divided into 6 
different functions of 0.5 minutes each. Function 1 included a full scan measurement in the 50-
500 m/z. Functions 2-6 included tandem MS measurements for each of the analytes. 
Calibration standards containing cocaine, BZE and EME in the range of 0-800 ng/mL were 
analysed using the same paper spray method as above (Figure 3-20). The same method of 
normalisation was used whereby the peak intensity of the fragment ion was divided by the peak 
intensity of the corresponding internal standard fragment ion (Equation 3-1). Cocaine was 
normalised to BZE-D3 and EME-D3 to observe which produced the better results. LOD in 
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normalised counts was calculated using the uncertainty of the regression line in the y-direction 
(𝑆𝑦/𝑥, Equation 3-3), which was then substituted into Equation 3-2 (𝐿𝑂𝐷 = 3 ∙ 𝜎𝑏𝑙𝑎𝑛𝑘 +
?̅?𝑏𝑙𝑎𝑛𝑘) instead of the standard deviation of the blank measurements (𝜎𝑏𝑙𝑎𝑛𝑘). The average 
blank signal (?̅?𝑏𝑙𝑎𝑛𝑘) was also substituted by the y-intercept value from the linear regression 
equation.  The LOD in concentration was calculated from the linear regression equation. (Miller 
et al., 2005) 
𝑆𝑦/𝑥 = √
∑(𝑦𝑖 − ?̂?𝑖)2
𝑛 − 2
 
Equation 3-3 – Uncertainty of the regression line equation used to calculate the limit of detection 
where 𝒚𝒊 refers the difference between the measured values, ?̂?𝒊 refers to the values predicted for 
the actual concentrations using the regression line equation and 𝒏 − 𝟐 refers to the degrees of 
freedom (𝒏 = number of standards in the calibration curve). (Miller et al., 2005) 
Normalisation of the cocaine fragment peak intensity to the peak intensity of the BZE-D3 
resulted in a lower LOD (0.47) in normalised counts in comparison with normalisation to EME-
D3 (0.64) – see Table 3-7. Figure 3-13 (A) shows the calibration curve for cocaine in artificial 
sweat using the ratio of the cocaine fragment peak intensity to the BZE-D3 fragment peak 
intensity. The R2 is lower (0.9645) compared to the previous calibration curve (Figure 3-21 
(A)). The LOD in ng/mL was calculated to be 124 ng/mL, which is higher than the LOD 
obtained for cocaine in the previous calibration curve (21 ng/mL). This can be the result of the 
shorter acquisition time for each analyte and the lack of cocaine-D3. The RSD% for cocaine 
increased with increasing concentration which may be the cause of the poor correlation factor. 
The LOD for BZE in normalised counts was calculated to be 0.17, which meant that BZE could 
be detected in standards of concentration above 200 ng/mL and this resulted in a R2 value of 
0.9913. Similarly to cocaine, the RSD % was found to increase with increasing BZE 
concentration. The LOD was calculated to be 105 ng/mL, which was a clear improvement on 
the previous experiment where a calibration curve could not be plotted for BZE due to the high 
limit of detection. 
The LOD for EME was calculated to be 0.51 in normalised counts, which meant that EME was 
only detected in standards of concentration 400 ng/mL and above. However, the response 
between the concentration of EME and the ratio between EME/EME-D3 was not linear and a 
calibration curve could not be plotted. 
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Table 3-7 – Average normalised peak intensities and RSD % for cocaine, BZE and EME in 
artificial sweat analysed with paper spray. LOD in normalised counts was calculated using the 
uncertainty of the regression line (𝑺𝒚/𝒙) instead of the standard deviation of the normalised blank 
signals. Cells highlighted in green indicate that the average normalised peak intensity is above the 
LOD. 
Standard Concentration 
(ng/mL) 
Ratio cocaine to BZE-D3 Ratio cocaine to EME-D3 
Average  RSD % 
LOD 
(normalised 
counts) 
Average  RSD % 
LOD 
(normalised 
counts) 
0 0.00 N/A 
0.47 
0.00 N/A 
0.64 
50 0.27 27% 0.14 4% 
100 0.29 23% 0.19 72% 
200 0.60 44% 0.32 23% 
400 1.80 39% 1.72 39% 
600 3.02 45% 1.28 17% 
800 5.08 41% 3.36 16% 
Standard Concentration 
(ng/mL) 
Ratio BZE to BZE-D3 Ratio EME to EME-D3 
Average  RSD % 
LOD 
(normalised 
counts) 
Average  RSD % 
LOD 
(normalised 
counts) 
0 0.00 N/A 
0.17 
0.00 N/A 
0.51 
50 0.08 27% 0.16 27% 
100 0.14 23% 0.22 23% 
200 0.30 44% 0.27 44% 
400 0.73 39% 1.13 39% 
600 1.16 45% 1.27 45% 
800 1.36 41% 1.23 41% 
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Figure 3-23 - Calibration curve for (A) cocaine and (B) BZE in spiked artificial sweat and 
analysed using paper spray mass spectrometry in tandem MS mode. Data was acquired using 80 
μL of 70:30 (%v/v) MeOH:H2O and an applied voltage of 4.0 kV. 
One of the known limitations of QToF mass spectrometers is the loss in sensitivity going from 
full scan mode to tandem MS mode, as discussed in Section 2.3.1. For this reason, quantification 
using QToF is often achieved in full scan mode with MS/MS measurements as a qualitative 
confirmation of the peak assignment. This was seen for all three analytes – cocaine, BZE and 
EME where the LODs were higher in tandem MS mode than previously in full scan mode. 
Using the same paper spray method described in Figure 3-20 and the MS settings described in 
Table 3-5, a new MS method was created to include 2 minutes of full scan measurements in the 
m/z 50-500 range and three individual MS/MS measurements of 0.3 minutes for each of the 
analytes of interest (Figure 3-24). Collision energy was set at 25 eV for all three analytes. 
 
Figure 3-24 – MS method for the analysis of cocaine, BZE and EME in artificial sweat using 
paper spray. The method was divided into 4 separate functions: full scan measurement for 2 
minutes followed by 0.3 minutes MS/MS scan of each of the analytes of interest. Collision energy 
was set at 25 eV for all analytes. 
Standards were prepared in artificial sweat with concentrations of cocaine, BZE and EME 
varying between 0-400 ng/mL. Internal standard was prepared in acetonitrile with BZE-D3 and 
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EME-D3 at 500 ng/mL. Cocaine-D3 was not available and therefore the peak intensity of 
cocaine was normalised to BZE-D3, considering the results obtained from the previous 
experiment. Standards and blanks were analysed in triplicate and the same data manipulation 
steps (normalisation and blank correction) were taken as in the previous section. LOD was 
calculated as 3×𝜎𝑏𝑙𝑎𝑛𝑘 + ?̅?𝑏𝑙𝑎𝑛𝑘 and the LOQ as 10×𝜎𝑏𝑙𝑎𝑛𝑘 + ?̅?𝑏𝑙𝑎𝑛𝑘. 
Table 3-8 – LOD, LOQ, average normalised peak intensities for cocaine, BZE and EME in 
artificial sweat analysed with paper spray and the associated RSD%.   
Standard 
Concentration 
(ng/mL) 
Cocaine to BZE-D3 
Average  RSD % 
LOD 
(normalised 
counts) 
LOQ 
(normalised 
counts) 
LOD 
(ng/mL) 
LOQ 
(ng/mL) 
0 0.00 16% 
0.15 0.26 41 60 
50 0.28 32% 
100 0.37 21% 
200 0.91 24% 
400 2.25 30% 
Standard 
Concentration 
(ng/mL) 
BZE to BZE-D3 
Average  RSD % 
LOD 
(normalised 
counts) 
LOQ 
(normalised 
counts) 
LOD 
(ng/mL) 
LOQ 
(ng/mL) 
0 0.00 20% 
0.15 0 99 180 
50 0.00 N/D 
100 0.15 60% 
200 0.31 26% 
400 0.64 18% 
Standard 
Concentration 
(ng/mL) 
EME to EME-D3 
Average  RSD % 
LOD 
(normalised 
counts) 
LOQ 
(normalised 
counts) 
LOD 
(ng/mL) 
LOQ 
(ng/mL) 
0 0.00 40% 
0.03 0 8 25 
50 0.12 25% 
100 0.21 17% 
200 0.41 25% 
400 0.78 12% 
 
The LOD for cocaine (41 ng/mL) was improved in comparison to the previous calibration curve 
plotted using tandem MS measurements. The LOQ was calculated to be 60 ng/mL which is still 
very high if the method is to be made quantitative. All of the standards were detected and the 
error in the three replicate measurements was also much smaller (16-30%). The LOD for BZE 
was also lower (99 ng/mL) than previously but BZE could only still be detected in 3 standards, 
making a 4 point calibration curve when the blank is included. LOQ was found to be 180 ng/mL, 
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which will need to be further improved. EME had the lowest LOD of 8 ng/mL and a LOQ of 
25 ng/mL with RSD % of 12-25% for the standards analysed.  
The measured peak intensities for the fragments of cocaine, BZE and EME are shown in Table 
3-9. The characteristic fragments of the three analytes were found in 11 of the 12 measurements 
(not including the blank) which confirms the peak assignment in the full scan measurements. 
The fragments were not detected in one of the replicate measurements of one standards analysed 
due to a failed spray, which meant no ionisation took place. The variability in the measured 
peak intensities for the fragment ions in the three replicate measurements was quite high. This 
could be the result of the inherent variability of the technique, which was observed to be affected 
by changes in ambient (flow of air, perfume in the atmosphere, etc.). This affects the spray 
produced and therefore the intensity of the ions detected. Variations in peak intensity could 
potentially be corrected through measurement of the internal standard also in MS/MS mode but 
due to the restricted duration of the spray (3 minutes in this case) there was no spray time 
available for more MS/MS functions. 
Table 3-9 - Cocaine, BZE and EME fragments detected in calibration standards through tandem 
MS measurements using paper spray. x = not detected; √ = detected; * = one replicate 
measurement failed. 
 
Cocaine fragment (m/z 
182) detected? 
BZE fragment (m/z 
168) detected? 
EME fragment (m/z 
182) detected? 
0 ng/mL x x x 
50 ng/mL √* √ √ 
100 ng/mL √ √ √ 
200 ng/mL √ √ √ 
400 ng/mL √ √ √ 
600 ng/mL √ √ √ 
800 ng/mL √ √ √ 
 
The data presented above has shown the quantitative potential of the paper spray method. The 
limit of detection for cocaine, BZE and EME in spiked artificial sweat was calculated to be 41 
ng/mL, 99 ng/mL and 8 ng/mL respectively. These limits of detection will have to be lower to 
be competitive with the LODs offered by other techniques such as liquid chromatography-mass 
spectrometry (LC-MS), that for the detection of cocaine in urine and oral fluid have cut-off 
limits of 150 and 8 ng/mL respectively. Nonetheless, the technique was able to positively 
confirm the peak assignment through MS/MS measurements. The fragments could not be 
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consistently identified in the samples using MS/MS, which suggests that the method can be 
optimised to increase the repeatability of the detection of the fragment ions when present in the 
fingerprint samples. 
Preventive maintenance of the QToF mass spectrometer was carried out and the MS settings 
(Table 3-5) were retested using an ESI infusion and it was found that the method still offered 
the optimal conditions for the detection of cocaine, BZE and EME. The collision energies for 
cocaine, BZE and EME were optimised through ESI infusion of a mixture of the drugs at a flow 
rate of 3 mL/h and a desolvation temperature of 400 ºC. Source temperature was kept at 100 ºC 
and a capillary voltage of 3.5 kV was applied to the ESI source. Analyses were carried out in 
positive ion mode. Optimal collision energies – that produced the highest peak intensity for the 
main fragment peaks (see Section 9.2 – Appendix II) – were found to be 21, 19 and 21 eV for 
cocaine, BZE and EME respectively.  
To assess the sensitivity of the method, sweat standards containing cocaine, BZE and EME with 
varying concentrations between 0-100 ng/mL were prepared and analysed with the developed 
and optimised method. It was found that the peak resolution at the lower concentrations was 
poor. Figure 3-25 shows the overlay of the spectra around m/z 290 where the mass peak 
corresponding to BZE appears. This might be the result of background signals originating of 
the spray solvent (70:30 MeOH:H2O), from the matrix (artificial sweat) or because of ambient 
signals surrounding the area of analysis. The use of artificial sweat was based on the lack of a 
matrix that mimics the composition of a fingerprint in terms of components that may cause 
matrix effects – both ionisation suppression and enhancements. Ambient signals could not be 
controlled but the effect of the solvent can be observed.   
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Figure 3-25 – Overlay of spectra from around m/z 290 (BZE) for spiked sweat standards of 
concentrations between 0-100 ng/mL of cocaine, BZE and EME analysed using paper spray. 
Cocaine, BZE and EME are commercially available dissolved in acetonitrile, methanol and 
acetonitrile, respectively. This indicates that the solubility of each of the analytes is greater in 
these solvents. Thus, the use of acetonitrile as a spray solvent was retested by preparing a 50 
ng/mL solution of cocaine, BZE and EME in artificial sweat and analysing it in triplicate using 
the same method developed above (same MS tune settings, paper spray method and MS 
method) but using 70:30 MeOH:H2O (%v/v) and 100% ACN as separate spray solvents. 
Cocaine-D3 was again available as an internal standard. 
Figure 3-26 shows the overlay of spectra obtained using 70:30 (%v/v) MeOH:H2O and 100% 
ACN as spray solvents for (A) cocaine, (B) BZE and (C) EME in artificial sweat. Previously, 
both methanol and acetonitrile solvents yielded similar results in terms of measured intensities 
for cocaine, BZE and EME. Yet, the methanol-containing spray permitted the detection of more 
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amino acids and was therefore selected as the optimal spray solvent. However, it was found 
from the DESI and LESA experiments (described in sections 6.2 and 6.3) that normalisation to 
endogenous substances commonly found in fingerprints does not improve the variability seen 
with natural fingerprints and thus this approach was discarded. After full optimisation of the 
method, the use of acetonitrile yielded much higher peak intensities and improved peak 
resolution (Figure 3-26), which was possibly the result of reduced background noise around the 
peaks of interest.  
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Figure 3-26 – Overlay of the spectra of (A) cocaine, (B) BZE and (C) EME spiked into artificial 
sweat and analysed with paper spray using 70:30 (%v/v) MeOH:H2O and 100% ACN. Labelled 
peaks indicate the measure peak intensities for the analytes of interest. 
One disadvantage of using 100% ACN was the instability of the resulting total ion 
chromatogram. To attempt to stabilise the spray produced, water was added at three different 
% v/v – 100% ACN, 90:10 ACN:H2O and 80:20 ACN:H2O. Each spray solvent mixture was 
tested at two volumes – 80 µL and 100 µL – and the optimal geometry (distance between the 
tip of the paper and the cone inlet) was also optimised to yield the most stable total ion 
chromatogram over the 3 minute acquisition time (as MS method was 3 minutes long). This 
was achieved by pipetting the spray solvents onto a blank piece of triangular paper and applying 
4.0 kV. No sample or internal standard was loaded onto the paper. Distances were measured 
using a ruler (refer to Figure 3-12 for schematic representation of the paper spray 
configuration). Table 3-10 shows the best volume and distance from the inlet for each of the 
three solvents. The increase in spray solvent volume resulted in more stable sprays that lasted 
for longer. 
Table 3-10 – Optimal volume and distance to the cone inlet for each of the solvent compositions 
being tested. Parameters were optimised based on the resulting total ion chromatogram that gave 
the best stability over the acquisition time using each of the solvents on blank paper. Refer to 
Figure 3-12 for the schematic representation of the paper spray configuration. 
Solvent Composition Volume Distance from inlet (𝒙×𝒚) 
80:20 ACN:H2O 100 µL 2x3 mm 
90:10 ACN:H2O 100 µL 2x3 mm 
100:0 ACN:H2O 100 µL 2x2 mm 
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Using the information from Table 3-10, the spray solvent composition was tested by analysing 
artificial sweat spiked with cocaine, BZE and EME at 50 ng/mL (20 µL of each the standard 
and internal standard and 4.0 kV). The MS method was altered to allow for 3 minutes of full 
scan measurements in order to observe if the spray could last for the entire length of the data 
acquisition period. Figure 3-27 show the average measured intensities for cocaine, BZE and 
EME at 50 ng/mL using the three different spray compositions. The effect of the increased 
water content was not highly noticeable but 80:20 (%v/v) ACN:H2O resulted in the most stable 
and longer sprays. 
 
Figure 3-27 – Average measured intensity (n=3) for cocaine, BZE and EME detected in artificial 
sweat (50 ng/mL) using three different spray solvent compositions 
Thus, 80:20 (%v/v) ACN:H2O was chosen as the final paper spray solvent for the detection of 
cocaine, BZE and EME in artificial sweat. The paper spray method was kept the same as 
described in Figure 3-20 where 20 µL of sweat standard is pipetted onto the treated triangular 
piece followed by 20 µL of internal standard (500 ng/mL of each of cocaine-D3, BZE-D3 and 
EME-D3 in 100% ACN). Loaded paper is allowed to air dry for 10 minutes before being placed 
on the paper spray source, adding 100 µL of 80:20 (%v/v) ACN:H2O spray solvent and applying 
a 4.0 kV voltage.  
This method was then applied to the analysis of fingerprints collected from an individual 
seeking treatment at a drug rehabilitation clinic (fingerprint collection kits described in Figure 
3-7). Prior to collection, fingertips were wiped using alcohol free wipes (Steroplast®, 
Manchester, UK) and individuals were asked to wear nitrile gloves for 10 minutes to stimulate 
sweat. Upon removal of the gloves, participants were asked to touch their face with their hands, 
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rub the fingertips together and deposit the samples with a pressure between 800-1200 g 
measured using kitchen scales. Quantitation by LC-MS (analysis performed by Claritest 
(Norwich, UK) of the corresponding oral fluid sample revealed the presence of cocaine and 
BZE at a concentration greater than 64 ng/mL. Analysis were carried out using the paper spray 
method described above. Results showed that the sprays were not stable and occasionally the 
spray would fail during the MS/MS measurements. Figure 3-28 shows an example of the failed 
MS/MS ion chromatograms obtained for (A) cocaine, (B) BZE, (C) EME and (D) total ion 
chromatogram (full scan) obtained from a natural fingerprint. Because of the inconsistency in 
MS/MS measurements, presence of EME, BZE and cocaine could only be confirmed in 3/10, 
2/10 and 5/10 samples, respectively. In contrast, Figure 3-29 shows an example of successful 
MS/MS measurements taken from a fingerprint sample with paper spray. 
 
Figure 3-28 – Ion chromatograms from failed MS/MS measurements of (A) cocaine, (B) BZE 
and (C) EME and (D) full scan total ion chromatogram from natural fingerprints. 
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Figure 3-29 - Ion chromatograms from successful MS/MS measurements of (A) cocaine, (B) BZE 
and (C) EME and (D) full scan total ion chromatogram from natural fingerprints. 
To increase the length of the sprays and decrease the chances of the spray failing during the 
MS/MS measurements, voltage was turned off after the 2 minutes of full scan and a further 100 
µL of spray solvent (80:20 (%v/v) ACN:H2O) were added to the paper before restarting the 
voltage (4.0 kV). The second MS method consisted of 4 individual functions each lasting 0.5 
minutes. The first function consisted of a full scan, followed by MS/MS scans for EME (m/z 
200.1, collision energy = 21 eV), BZE (m/z 290.1, collision energy = 19 eV) and cocaine (m/z 
304.1, collision energy = 21 eV) – see Figure 3-30.  
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Figure 3-30 - MS method for the analysis of cocaine, BZE and EME using a two-step paper 
spray method. Data was acquired in full scan mode for 2 minutes, after which voltage was 
turned off and more spray solvent added. Voltage was restarted and second MS method 
consisted of four individual functions each lasting 0.5 minutes. The first function consisted of a 
full scan followed by MS/MS scans for EME, BZE and cocaine. 
A set of fingerprints collected from a second individual (Donor 1) was analysed using the same 
paper spray method but the new MS method. Corresponding oral fluid samples were analysed 
at Claritest (Norwich, UK) and cocaine and BZE were detected above 64 ng/mL.  
Figure 3-31 shows the ratio of A/IS measured for cocaine, BZE and EME in full scan mode. 
The three analytes could not be detected in full scan or MS/MS modes for the left ring finger 
due to a failed spray (poorly cut paper where tip of the paper was not sharp).  
 
Figure 3-31 – Plot of the average (n=3) ratio of analyte (A) to internal standard (IS) measured 
from 10 fingerprint samples collected from Donor 1. Data for BZE is plotted on the secondary 
axis. 
The resulting MS/MS measurements were more successful than previously. The presence of 
EME was confirmed in 7/9, BZE in 6/9 and cocaine in 7/9 fingerprint samples successfully 
(discarding the failed spray) analysed (Table 3-11).  
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Table 3-11 - Cocaine, BZE and EME fragments detected in fingerprint samples from Donor 1 
through tandem MS measurements using paper spray. x = not detected; √ = detected. 
 Cocaine fragment (m/z 
182) detected? 
BZE fragment (m/z 
168) detected? 
EME fragment (m/z 
182) detected? 
Left Thumb √ √ √ 
Left Index √ √ √ 
Left Middle x x x 
Left Ring √ x x 
Left Little √ √ √ 
Right Thumb x √ √ 
Right Index √ √ √ 
Right Middle √ x √ 
Right Ring x x x 
Right Little √ √ √ 
 
3.6.2. Investigation of matrix effects 
The use of sweat standards was thought to mimic the matrix effects of the fingerprint matrix. 
However, the volume of sweat standard (20 µL) added to the substrate is much higher than the 
volume of a single fingerprint. In addition, the drying of the sweat leads to pre-concentration 
of the sweat components on the substrate. These components may compete with the analytes of 
interest, leading to ionisation suppression effects. Thus, to observe the matrix effects of sweat 
versus fingerprints and acetonitrile, standards of cocaine, BZE and EME (50 ng/mL) were 
prepared in sweat and acetonitrile. The matrix effects of real fingerprints was tested by 
depositing five fingerprints (as the worst case scenario) and one single fingerprint (the real 
scenario) before the addition of the analyte standard prepared in acetonitrile (20 µl). Drug 
standards (in either acetonitrile or sweat) were pipetted onto the substrate (20 µL), followed by 
internal standard (500ng/mL of cocaine-D3, BZE-D3 and EME-D3) and allowed to air dry before 
being placed on the paper spray source. To the loaded paper, 100 µL of spray solvent (80:20 
(%v/v) ACN:H2O) was added and a voltage of 4.0 kV was applied. Data was acquired in full 
scan mode for 2 minutes.  
Figure 3-32 shows the average (n=3) measured peak intensities for cocaine, BZE and EME 
using acetonitrile and sweat standards and the presence of one or five fingerprint samples. There 
is a clear loss in measured intensities when artificial sweat is used for standard preparation, 
which suggests that the presence of sweat in the sample causes ionisation suppression of the 
analytes of interest. The addition of the fingerprint prior to the standard addition did not cause 
99 
 
significant losses in measured peak intensities. This suggests that the matrix effects caused by 
the artificial sweat are not representative of those seen with fingerprint samples. In addition, 
the matrix effects seen when a fingerprint is present is negligible when compared to the use of 
acetonitrile standards on their own.  
 
Figure 3-32 – Average (n=3) peak intensities for cocaine, BZE and EME in sweat, acetonitrile 
and in the presence of 1 or 5 fingerprint samples (standards used in these cases were also 
prepared in acetonitrile). 
As a result, sweat standards were replaced with acetonitrile standards. The final optimised paper 
spray method is described in Figure 3-33. 
 
Figure 3-33 – Final optimised paper spray method for the analysis of fingerprint samples and 
calibration standards. 
3.6.3. Final optimised paper spray method 
The final optimised paper spray method was used for the analysis of calibration standards 
(prepared in acetonitrile) in the range 0-700 ng/mL of cocaine, BZE and EME. An internal 
standard (cocaine-D3, BZE-D3 and EME-D3) was added to all standards analysed at 50 ng/mL. 
The concentration of the internal standard was lowered (from 500 ng/mL to 50 ng/mL) to reduce 
the possibility of competing ionisation with the analytes, as previously, the internal standard 
peaks would dominate the spectra with high peak intensities. The linear dynamic range was 
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found to be between 0-500 ng/mL for all three analytes and Figure 3-34 shows the calibration 
curves for (A) cocaine, (B) BZE and (C) EME. 
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Figure 3-34 - Calibration curves for (A) cocaine and (B) BZE  and (C) EME. Data was acquired 
using 100 μL of 80:20 ACN:H2O and an applied voltage of 4.0 kV. Internal standard was added 
at 50 ng/mL to every standard. 
Limits of detection (?̅?𝑏𝑙𝑎𝑛𝑘 + (3 ∙ 𝜎𝑏𝑙𝑎𝑛𝑘)) and quantification (?̅?𝑏𝑙𝑎𝑛𝑘 + (10 ∙ 𝜎𝑏𝑙𝑎𝑛𝑘)) were 
calculated in normalised counts and in ng/mL and are shown in Table 3-12. The LOD for 
cocaine and BZE were improved from the previously calibration curve (41 and 99 ng/mL, 
respectively). The calculated LODs for cocaine and BZE are also lower than the cut-off limits 
set by commercial providers for the detection of cocaine and BZE in oral fluid (8 ng/mL). In 
the case of EME, peak resolution at m/z 200 is poor and this is reflected in the calculated LOD 
of 31 ng/mL. The peak assignments in full scan mode were confirmed by the MS/MS 
measurements. 
Table 3-12 – Limit of detection (LOD) and limit of quantification (LOQ) for cocaine, BZE and 
EME in acetonitrile using the optimised paper spray method. 
 
LOD (normalised 
counts) 
LOD (ng/mL) 
LOQ (normalised 
counts) 
LOQ (ng/mL) 
Cocaine 0.03 1 0.09 5 
BZE 0.03 2 0.10 8 
EME 0.27 31 0.90 70 
 
3.7. Summary  
The paper spray method was optimised for the detection of cocaine, BZE and EME. The 
optimised method uses chromatography paper (Whatman grade 1) cut into a triangular shape 
(1.6mm at the base x 2.1 mm height). Paper is treated by immersing the pre-cut triangles in 
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0.1% HCl solution followed by 50:50 MeOH:H2O and air drying. For fingerprint collection and 
analysis, paper was cut into a specified shape (Figure 3-7) which could be cut along the base of 
the triangle before analysis. The same paper treatment described above is applied.  
The final optimised paper spray method of analysis includes loading of the sample on the pre-
cut and treated substrate – 20 µL of calibration standard or fingerprint sample -, addition of 
internal standard (20 µL) and air drying for 10 minutes. Loaded paper is placed on top of a glass 
slide and below a folded piece of aluminium foil and positioned on the paper spray. Spray 
solvent (80:20 (%v/v) ACN:H2O) is pipetted (100 µL) onto the paper and voltage is applied 
(4.0 kV). Data is acquired for 2 minutes in full scan mode (m/z 50-500), after which the voltage 
is turned off. Another 100 µL of spray solvent is added to the paper and voltage is restarted for 
another two minutes for MS/MS scan measurements. 
Using the method described above, limits of detection of cocaine, BZE and EME were 
calculated to be 1 ng/mL, 2 ng/mL and 31 ng/mL, respectively. The limits of quantification for 
cocaine and BZE, are below those employed by drug testing services for oral fluid (5 and 8 
ng/mL, respectively). 
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4. Investigation of the robustness of fingerprint 
testing 
4.1. Introduction 
This chapter applies the final optimised paper spray method described in Chapter 3 to 
fingerprint samples. First, the optimal sampling strategy for fingerprints was evaluated, 
followed by the qualitative correlation with cocaine use, using a large number of samples. Then, 
the quantitative capability of the technique is assessed and finally, various experiments to 
monitor secondary transfer, removal of contact residue and samples from the background 
population were carried out.  
Fingerprint and oral fluid samples were collected from rehabilitation clinics in Guildford 
(ACORN Drug and Alcohol Services, Guildford), Woking (The Xchange) and Chertsey (ACU, 
St Peter’s Hospital). Individuals attending these clinics are seeking treatment for substance 
addiction and are likely to have taken illicit substances. A favourable ethical opinion was 
received from the National Research Ethics Service (NRES) (REC reference: 14/LO/0346). 
Oral fluid samples were collected using a QuantisalTM (AllereTM) oral fluid collection device, 
which includes an absorbent pad with a volume indicator that turns blue when 1 mL of sample 
(±10%) has been collected. After collection, device is placed inside a buffer solution to stabilise 
the specimen (Alere, 2016b). Analysis of the oral fluid samples were carried out at Claritest 
(Norwich, UK). Claritest screening uses immunoassay testing followed by LC-MS/MS 
quantitation if screening is positive (Claritest, 2015). 
Fingerprint samples were collected using collection devices as shown in Figure 3-7 (Chapter 
3). The chromatography paper was cut into a “house shape”; the dimensions of triangle were 
kept as 1.6 x 2.1 cm (base x height) and a rectangular extension was used to tape the paper to a 
glass slide. This avoided contamination of the area of analysis (the triangle) by the tape. The 
sample was cut at the bottom of the triangle prior to analysis. Fingerprints were collected using 
kitchen scales that were used to measure the pressure applied during collection, which was kept 
between 800-1200 g for 10 seconds, unless otherwise specified. As discussed above, the 
presence of the parent drug, cocaine, may not exclusively relate to cocaine excreted from the 
eccrine glands because of the possibility of cocaine being picked up through contact with a 
contaminated surface. Thus, the ideal fingerprint collection procedure developed should ensure 
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that any traces of contact residues are removed whilst simultaneously guaranteeing that enough 
eccrine sweat is collected for the detection of cocaine and metabolites. Table 4-1 shows the 
number of samples collected for each collection procedure (described later). 
Table 4-1 - Oral fluid results and fingerprint detection rate (number of fingerprints positive) for cocaine, 
BZE and EME obtained for Donors 1 to 12 analysed using paper spray mass spectrometry. *Data for Donor 
1 was previously reported in Section 3.6.1. 
Sample Collection 
Procedure 
 Cocaine EME BZE 
“Wipes” 
Donor 1* >64.0 ng/mL - >64.0 ng/mL 
Donor 2 >64.0 ng/mL - >64.0 ng/mL 
Donor 3 8.2 ng/mL - >64.0 ng/mL 
Donor 4 >64.0 ng/mL - >64.0 ng/mL 
“Soap” 
Donor 5 >64.0 ng/mL - >64.0 ng/mL 
Donor 6 12 ng/mL - 30.0 ng/mL 
Donor 7 Negative - Negative 
“Ungroomed – wipes” 
Donor 8 >64.0 ng/mL - >64.0 ng/mL 
Donor 9 >64.0 ng/mL - >64.0 ng/mL 
Donor 10 >64.0 ng/mL - >64.0 ng/mL 
Donor 11 >64.0 ng/mL - >64.0 ng/mL 
Donor 12 >64.0 ng/mL - >64.0 ng/mL 
 
4.2. Fingerprint collection procedure  
Two fingerprint collection procedures were trialled. The first collection procedure included 
wiping the fingertips using alcohol free wipes (Steroplast®, Manchester, UK), wearing nitrile 
gloves for 10 minutes, touching the face, rubbing the fingertips together and depositing the 
samples. For the second collection procedure, participants were asked to wash their hands with 
soap and wear nitrile gloves for 10 minutes before following the same procedure as above. For 
simplicity, Method 1 will be referred to as “wipe” and Method 2 as “soap”. A total of 30 
fingerprint samples (10 samples from 3 different donors) were analysed for each collection 
procedure (total of 60 samples). Oral fluid samples were simultaneously collected and Table 
4-1 shows the quantitative oral fluid results.  
Samples were analysed using the final optimised paper spray method (Chapter 3, Figure 3-33) 
and the MS method described in Figure 3-30. MS tune settings are described in Table 3-5. Full 
scan spectra were interrogated for the presence of cocaine, BZE and EME and respective 
internal standards, with a mass accuracy of ±118 ppm. Full scan data was used for semi-
quantitative purposes. MS/MS spectra were interrogated for the presence of the main fragments 
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of each of the analytes, for qualitative identification of the analytes (Section 9.2 – Appendix 
II). 
Figure 4-1 shows the ratio of cocaine to cocaine-D3 from the fingerprint samples from Donors 
2, 3, 5 and 6 (see Section 9.3 – Appendix III for data on Donors 4 and 7). Cocaine (confirmed 
by MS/MS, see Table 4-2) was consistently detected in all 30 fingerprint samples collected 
from all three participants using the “wipes” method. Using the “soap” method, cocaine 
fragment was only detected in 28 out of 30 samples analysed in MS/MS mode. The oral fluid 
for Donor 7 tested negative for the presence of cocaine in the screening test (and therefore no 
confirmatory test was carried out). However, cocaine was detected in 9/10 samples analysed 
(in MS/MS mode) and BZE in 4/10 samples (in MS/MS mode). This could be the result of 
different detection windows for the two matrices (oral fluid and sweat) or because BZE (the 
target analyte of the immunoassay screening test) was below the detection limit of the test (20 
ng/mL). The participant reported taking cocaine. 
Based on the ratio of analyte to IS (A/IS), hand washing with soap is more efficient at removing 
cocaine from the hands as the levels are much lower with the “soap” method than with the 
“wipes” method (Figure 4-1). However, the two methods were compared using different 
donors, which will have taken different amounts of cocaine and will have different metabolism 
and excretion rates. Therefore, the observed concentration of cocaine and metabolites in their 
fingerprints could be different for reasons other than the difference in sampling method. For 
this reason, caution must be taken when taking any conclusions from this data. Furthermore, 
the participants were asked to touch their face and could therefore, have picked up residues 
from the face. 
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Figure 4-1 – Ratio of cocaine/cocaine-D3 detected in full scan in natural fingerprint samples 
collected from individuals seeking treatment at a drug rehabilitation centre after (A) wiping 
fingertips with alcohol free wipes and (B) washing hands with soap. Internal standard was 
present in every sample at 500 ng/mL. 
For the “wipes” method, BZE was detected in 21 out of the 30 samples analysed in full scan 
and this was confirmed by the MS/MS scans where the main BZE fragment was detected in 22 
out of the 30 samples (see Table 4-2). For donor 3, BZE could only be detected in 2 fingerprint 
samples in full scan (and in 5/10 in MS/MS scans) even though cocaine was detected in 10/10 
samples and EME in 7/10 samples (as confirmed by MS/MS in both cases). Consequently, the 
origin of cocaine (ingestion or contact residue) could not be determined. For the “soap” method, 
BZE was detected in 12 out of 30 samples in full scan and in 10/30 in MS/MS scans (Table 
4-2). Similarly to cocaine, the ratios of A/IS for BZE measured using the “wipes” method were 
higher than with the “soap” method (Figure 4-2). This adds to the conclusions previously taken 
that suggested that washing the hands with soap is more efficient at removing material from the 
fingertips. Furthermore, sweating into gloves for 10 minutes might not be sufficient to stimulate 
enough material for the detection of the metabolites. However, as previously highlighted, the 
fingerprints were collected from different donors, which makes the comparison inadequate. 
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Figure 4-2 - Ratio of BZE/BZE-D3 detected in natural fingerprint samples collected from 
individuals seeking treatment at a drug rehabilitation centre after (A) wiping fingertips with 
alcohol free wipes and (B) washing hands with soap. Internal standard was present in every 
sample at 500 ng/mL. 
EME could not be detected in full scan mode in any of the fingerprint samples analysed due to 
the lack of peak resolution. However, the main EME fragment was detected in MS/MS scans 
of 24/30 samples analysed using the “wipes” method and in only 6/30 samples analysed using 
the “soap” method (Table 4-2). Therefore, EME proposes similar conclusions as cocaine and 
BZE where after hand washing, the substance was detected less frequently. 
The samples analysed above were collected after touching the face and although this may 
increase the amount of sebaceous content in the samples, it is not representative of the eccrine 
sweat normally excreted at the fingertips. Furthermore, touching the face will lead to an 
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exchange of material between the face and the fingers, which may lead to loss of the analytes 
and a consequent gain of other compounds. The data presented in this section shows that wiping 
is preferable to washing hands with soap the collection procedure.  
New sets of fingerprint samples were collected using the “wipes” method – but after sweating 
into gloves for 10 minutes, samples were immediately deposited on the collection kit (pressure 
between 800-1200 g) without touching any other surface – “ungroomed – wipes” method. 
Samples were collected from 5 individuals. The same paper spray method, MS tune settings 
and MS method as described above were applied. Internal standard (cocaine-D3, BZE-D3 and 
EME-D3) was added to every sample analysed at 50 ng/mL. Oral fluid samples were 
simultaneously collected and quantitative results are shown in Table 4-1. 
Analysis of the fingerprint samples was carried out in both full scan and MS/MS modes. Table 
4-2 shows the detection rate for each donor (out of 10 samples) for each of the three analytes. 
For each donor, the presence of the parent drug or one of the metabolites was confirmed through 
MS/MS measurements in all ten fingers (highlighted in green). This was corroborated by the 
oral fluid results. Table 4-2 shows the detection rate of cocaine, BZE and EME in MS/MS 
mode. 
The oral fluid confirmation test showed that all donors had more than 64 ng/mL of cocaine and 
BZE in their oral fluid. However, comparison of the ratios of A/IS for cocaine obtained from 
the full scan measurements (Figure 4-3) show that Donor 10 had the highest levels of cocaine 
and Donor 8 the lowest in their respective fingerprint sample. BZE was consistently detected 
in Donor’s 10 fingerprints in full scan mode (see Section 9.4 – Appendix IV). EME was only 
detected for Donor 12 (see Section 9.4 – Appendix IV). 
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Figure 4-3 - Ratio of A/IS for cocaine detected in natural fingerprint samples collected from 
Donors 8 to 12 after wiping fingertips with alcohol free wipes, wearing gloves for 10 minutes and 
depositing samples with a pressure between 800-1200 g. Internal standard was present in every 
sample at 50 ng/mL. 
Table 4-2 shows the MS/MS results obtained from all fingerprint samples analysed with the 
final optimised paper spray method. Donors 29 to 32 are later discussed in Section 5.3. A total 
of sixteen donors (10 fingerprint samples from each) were analysed and of those, thirteen tested 
for positive for at least one of the substances of interest (cocaine, BZE and EME) in all ten 
fingerprint samples. For Donor 5 (used the “soap” method), cocaine was only detected in 9/10 
samples. Therefore, the lack of sensitivity is explained by the washing method. For Donor 7, 
the spray failed for the right index finger, hence why the substances were not detected. For 
Donor 14, none of the substances could be detected on the left index sample and this is a true 
false negative, possibly arising from insufficient fingerprint collection. Thus, if the failed spray 
sample is ignored, out of the 159 fingerprint samples successfully analysed, 99% (158) tested 
positive for cocaine, 54% tested positive for EME and 43% tested positive for BZE.  
4.2.1. Quantification 
It is interesting to note that Donors 2 and 3 have distinctively different levels of cocaine in their 
corresponding oral fluid samples (>64 ng/mL and 8.2 ng/mL, respectively). This was also seen 
with the fingerprint samples, where the ratio of A/IS in any given finger was systematically 
higher for Donor 2 compared to Donor 3. Additionally, there is a pattern in the data where the 
little fingers have consistently lower levels of the parent drug than the remaining fingers. The 
RSD% for the fingerprints of Donors 2 and 3 was calculated as 49% and 83%, respectively. 
This could be a result of the difficulty in positioning the finger accurately on the paper triangle, 
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variability in eccrine sweat produced by each finger and the difficulty in controlling the contact 
pressure. The precision of the paper spray method was calculated to be 3-18% for cocaine (see 
Chapter 3, Section 3.6) using calibration standards and therefore the fingerprint samples are 
significantly different from one another. In contrast, the amount of BZE measured in the 
fingerprint samples of these donors does not always indicate a higher level in Donor 2 than 
Donor 3, and this highlights the difficulty in correlating oral fluid and fingerprint measurements 
in a quantitative manner. This could be due to a difference in detection window between the 
two matrices. Reports in the literature suggest the possibility of using endogenous substances 
as “normalising” factors. However, these substances are also subject to the different areas of 
the fingerprints and further studies are required to ensure that these are secreted at a constant 
rate.  This is briefly explored in Sections 6.2 and 6.3 (DESI and LESA), but it was found that 
the use of endogenous substances did not smooth the variability seen within and between 
fingerprints samples from the same donor. Thus, due to the variability in fingerprint depositions, 
the method developed is more appropriate as a semi-quantitative method.  
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Table 4-2 – Oral fluid and fingerprint results obtained for Donors 1 to 16 analysed with the optimised paper spray method. √ = detected; N/D = not 
detected. 
Drugs & 
Metabolites 
Oral Fluid Results  
Fingerprint Results  
R. 
Little  
R. 
Ring 
R. 
Middle 
R. Index R. Thumb 
L. 
Little  
L. 
Ring 
L. 
Middle 
L. 
Index 
L. 
Thumb 
    Donor 1 
Cocaine >64.0 ng/mL √ √ √ √ √ √ √ √ √ √ 
EME - √ √ √ √ √ √ N/D N/D √ √ 
BZE >64.0 ng/mL √ √ √ √ √ √ N/D √ √ √ 
    Donor 2 
Cocaine >64.0 ng/mL √ √ √ √ √ √ √ √ √ √ 
EME - √ √ √ √ √ √ √ √ √ √ 
BZE >64.0 ng/mL √ √ √ √ √ √ √ √ √ √ 
    Donor 3 
Cocaine 8.2 ng/mL √ √ √ √ √ √ √ √ √ √ 
EME - √ N/D √ √ √ N/D √ √ √ N/D 
BZE 42.5 ng/mL N/D √ √ √ √ N/D N/D √ √ √ 
    Donor 4 
Cocaine >64.0 ng/mL √ √ √ √ √ √ √ √ √ √ 
EME - N/D √ √ √ N/D N/D √ √ √ √ 
BZE >64.0 ng/mL N/D √ √ N/D N/D N/D √ √ N/D √ 
    Donor 5 
Cocaine >64.0 ng/mL √ √ √ √ √ N/D √ √ √ √ 
EME - N/D N/D N/D N/D √ N/D √ √ N/D √ 
BZE >64.0 ng/mL N/D N/D N/D N/D √ N/D N/D N/D √ N/D 
    Donor 6 
Cocaine 12.0 ng/mL √ √ √ √ √ √ √ √ √ √ 
EME - N/D N/D N/D N/D N/D N/D N/D √ √ N/D 
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BZE 30.0 ng/mL N/D √ √ N/D N/D N/D N/D √ √ N/D 
    Donor 7 
Cocaine Negative √ √ √ 
Failed 
Spray 
√ √ √ √ √ √ 
EME - N/D N/D N/D N/D N/D N/D N/D N/D N/D 
BZE Negative N/D N/D N/D √ N/D √ √ √ N/D 
    Donor 8 
Cocaine >64.0 ng/mL √ √ √ √ √ √ √ √ √ √ 
EME - √ √ √ N/D N/D N/D √ N/D √ N/D 
BZE >64.0 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
    Donor 9 
Cocaine >64.0 ng/mL √ N/D √ N/D √ N/D √ √ √ √ 
EME - √ √ √ √ √ √ √ √ √ √ 
BZE >64.0 ng/mL N/D √ √ √ √ √ N/D N/D √ √ 
    Donor 10 
Cocaine >64.0 ng/mL N/D √ √ √ √ √ √ √ √ √ 
EME - √ √ √ √ √ √ √ √ √ √ 
BZE >64.0 ng/mL √ √ √ √ √ √ √ √ √ √ 
    Donor 11 
Cocaine >64.0 ng/mL √ √ √ √ √ √ √ √ √ √ 
EME - N/D N/D N/D N/D N/D √ √ N/D √ √ 
BZE >64.0 ng/mL N/D N/D N/D √ N/D N/D N/D N/D N/D N/D 
    Donor 12 
Cocaine >64.0 ng/mL √ √ √ √ √ √ √ √ √ √ 
EME - N/D N/D N/D N/D N/D √ √ √ N/D √ 
BZE >64.0 ng/mL N/D N/D N/D √ N/D N/D N/D N/D N/D N/D 
  Donor 29 
Cocaine >64.0 ng/mL √ √ √ √ √ √ √ √ √ √ 
EME - N/D √ N/D N/D N/D √ √ N/D N/D √ 
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BZE >64.0 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
  Donor 30 
Cocaine >64.0 ng/mL √ √ √ √ √ √ √ √ N/D √ 
EME - √ N/D N/D √ √ √ √ √ N/D √ 
BZE >64.0 ng/mL √ √ √ √ √ √ N/D √ N/D √ 
 Donor 31 
Cocaine 40.3 ng/mL √ √ √ √ √ √ √ √ √ √ 
EME - N/D N/D N/D N/D N/D √ √ N/D √ √ 
BZE >64.0 ng/mL N/D N/D N/D N/D √ √ √ √ √ √ 
  Donor 32 
Cocaine 
Negative (5.77 
ng/mL) 
√ √ √ √ √ √ √ √ √ √ 
EME - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
BZE >64.0 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
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4.2.2. Stability of Cocaine 
No studies have been reported on the stability of cocaine, BZE and EME in fingerprint 
samples. To briefly test this, fingerprint samples collected from an individual attending a 
rehabilitation clinic were analysed on two different days. Fingerprint samples were collected 
on the 2nd of February 2016 using the same procedure as described above and oral fluid 
confirmation testing detected the presence of cocaine and BZE at 53.1 ng/mL and 9.39 
ng/mL, respectively. Samples were stored in a fridge at 2-5 °C. 
The left hand was analysed on the 3rd of March 2016 using 80 µL of 100% ACN (with 0.1% 
formic acid) and the right hand was analysed on the 17th of May 2016 using 100 µL of 80:20 
ACN:H2O (with 0.1% formic acid). The analyses of the two hands was carried out using 
different solvents because the paper spray method was under optimisation. Figure 3-27 
(Chapter 3) shows the average measured intensities measured when different percentages of 
acetonitrile were applied for the detection of cocaine, BZE and EME in artificial sweat. The 
average measured intensity was found to not vary significantly, with the varying acetonitrile 
content. Thus, the two different solvents employed should not affect the detection of cocaine, 
BZE and EME.  
Figure 4-4 shows the ratio of A/IS for cocaine, BZE and EME measured from the fingerprint 
samples analysed on two separate occasions. For cocaine and EME, the ratio of A/IS 
measured on the 17th of May were lower than those measured on the 3rd of March, especially 
for EME. BZE, on the other hand, was detected more frequently and with higher ratios on 
the second day of analysis.  
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Figure 4-4 – Ratio A/IS for cocaine, BZE and EME measured from fingerprints of the left 
and right hand of one single donor, analysed at two different time points after collection. 
This suggests that cocaine could have hydrolysed in the sample to yield BZE, although the 
variability encountered with fingerprint samples collected from the same donor might 
influence the ratios detected on the two hands. One other metabolite of cocaine is ecgonine 
(m/z 186.11). The full scan data obtained on both days was interrogated for the presence of 
ecgonine. It was detected only in the samples analysed on the 17th of May with a mass 
accuracy of approximately 55 ppm. Figure 4-5 shows the overlay of spectra around the mass 
of ecgonine (m/z 186) for the left middle and right middle fingers analysed on the 3rd March 
and 17th May, respectively. Therefore, this proposed that cocaine, BZE and EME can 
potentially hydrolyse on the paper substrate, which suggests further studies on the stability 
of the analytes in fingerprint samples should be carried out to ensure that the samples are 
analysed before any change occurs. This also suggests that quantification of drugs and 
metabolites in a fingerprint is subject to changes in the fingerprint composition. From a 
qualitative screening point-of-view, all five samples tested 3 months after collection 
provided positive results. 
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Figure 4-5 – Overlay of the spectra obtained from fingerprints analysed on the 03/03/2016 
and 17/05/2016 at the m/z 186 region (ecgonine). 
The stability of cocaine, BZE and EME in acetonitrile and artificial sweat (used to prepare 
standards throughout the experiments in this thesis) was tested by Mahado Ismail, using LC-
MS. The system comprised of a Waters® ACQUITY UPLC™ and a Waters® Q-ToF 
Premier™ mass spectrometer (Waters, Hertfordsire). The chromatography method used a 
Kinetex XB-C18 (5 µm, 100 x 2.1 mm) column (Phenomenex, Cheshire), which was kept 
at 30 °C throughout the analysis. The mobile phase was delivered through a gradient of 
mobile phase A (20 mM ammonium acetate in 95:5 H2O:ACN) and mobile phase B (0.1% 
FA in ACN) at 0.25 mL/min. Table 4-3 shows the gradient profile of the chromatography 
method used. The injection volume was set at 10 µL, with a 3 minute run time. The mass 
spectrometer was run in full scan mode, with a capillary voltage of 3.0 kV, a sampling cone 
of 30 V and an extraction cone voltage of 5.0 V. The source temperature was kept at 100 °C 
and the desolvation temperature was set to 400 °C.  
Table 4-3 – Gradient profile of the LC method used to test the stability of cocaine, BZE and 
EME in acetonitrile and artificial sweat.  
Time (min) % A % B 
0.0 80 20 
2.0 20 80 
2.5 20 80 
2.6 80 20 
3.0 80 20 
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Stock solutions containing a mixture of cocaine, BZE and EME (at 500 ng/mL, 1000 ng/mL 
and 500 ng/mL, respectively) were prepared in acetonitrile and sweat. At each time point (t 
= 0 to t = 72 hours), the stock solutions were individually diluted into the initial mobile phase 
composition to make up a concentration of 50 ng/mL for cocaine and EME and 100 ng/mL 
for BZE. An internal standard solution containing cocaine-D3, BZE-D3 and EME-D3 was 
added to every sample at 50 ng/mL. 
Section 9.5 – Appendix V shows the ratio of A/IS of cocaine, BZE and EME in artificial 
sweat and acetonitrile measured over a 72 hour period. All three analytes were found to be 
stable with relative standard deviations of 4%, 7% and 7% for cocaine, BZE and EME over 
the 72-hour period. 
These findings indicate that the three analytes were stable in the artificial sweat used for 
paper spray optimisation but not in fingerprint samples collected from participants. This 
might be the result of the different pH of the artificial sweat (pH = 4.5) and human sweat 
(approximately 5.8) (Kidwell et al., 1998). The presence of enzymes in the sweat may also 
contribute to the metabolism of these substances.  
4.3. Cocaine in the fingerprints of the background population 
Fingers are exposed to general environmental conditions and are likely to be exposed to 
surfaces that are contaminated with all sort of substances, including drugs of abuse. To 
observe the background levels of cocaine, BZE and EME in the general population, 
fingerprint samples were collected from 40 participants from the general population. 
Fingertips were wiped with alcohol free wipes and gloves were worn for 10 minutes to 
induce sweating. Samples were collected using the same collection kit described earlier 
(Figure 3-7) with a pressure of 800-1200 g (measured with kitchen scales and held for 10 
seconds). Two samples – right index and right middle – were collected from each donor (a 
total of 80 samples). The paper spray method is described in Figure 3-33, MS method is 
defined in Figure 3-30 and MS tune settings can be found in Table 3-5. Internal standard 
(cocaine-D3, BZE-D3 and EME-D3) was added to every sample and blank at 50 ng/mL. 
Fragment ions relating to cocaine and EME were detected in MS/MS mode in 2 (from two 
different donors) of the 80 samples analysed. The origin of these two substances could not 
be confirmed as only one of the two samples collected from the two donors tested positive 
and no oral fluid sample was collected from the donors. This could be the result of 
contamination of the sample prior to or during the analysis or the result of contact residues 
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that could not be removed by the cleaning procedure. Alternatively, the presence of the 
analytes could have been due to contact residue that was not removed by the collection 
procedure. This makes a > 2.5% false positive rate from the paper spray method developed 
based on a single fingerprint. BZE was not detected in any of the samples. To minimise the 
false-positive rate, the final protocol should use two fingerprint samples per donor which, 
based on the data reported above, would result in a 0% false-positive rate. As a result, a true-
positive result would be based on the detection of at least one of the analytes in both 
fingerprint samples. 
4.3.1. Cocaine from currency 
As of 2011, findings from police investigations across 15 police forces in Great Britain 
suggested that 11% of UK bank notes contain traces of cocaine (Travis, 2011). 
Consequently, there may be chances of detecting traces of cocaine in fingerprint samples 
from people who are not drug users, particularly for occupations where money is handled 
(e.g. bank teller, cashier). Thus, in a small scale experiment (total of 16 fingerprint samples), 
samples were collected from two cashiers from two small businesses at the University and 
from two participants who were asked to handle the same £20 bank note. Samples were 
collected as presented (pre-wipe) and after (post-wipe) the previously described wiping 
procedure and fingerprint collection method. Samples were collected from the right thumb 
and index fingers. The final optimised paper spray method was applied (Figure 3-33). 
Cocaine, BZE and EME were not detected in any of the samples analysed, as confirmed by 
MS/MS, with the exception of the first donor to handle the £20 bank note who picked up 
cocaine (but not the metabolites) on both fingers (Table 4-4). The sample collection 
procedure (which included wiping the fingertips) was not sufficient to remove the traces of 
cocaine from both fingers as the right index also tested positive for cocaine in MS/MS mode 
after wiping. There is therefore an implication on the interpretation of a cocaine test applied 
to a fingerprint. The sprays for Donor 14 pre-wiping right thumb and Donor 16 pre-wiping 
right index failed and therefore, no conclusions can be made regarding these samples. 
Samples were not re-analysed as this could result in a loss of sensitivity.  
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Table 4-4 – MS/MS results for fingerprint samples collected from cashiers (Donors 13 and 14) 
and from individuals after handling a bank note (Donors 15 and 16). √ = detected; N/D = not 
detected 
  
Cocaine  
Fragment  
(304>182) 
BZE  
Fragment  
(290>168) 
EME  
Fragment  
(200>182) 
Donor 13 Pre Wiping 
Right Index N/D N/D N/D 
Right Thumb N/D N/D N/D 
Donor 13 Post Wiping 
Right Index N/D N/D N/D 
Right Thumb N/D N/D N/D 
Donor 14 Pre Wiping 
Right Index N/D N/D N/D 
Right Thumb Failed Spray 
Donor 14 Post Wiping 
Right Index N/D N/D N/D 
Right Thumb N/D N/D N/D 
Donor 15 Pre Wiping 
Right Index √ N/D N/D 
Right Thumb √ N/D N/D 
Donor 15 Post Wiping 
Right Index √ N/D N/D 
Right Thumb N/D N/D N/D 
Donor 16 Pre Wiping 
Right Index Failed Spray 
Right Thumb N/D N/D N/D 
Donor 16 Post Wiping 
Right Index N/D N/D N/D 
Right Thumb N/D N/D N/D 
 
4.4. Contact residue and secondary transfer 
Previous authors have argued that the use of fingerprint samples for drug testing depends on 
the ability to differentiate between detection of the parent drug and a metabolite as a result 
of contact versus ingestion (Bailey et al., 2015, Groeneveld et al., 2015). No formal studies 
have been reported on the detection of cocaine and metabolites in fingerprints after 
controlled administration of the drugs. However, a few studies have been reported on the 
dermal absorption and dermal detection of drugs of abuse and respective metabolites under 
controlled measures (Baselt et al., 1990, Cone et al., 1994, Kidwell et al., 2001). 
Additionally, cocaine was also found to decompose to BZE when present on the skin 
(Kidwell et al., 2001). Consequently, it is possible that the detection of the metabolites in a 
fingerprint cannot be used as concrete proof that the drug was administered. Other research 
has also shown that drugs of abuse can remain on the skin for several days (Kidwell et al., 
1997). Therefore, the fingerprint collection protocol will have to remove any contamination 
that may have occurred through contact with a contaminated surface.  
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To observe the appropriateness of the fingerprint collection methods described in Section 
4.2 and the effect of secondary transfer between people, a set of experiments were carried 
out where participants were asked to handle cocaine seized by the police. Seized cocaine 
(free base) samples were provided by the Forensic Science Ireland (FSI) and the purity of 
the sample was measured (using GC-MS) and determined to be 41%, by the FSI. Adulterants 
such as caffeine, lignocaine and levamisole were identified as cutting agents. GC-MS 
analysis also revealed traces of BZE and EME in the seized sample (see Section 9.6 – 
Appendix VI for GC-MS results).  
Fingerprint samples were collected using the same fingerprint collection device as pictured 
in Figure 3-7 and stored in microscope slide storage boxes organised by four different 
scenarios (i.e. each box contained all the samples collected for each scenario, including 
samples collected for with drugs of abuse). Four individual scenarios were considered and 
the Table 4-5 shows the number of participants (two samples collected per donor) used for 
each experiment. 
Table 4-5 – Number of participants (two samples per donor) recruited per scenario for the 
contact residues and secondary transfer experiments. See description of each individual 
scenario below. 
 
Donor 
21 
Donor 
22 
Donor 
23 
Donor 
24 
Donor 
25 
Donor 
26 
Donor 
27 
Donor 
28 
Scenario 1 x x x      
Scenario 2 x x x      
Scenario 3    x x x   
Scenario 4       x x 
 
4.4.1. Scenario 1 
Three lots of 2 mg of cocaine were weighed into individual weighing boats. The three 
participants (Donors 21, 22 and 23) were individually asked to touch the 2 mg of cocaine 
with all ten fingers consecutively before dusting the excess off and immediately depositing 
fingerprint samples from the left index and middle fingers using kitchen scales and an 
applied pressure between 800 – 1200 g for 10 seconds. 
As expected, cocaine was detected in all samples analysed using paper spray. BZE was 
detected in 5/6 samples and EME was detected in 6/6 samples (Table 4-6). This represents 
the worst-case scenario and shows unequivocally that the detection of drug and metabolites 
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in a fingerprint is not unique to ingestion of a drug. As discussed earlier in Section 1.2.1, the 
illicit production of cocaine may result in the simultaneous production of its two main 
metabolites – EME and BZE - which are not removed from the final product. The data further 
demonstrates that the fingerprint collection procedure should include a hand cleaning step 
that will remove any contact residue from the fingertips. The next two scenarios explore two 
different hand cleaning procedures and determines which one is more efficient at removing 
contact residues. Section 9.7 – Appendix VII, shows the ratios of A/IS calculated for the 
fingerprint samples analysed as part of the Scenario 1 experiments. 
Table 4-6 – Detection rate for cocaine, BZE and EME fragments measured from fingerprint 
samples collected after contact with cocaine powder seized from the police (Scenario 1) based 
on MS/MS data. Internal standard was added to every sample at 50 ng/mL. √ = detected; N/D 
= not detected. 
 
Cocaine fragment 
(m/z 182) detected? 
BZE fragment 
(m/z 168) detected? 
EME fragment 
(m/z 182) detected? 
Donor 21 
Left Index √ √ √ 
Left Middle √ √ √ 
Donor 22 
Left Index √ N/D √ 
Left Middle √ √ √ 
Donor 23 
Left Index √ √ √ 
Left Middle √ √ √ 
 
4.4.2. Scenario 2 
After providing samples as part of Scenario 1, participants (Donors 21, 22 and 23) had their 
fingertips wiped using alcohol free wipes (Steroplast®, Manchester, UK) and were asked 
wear gloves for 10 minutes to induce sweat. After the 10 minutes, participants rubbed their 
hands together and deposited fingerprint samples from left index and middle fingers using 
kitchen scales and an applied pressure between 800 – 1200 g for 10 seconds. 
Cocaine was identified through the detection of the main fragment ion (304>182) in all 
samples analysed. EME, on the other hand, was only detected in 3/6 samples analysed and 
BZE was not present in any of the samples (Table 4-7). This suggests that the hand cleaning 
procedure was not sufficient to remove contact residues of cocaine and EME but enough to 
remove traces of BZE. Section 9.7 – Appendix VII, shows the plot of the ratios of A/IS 
calculated for the fingerprint samples analysed as part of the Scenario 2 experiments. The 
calculated A/IS ratio for cocaine  in Scenario 1 are generally higher than those calculated for 
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Scenario 2, with the exception of the left middle finger from Donor 21. However, the 
difference may be within the error of the measurements (shown to vary between 3-33% with 
calibration standards). In the case of EME, the A/IS ratio for both samples from Donor 21 
and the left index from Donor 22 are higher in Scenario 1 than Scenario 2. This was not the 
result of the low sensitivity of the method to EME as all of the calculated ratios were above 
the limit of detection (LOD = 0.08) calculated from the three blank measurements taken at 
the beginning of the run. The same alcohol free wipe was used to wipe all ten fingers and 
this could have resulted in carryover of analytes from one finger to the other - however, this 
effect was only seen in one other sample for cocaine (as explained above). The metabolism 
of cocaine to EME on the skin is unlikely as BZE is the primary metabolite of cocaine and 
not EME. Lastly, it could the result of the variability of the fingerprint collection procedure 
that results in different amounts of substances to be transferred to the paper.  
Table 4-7 – Detection rate for cocaine, BZE and EME fragments measured from fingerprint 
samples collected after contact with cocaine powder seized from the police and wiping 
fingertips (Scenario 2) based on MS/MS data. Internal standard was added to every sample at 
50 ng/mL. √ = detected; N/D = not detected. 
 
Cocaine fragment 
(m/z 182) detected? 
BZE fragment 
(m/z 168) detected? 
EME fragment 
(m/z 182) detected? 
Donor 21 
Left Index √ N/D √ 
Left Middle √ N/D √ 
Donor 22 
Left Index √ N/D N/D 
Left Middle √ N/D √ 
Donor 23 
Left Index √ N/D N/D 
Left Middle √ N/D N/D 
 
4.4.3. Scenario 3 
Three lots of 2 mg of cocaine were weighed into individual weighing boats. The three 
participants (Donors 24, 25 and 26) were individually asked to touch the 2 mg of cocaine 
with all ten fingers consecutively before dusting the excess off and washing hands using 
soap (Dove Caring Hand Wash, batch no. 60497BX). Participants were then asked wear 
gloves for 10 minutes to induce sweat. After the 10 minutes, participants rubbed their hands 
together and deposited fingerprint samples from left index and middle fingers using kitchen 
scales and an applied pressure between 800 – 1200 g for 10 seconds. 
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Table 4-8 shows the detection rate for the main cocaine fragment (304>182). Similarly to 
Scenario 2, the hand cleaning procedure did not completely remove traces of cocaine. On 
the other hand, BZE and EME were not detected in MS/MS or full scan. Thus, washing the 
hands with soap is much more efficient at removing contact residue that wiping the 
fingertips. Section 9.7 – Appendix VII shows the plot of the ratios of A/IS calculated for the 
fingerprint samples analysed as part of the Scenario 3 experiments. The A/IS ratio calculated 
for cocaine is much lower than those calculated for Scenarios 1 and 2, as shown in Figure 
4-6 where the average A/IS ratio was calculated for each scenario (average of all samples 
collected from all three donors). Error bars show the standard deviation of the measurements.  
Table 4-8 – Detection rate for cocaine, BZE and EME fragments measured from fingerprint 
samples collected after contact with cocaine powder seized from the police and washing hands 
(Scenario 3) based on MS/MS data. Internal standard was added to every sample at 50 ng/mL. 
√ = detected; N/D = not detected. 
 
Cocaine fragment 
(m/z 182) detected? 
BZE fragment 
(m/z 168) detected? 
EME fragment 
(m/z 182) detected? 
Donor 24 
Left Index √ N/D N/D 
Left Middle √ N/D N/D 
Donor 25 
Left Index √ N/D N/D 
Left Middle √ N/D N/D 
Donor 26 
Left Index N/D N/D N/D 
Left Middle √ N/D N/D 
 
 
Figure 4-6 – Average analyte to internal standard (A/IS) ratio calculated for cocaine for each 
scenario. 
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4.4.4. Scenario 4 
One lot of 2 mg of cocaine was weighed into an individual weighing boat. One participant 
(Participant 1) was asked to touch the 2 mg of cocaine with all ten fingers consecutively 
before dusting the excess off. Participant 1 was asked to shake hands with a second 
participant (Donor 27) who immediately provided with fingerprint samples from left index 
and middle fingers using kitchen scales and an applied pressure between 800 – 1200 g for 
10 seconds. After this, Donor 27 washed their hands with soap, wore gloves for 10 minutes 
and deposited fingerprint samples using the same procedure as above (Donor 27-1). 
Participant 1 further shook hands with a third participant (Donor 28) who immediately 
provided with fingerprint samples from left index and middle fingers (same collection 
procedure). After this, Participant 2 washed their hands with soap, wore gloves for 10 
minutes and deposited fingerprint samples from left index and middle fingers as described 
above (Donor 28-1). Participant 1 did not provide with fingerprint samples. 
Table 4-9 shows the detection rate for the cocaine and EME fragments detected from the 
samples collected as part of Scenario 4 (MS/MS results). For Donor 27, the presence of 
cocaine was detected in both fingers straight after shaking hands with Participant 1. 
However, after washing the hands, cocaine could only be detected on the left index finger. 
For Donor 28, cocaine was detected in all samples before and after washing the hands. 
However, the full scan results (see Section 9.7 – Appendix VII) presented lower A/IS ratios 
after washing the hands, suggesting that some of the residues were removed through the 
cleaning procedure. BZE was not detected in any of the samples analysed, before or after 
washing the hands. EME, on the other hand, was detected 1 out of the 2 fingerprint samples 
for both Donors 27 and 28. This follows the results seen for Scenario 2 where the hand 
cleaning procedure (wiping) in that case was not sufficient to remove traces of cocaine and 
EME.  
Table 4-9 – Detection rate for cocaine, BZE and EME fragments taken from fingerprint 
samples collected as part of Scenario 4, based on MS/MS data. Internal standard was added to 
every sample at 50 ng/mL. √ = detected; N/D = not detected. 
 
Cocaine fragment 
(m/z 182) detected? 
BZE fragment 
(m/z 168) detected? 
EME fragment 
(m/z 182) detected? 
Donor 27 
Left Index √ N/D N/D 
Left Middle √ N/D √ 
Donor 27-1 
Left Index √ N/D N/D 
Left Middle N/D N/D N/D 
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Donor 28 
Left Index √ N/D √ 
Left Middle √ N/D N/D 
Donor 28-1 
Left Index √ N/D N/D 
Left Middle √ N/D N/D 
 
To rule out cross-contamination of the samples during storage, three samples collected under 
Scenarios 1, 2 and 3 conditions, but after contact with amphetamines (that were stored in the 
same box as the cocaine samples) were analysed using the same paper spray method and 
conditions. MS/MS results from these samples revealed the presence of cocaine in all three 
samples analysed. This could suggest that cocaine can travel from sample to sample within 
the storage box. This also has implications for the samples in Scenario 4, where the pre- and 
post-hand washing samples were stored in the same box. No BZE or EME were detected. 
Conversely, the same donors who took part in the cocaine experiments also took part in the 
amphetamine experiments. Because, as concluded above, none of the hand washing 
procedures was not sufficient to remove traces of cocaine, the detection of cocaine in the 
amphetamine samples may be the result of carry over effects from the cocaine experiments.  
The results obtained from the experiments described above suggested that washing the hands 
is more efficient at removing BZE and EME from the fingertips. Cocaine, on the other hand, 
could not be removed irrespective of the hand cleaning procedure applied. Cocaine and EME 
were shown to be transferred through handshakes, although washing the hands did remove 
the traces of EME from the samples. This suggests that the detection of cocaine in fingerprint 
samples does not necessarily indicate ingestion and data should be interpreted carefully. 
4.5. Other drugs of abuse 
The work described in this report focusses on the optimisation of a paper spray method for 
the detection of cocaine, BZE and EME in finger residues. However, one of the advantages 
of mass spectrometry is being able to detect several analytes simultaneously. Thus, resulting 
full scan spectra for all fingerprints analysed (the same samples shown in Table 4-2), where 
interrogated for the presence of methadone, 2-ethylidene-1,5-dimethyl-3,3-
diphenylpyrrolidine (EDDP), 2-ethyl-5-methyl-3,3-diphenylpyrroline (EMDP), 
diamorphine, 6-monoacetyl morphine (6-MAM), morphine and codeine only when the oral 
fluid results also tested positive for these drug classes. Spectra obtained for fingerprints 
sample were overlaid with blank spectra to ensure that the signals were not background 
peaks and a mass accuracy within ±118 ppm was accepted (as per the QToF capabilities). 
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Methadone was detected in 73% of the fingerprint samples collected from donors who tested 
positive for methadone; EDDP and EMDP were individually detected in 8% of all samples 
corresponding to a positive oral fluid sample. Diamorphine was detected in 32% of the 
fingerprint samples analysed (of the 12 donors with a positive oral fluid for 6-MAM) and 6-
MAM was detected on 6% of the samples with a corresponding positive oral fluid. Morphine 
was detected in 6% of the fingerprint samples (9 donors tested positive for morphine in their 
oral fluid) and codeine was detected in only 2% of the samples (11 donors tested positive for 
codeine in their oral fluid). Although the detection rate for these compounds was found to 
be smaller than for cocaine (Table 4-2), the method applied was optimised for the detection 
of cocaine, BZE and EME. This shows the importance of studying the conditions of the 
analysis and how different solvents, volumes and voltages can influence the sensitivity of 
the method. Furthermore, no MS/MS data was available for these compounds and, like in 
the case of EME, poor peak resolution in full scan mode can lead to a loss in sensitivity and 
selectivity. However, the results described in Section 9.8 – Appendix VIII show the potential 
of paper spray to detect other analytes in fingerprints.  
Given the sensitivity and selectivity of the method, paper spray mass spectrometry could be 
applied as a fingerprint confirmatory test for drug testing. A screening test (e.g. the 
Intelligent Fingerprinting immunoassay test) would provide a presumptive test for the 
detection of the substances, and paper spray would be used as a confirmatory test. One or 
two fingers could be used for cocaine testing and other fingers could be used for other 
analytes.  Alternatively, paper spray could be used as a screening test, instead of 
immunoassays, as it rapid and carries the selectivity of mass spectrometry. The use of the 
fingerprint pattern for donor identification also adds to confidence to the chain of custody 
and this will be discussed in the next chapter. 
Whilst portable and low cost, the Intelligent Fingerprinting method costs a few pounds per 
sample and takes 10 minutes. In contrast, a mass spectrometer with paper spray can be 
acquired for £300,000. The running cost (including depreciation) is estimated at £60k per 
annum, and approximately £40 per hour (based on 50 weeks of running at 30 hours per 
week). It is easily possible to run 10 samples per hour, and therefore the estimated cost is £4 
per sample.  
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4.6. Summary 
In this chapter, fingerprint samples (collected from individuals seeking treatment for 
substance addiction) were collected after two different hand cleaning procedures – wiping 
the fingertips (“wipes”) and washing the hands with soap (“soap”). Washing the hands with 
soap was found to be more effective at removing the drugs and metabolites. However, very 
little was detected after washing the hands with soap even after sweating for 10 minutes 
using nitrile gloves (see Section 4.2). These results were corroborated by experiments carried 
out using cocaine powder at the Forensic Science Ireland (FSI) where the two hand cleaning 
procedures were evaluated for their contact residue removal efficacy (Section 4.4).  The two 
hand cleaning procedures were not sufficient to completely remove contact traces of cocaine 
or EME. Furthermore, studies on the secondary transfer of cocaine, BZE and EME through 
handshakes showed that cocaine and EME can be transferred, although the latter can be 
removed by washing the hands.  
Quantitative detection of cocaine, BZE and EME could not be evaluated due of the wide 
variability observed between samples collected from different fingers of the same donor. 
However, a semi-quantitative approach showed a good correlation between the A/IS ratio 
measured from fingerprints against the quantitative oral fluid result (Donors 2 and 3) for 
cocaine. The true positive rate for cocaine was calculated to be 99% (157 of 159 samples 
analysed). 
Analysis of samples collected from the general population showed a > 2.5% false positive 
rate based on a single fingerprint sample. The use of two fingerprint samples – where both 
would test positive -  instead of only one, was shown to reduce the false-positive rate to 0%. 
Traces of cocaine were detected in a participant’s fingerprint samples after handling a bank 
note, highlighting the importance of employing a hand cleaning procedure before sample 
collection (Section 4.3.1). 
Interrogation of the spectra obtained from the fingerprint samples collected from individuals 
at the drug rehabilitation clinic enabled the detection of the presence of methadone, 
diamorphine, morphine, codeine and respective metabolites. This shows the wide 
applicability of a paper spray method for drug testing from a single fingerprint.   
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5. Fingerprint visualisation methods 
5.1. Introduction 
One of the advantages of using fingerprint samples over urine or oral fluid is that the identity 
of the fingerprint donor is encapsulated in the sample. Thus, the inclusion of a step that 
enables the visualisation of the fingerprint pattern than can be used for donor identification, 
adds value to the test and will ensure that the sample belongs to the intended donor being 
tested. Because of the nature of the test being developed, fingerprint samples should be 
collected on a paper substrate. Thus, the choice of chemical developer will have to be 
appropriate to the substrate. In this chapter, ninhydrin and silver nitrate were tested for their 
ability to develop fingerprints on the paper spray substrate and to test whether or not the 
presence of the chemical developer interferes with the detection of the analytes of interest. 
Ninhydrin was chosen because it is widely used by police forces and forensic providers and 
it is also recommended by the Home Office (Home Office, 2013). Silver nitrate was tested 
as per suggestion of Intelligent Fingerprinting Ltd. 
5.2. Ninhydrin  
According to the Home Office’s Fingerprint Source Book (Home Office, 2013), ninhydrin 
is an effective fingerprint developer for paper or other porous substrates. Ninhydrin reacts 
with primary amine groups to form a purple colouration called Ruhemann’s purple. In 
fingerprints, ninhydrin reacts with the naturally secreted amino acids to turn the fingerprint 
ridge details purple, enabling visualisation of the fingerprint pattern (Friedman, 2004).  
For the purpose of this work, ninhydrin was required to develop the fingerprint sample on 
the paper spray substrate (Whatman grade I chromatography paper) but not affect the 
detection of any of the analytes of interest. Chromatography paper was cut in the shape of a 
house (same shape used for fingerprint collection kits) and taped to the long edge glass slide 
(Figure 5-1).  
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Figure 5-1 – Fingerprint visualisation testing kits. The triangular parts of the sample 
substrate (treated chromatography paper) has the same dimensions as the standard paper 
spray sample substrate. 
A second glass slide was placed under the triangular part of the paper during the collection 
of the sample to avoid damage to the paper as pressure is applied (donors were asked to press 
down fingertips on paper but the pressure was not measured). The second glass slide was 
removed and 20 µL of internal standard (500 ng/mL cocaine-D3, BZE-D3 and EME-D3 in 
100% ACN) was added to observe whether the addition of a solvent disrupted the fingerprint 
pattern. The 5 mg/mL ninhydrin solution (ninhydrin (Sigma Aldrich, Dorset) in 95:5 (%v/v) 
absolute ethanol:acetone (Fischer Scientific, Leicestershire) was applied using a spray bottle 
(Sigma Aldrich, Dorset) over the triangular areas of the paper substrate. The choice of 
ninhydrin concentration followed the Home Office guidelines for ninhydrin working 
solution preparation (Home Office, 2013). Samples were left to stand under ambient 
conditions for 60 minutes, after which the samples were photographed (Figure 5-2). 
Fingerprint ridge details were successfully developed even with the addition of the internal 
standard. 
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Figure 5-2 - Ninhydrin development of fingerprint samples collected on chromatography 
paper (Whatman grade I). Internal standard was added after sample collection to observe 
whether the addition of solvent disrupted the fingerprint pattern. 
The effect of ninhydrin on the detection of cocaine was tested using spiked artificial sweat 
standards (20 µL of 50 ng/mL of cocaine, BZE and EME) and 20 µL of internal standard 
solution (500 ng/mL of BZE-D3 and EME-D3) prepared in a 5 mg/mL ninhydrin solution in 
100% ACN. Ninhydrin was added to the internal standard to establish if the fingerprint 
pattern development step could be easily integrated with the paper spray method. The 
concentration of ninhydrin prepared followed the Home Office guidelines for ninhydrin 
working solution preparation (Home Office, 2013). Loaded paper was allowed to air dry for 
30 minutes before being placed in the paper spray source. Samples were allowed to dry for 
30 minutes to allow time for ninhydrin to react with the amino acids present in the artificial 
sweat and develop the Ruhemann’s purple. Blank samples were also analysed and used for 
blank correction. At the time, the composition of the spray solvent was being investigated 
and 100% ACN had been shown to yield higher counts for the analytes of interest. Thus, 80 
µL of 100% ACN (0.1% formic acid) was added to the paper and a 4.0 kV voltage was 
applied. Acquisition was started and the MS method included 2 minutes of full scan 
measurements. 
Figure 5-3 shows the plot of the average (n=3) peak intensities for EME, BZE and cocaine 
detected with and without ninhydrin development. There is a clear decrease in measured 
peak intensity when ninhydrin is present in the sample, which suggested that ionisation 
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suppression effects were taking place, reducing the levels of analytes being ionised and 
detected. The presence of ninhydrin in the sample also caused the accumulation of purple 
material around the cone inlet of the mass spectrometer which had to be cleaned in-situ 
between samples. For this reason, ninhydrin was discarded as a process for fingerprint 
visualisation that could be integrated with the paper spray method developed. 
 
Figure 5-3 – Average (n=3) peak intensity for EME, BZE and cocaine in artificial sweat with 
and without ninhydrin development using paper spray analysis. 
5.3. Silver Nitrate 
The use of silver nitrate for fingerprint visualisation is well-established in the fingerprint 
field and, similarly to ninhydrin, it is used for development on porous substrates such as 
paper. The mechanism of action relies on the reaction of the silver ions with the chlorides in 
the fingerprints to form silver chloride ions that turn the fingerprint ridges brown, grey or 
black (Schwarz et al., 2011, Sodh et al., 2016).  
Testing kits were prepared as pictured in Figure 5-1 where fingerprints were collected in two 
of the pieces of paper and the remaining used as a blank control. Fingerprint samples were 
collected as presented by placing a second glass slide under the triangular part of the paper 
and pressing the finger against the paper (with no pressure control or any additional 
collection procedures).  Chromatography paper (Whatman grade I) was cut into the house 
shape and the dimensions of the triangular part were kept the same as the standard paper 
spray substrate. Silver nitrate stock solution (0.1 M) was bought from Sigma Aldrich 
(Dorset, UK) and diluted with deionised water (DI water) as required for the experiments. 
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A 0.05 M (50 mM) silver nitrate solution was prepared as a starting point for the initial 
experiments. The solution was poured into a spray bottle and sprayed onto two individual 
fingerprint visualisation kits; one of the kits was exposed to ultra-violet (UV) light (254 nm) 
and the other was left on the fume hood exposed to white light. No fingerprint samples were 
deposited on the paper. A brownish colouration appeared on the paper when exposed to UV 
within 10 minutes of application; a very faint brown colour appeared after several hours 
when exposed to white light in the fumehood. Thus, UV light was used to speed up the 
fingerprint development process.  
Most fingerprint enhancement methods work by applying the developer after the fingerprint 
but with the silver nitrate solution approach, no fingerprint was visible when the fingerprint 
and solution were applied in this order (Figure 5-4 (A)). The silver nitrate was sprayed onto 
one fingerprint visualisation kit and allowed to dry before collecting the fingerprint samples 
on two out of the three pieces of paper. The sample was then exposed to UV light for 10 
minutes. The control paper turned brown but no fingerprint pattern was present. Figure 5-4 
shows the resulting developed pieces of paper where the (A) fingerprint was placed before 
silver nitrate and (B) after the silver nitrate. Figure 5-4 (C) shows a close-up of the fingerprint 
ridge detail developed from (B). 
 
Figure 5-4 –Silver nitrate developed samples with (A) fingerprint applied before silver nitrate 
(50 mM) and (B) fingerprint applied after silver nitrate; (C) close up of one of the 
fingerprints developed in (B). Samples were exposed to UV light (254 nm) for 10 minutes. 
The application of the silver nitrate to the paper was required to be reproducible so that the 
same amount of developer was applied each time. Different modes of silver nitrate 
application were tested: spraying, dipping the paper and pipetting (20 µL) the solution. Silver 
nitrate was allowed to dry on the paper before depositing the fingerprint (collected as 
presented) and exposing to UV light for 10 minutes. All three methods of silver nitrate 
addition enabled the visualisation of the fingerprint pattern (see Figure 5-5) but the spraying 
and dipping methods were less controllable than pipetting.  
A B C 
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Figure 5-5 – Fingerprints developed after application of silver nitrate (50 mM) by (A) 
spraying, (B) dipping and (A) pipetting 20 µL and exposing the samples to UV light (254 nm) 
for 10 minutes. 
Simultaneously, the use of less concentrated solutions was tested by spraying silver nitrate 
(1, 5, 10 and 25 mM) onto the paper, allowing it to dry, collecting the fingerprint sample and 
developing under UV light (254 nm) for 10 minutes. It was found that concentrations below 
25 mM of silver nitrate were not sufficient to develop the finer ridge details, whilst 25 mM 
enabled the visualisation of a partial fingerprint (see Figure 5-6). However, this might be the 
result of a poorly collected fingerprint sample rather than the development method.  
 
Figure 5-6 – Fingerprint sampled developed under UV light (254 nm) by spraying (A) 1 mM, 
(B) 5 mM, (C) 10 mM and (D) 25 mM silver nitrate solution. 
A B C 
A B C D 
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As was previously mentioned, spraying or dipping cannot be made reproducible and 
therefore pipetting was found to be the preferred method of silver nitrate addition. However, 
the volume of silver nitrate pipetted onto the paper needs to sufficient to develop the 
fingerprint pattern but it must not interfere with the chemical analysis. Three different 
volumes – 20, 40 and 60 µL – were tested using the same method described above. As shown 
in Figure 5-7, 40 and 60 µL of silver nitrate enabled the visualisation of the fingerprint ridge 
patterns. To minimise the volume of silver nitrate solution added to the substrate, 40 µL was 
chosen as the optimal volume. In addition, it was also found that 5 minutes under the UV 
light (254 nm) was adequate to develop the fingerprint with the same level of visual detail 
as when samples were exposed for 10 minutes. 
 
Figure 5-7 - Fingerprint samples developed using (A) 20 µL, (B) 40 µL and (C) 60 µL of silver 
nitrate (25 mM) and exposing the paper for 10 minutes to UV light (254 nm). 
The effect of silver nitrate on the detection of cocaine and metabolites using paper spray was 
tested by pipetting 40 µL of 25 mM of silver nitrate onto a triangular piece of paper (see 
section 3.5.3 for more information on the substrate) and allowing it to dry. The drug standard 
(50 ng/mL of cocaine, BZE and EME in 100% ACN) was then pipetted onto the paper (20 
µL) and exposed to UV light (254 nm) for 5 minutes. The method of analysis followed the 
final optimised paper spray method (Figure 3-33) using full scan measurements over a 2-
minute acquisition time. Internal standard (500 ng/mL of cocaine-D3, BZE-D3 and EME-D3 
in 100% ACN) was added (20 µL) to every sample and blank. Blank samples were also 
prepared where the drug standard solution was replaced with 20 µL of acetonitrile.  
A B C 
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Figure 5-8 shows the average (n=5) peak intensities for cocaine, BZE and EME detected 
with and without the presence of silver nitrate. When silver nitrate is present, the peak 
intensity for all three analytes is consistently lower in comparison to when silver nitrate is 
not present. This might be the result of competing ionisation from the silver nitrate solution 
components as the overall spectra for the 2 minutes looks visually different with and without 
silver nitrate (see Figure 5-9). The two isotopes of silver, Ag-107 and Ag-109, were detected 
at m/z 106.95 and 108.95, respectively. Thus, the spectra dominating peaks at m/z 147 and 
149 are likely to result from complexes formed with acetonitrile (m/z 41.03), given that the 
m/z difference between the two sets of peak corresponds to the mass of acetonitrile. The 
extremely high intensity of these peaks is likely to have cause ionisation suppression of the 
analytes which were present at a much lower concentration. 
 
Figure 5-8 – Average (n=3) measured peak intensity of cocaine, BZE and EME measured 
using paper spray with and without the presence of silver nitrate (40 µL of 25 mM). 
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Figure 5-9 – Overlay of the two minute full scan spectra of (B) silver nitrate containing 
standard and (B) control standard sample obtained using paper spray. 
A new set of silver nitrate solutions of concentration 10, 15, 20 and 25 mM were prepared 
and tested for their ability to develop fingerprint patterns. The same visualisation testing kits 
as described in Figure 5-1 were used for these experiments. Each solution was individually 
pipetted (60 µL) onto the three pieces of paper on five visualisation kits. Solutions were 
allowed to air dry before depositing the fingerprint samples (pressure between 800-1200 g 
measured using kitchen scales). 
The use of 10 or 15 mM silver nitrate solution allowed the visualisation of the outer edge of 
the fingerprint pattern (see Figure 5-10). This suggested that the pressure with each the 
fingerprint sample was deposited was too high, resulting in “smudging” of the pattern. The 
remaining two concentrations – 20 and 25 mM – also allowed the visualisation of the 
fingerprint pattern. However, as concluded above, the 25 mM silver nitrate solution 
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interferes with the detection of cocaine, BZE and EME in full scan during the paper spray 
analysis.  
 
Figure 5-10 - Fingerprint sampled developed under UV light (254 nm) by pipetting 60 µL  (A) 
10 mM, (B) 15 mM, (C) 20 mM and (D) 25 mM silver nitrate solution. 
The same experiment was repeated with 10 and 15 mM of silver nitrate but fingerprints were 
collected with a pressure between 100-200 g. Figure 5-11 shows the results, where the use 
of 10 mM (A) silver nitrate did not enable the visualisation of the fingerprint detail but 15 
mM (B) of silver nitrate developed the fingerprint pattern. A lower volume of the 15 mM 
silver nitrate solution was tested (40 µL) but no fingerprint pattern could be visualised. 
 
Figure 5-11 - Fingerprint samples developed under UV light (254 nm) by pipetting 60 µL of 
(A) 10 mM and (B) 15 mM silver nitrate solution. 
A B C D 
A B 
138 
 
The effect of a lower concentration of silver nitrate on the detection of the cocaine using 
paper spray was tested by applying the same procedure as described before, but replacing 
the 40 µL of 25 mM silver nitrate with 60 µL of 15 mM silver nitrate. 
Figure 5-12 shows the average peak intensities measured for cocaine, BZE and EME with 
and without silver nitrate in the sample. The results showed that despite the lower 
concentration of silver nitrate, its presence still caused ionisation suppression of the analytes 
of interest. Although the concentration of silver nitrate was reduced from 25 mM to 15 mM, 
the volume was increased from 40 µL to 60 µL. Thus, in terms of dry mass of silver nitrate 
added to the paper, 40 µL of 25 mM is equivalent to 170 µg of silver nitrate and 60 µL of 
15 mM is equivalent to 153 µg of silver nitrate. Nonetheless, the presence of the analytes 
could still be qualitatively confirmed (through MS/MS measurements) even in the presence 
of silver nitrate.  
 
 
Figure 5-12 - Average (n=3) measured peak intensity of cocaine, BZE and EME measured 
using paper spray with and without (control) the presence of silver nitrate (60 µL of 15 mM). 
The effect of silver nitrate was tested with fingerprint samples collected at a drug 
rehabilitation centre. Prior to sample collection, silver nitrate was pipetted onto the paper on 
the fingerprint kits – 40 µL of 25 mM of silver nitrate was pipetted onto 10 kits and 60 µL 
of 15 mM of silver nitrate were pipetted onto another 10 other kits. Samples were allowed 
to dry before being placed in a storage box for transport to the clinic. Fingerprint samples 
were collected from 4 donors, where one hand was collected on a substrate treated with silver 
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nitrate and the other hand was collected on the normal paper substrate. Fingerprint samples 
were collected with a pressure between 100-200 g. Samples were transported to the 
laboratory in a box, where they were exposed to UV light (254 nm) for 5 minutes. Oral fluid 
samples were simultaneously collected and sent off to Claritest for confirmatory testing. Oral 
fluid results are shown in Table 5-1. 
Table 5-1 – Oral fluid confirmatory results for Donors 29-32 tested with silver nitrate. 
Donor Cocaine (ng/mL) BZE (ng/mL) 
29 >64.0 >64.0 
30 >64.0 >64.0 
31 40.3 >64.0 
32 Negative (5.77) >64.0 
 
Figure 5-13 shows example of the images of the fingerprint sample developed from each of 
the four donors. The higher concentration of silver nitrate resulted in clearer ridge patterns, 
although not all samples produced the same level of ridge details, as shown in Figure 5-13 
(A) and (B). The lower concentration of silver nitrate only allowed the visualisation of 
fingerprints collected from Donor 16 (Figure 5-13 (D)).  
 
Figure 5-13 – Example of silver nitrate treated fingerprints collected from individuals seeking 
treatment at a drug rehabilitation clinic using (A)(B) 40 µL of 25 mM and (C)(D) 60 µL of 15 
mM and developed under UV light (254 nm) for 5 minutes. 
For paper spray analysis, the triangle was cut from the glass slide and the optimised paper 
spray method described in Figure 3-33 was employed with the MS method described in 
Figure 3-30. Internal standard (cocaine-D3, BZE-D3 and EME-D3) was added to every 
sample and blank at 50 ng/mL. 
A B C D 
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Analysis of standards in the presence of the silver nitrate, regardless of the concentration, 
showed that silver nitrate causes a loss of sensitivity to cocaine, BZE and EME. Table 5-2 
shows the number of samples tested positive for cocaine, BZE and EME with and without 
silver nitrate. Out of the 20 samples analysed with silver nitrate, 20 tested positive for 
cocaine whilst only 19/20 tested positive when no silver nitrate was present. However, due 
to the high variability seen with fingerprint samples, it cannot be concluded whether this was 
the result of the presence/absence of the silver nitrate in the samples. BZE was detected in 
6/20 samples in the presence of silver nitrate and in 8/20 samples without the developer. 
Lastly, EME was detected in 6/20 samples with silver nitrate and 9/20 for the control 
samples.  
Table 5-2 – Fingerprint samples tested positive for cocaine, BZE and EME in MS/MS modes 
with and without the presence of silver nitrate.  
 
Cocaine Fragment 
304>182 
BZE Fragment 
290>168 
EME Fragment 
200>182 
Silver 
Nitrate 
Control 
Silver 
Nitrate 
Control 
Silver 
Nitrate 
Control 
Donor 29 5/5 5/5 0/5 0/5 3/5 1/5 
Donor 30 5/5 4/5 5/5 3/5 3/5 4/5 
Donor 31 5/5 5/5 1/5 5/5 0/5 4/5 
Donor 32 5/5 5/5 0/5 0/5 0/5 0/5 
Total 20/20 19/20 6/20 8/20 6/20 9/20 
 
The presence of silver nitrate still enabled the qualitative identification of cocaine, BZE and 
EME in fingerprint samples in MS/MS mode. If a positive result is to be based on the 
detection of either cocaine, BZE and EME in a sample then the silver nitrate developed 
samples had a success rate if 20/20, whereas the control samples were only 19/20. However, 
if the method were to be made quantitative, the presence of silver nitrate was found to cause 
ionisation suppression effects like reported previously for the standards. This is exemplified 
in Figure 5-14 that shows the measured peak intensities for cocaine, BZE and EME for 
Donors 30 and 31, as examples. Section 9.9 – Appendix IX, shows the measured peak 
intensities for cocaine for Donors 29 and 32 (BZE and EME were not detected in any of the 
samples from these two donors).  
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Figure 5-14 – Measured peak intensity (full scan) for Donors 30 and 31 for (A) cocaine, (B) 
BZE and (C) EME measured from fingerprint samples collected from individuals at a drug 
rehabilitation centre with and without the presence of silver nitrate. 
5.4. Summary 
Both ninhydrin and silver nitrate enable the visualisation of the fingerprint ridge detail on 
the paper spray substrate (Whatman grade I chromatography paper). However, the presence 
of these fingerprint chemical developers was found to cause ionisation suppression of 
cocaine, BZE and EME. The application of silver nitrate to fingerprint samples collected 
from individuals seeking treatment for substance abuse, although affected the peak intensity 
in full scan measurements, still enabled the identification of the substances in MS/MS scans.   
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6. Evaluation of other Ambient Ionisation 
Mass Spectrometry Techniques for Drug 
Detection in Fingerprints 
6.1. Introduction 
This chapter describes the evaluation of two other ambient ionisation mass spectrometry 
(AIMS) techniques for their applicability to drug testing from a single fingerprint. A suitable 
technique will offer the potential for quantitative analysis with minimal sample preparation 
steps, high throughput and cost effectiveness. Techniques explored include desorption 
electrospray ionisation (DESI) and liquid extraction surface analysis (LESA) mass 
spectrometry. A more in-depth description of each of these techniques is given in Chapter 2. 
The work described in this Chapter using DESI and LESA was, at the time, compared to the 
early work done with paper spray (Section 3.2) in order to decide on the best technique for 
the analysis of fingerprint samples. 
6.2. Desorption Electrospray Ionisation (DESI) 
Work done by Bailey et al. (2015) demonstrated the feasibility of DESI for the detection of 
drugs of abuse in fingerprints collected from drug users attending a rehabilitation clinic. 
However, the usefulness of the technique for drug testing applications will be dependent on 
its ability to produce quantitative results. Techniques such as liquid chromatography-mass 
spectrometry (LC-MS) or gas chromatography-mass spectrometry (GC-MS) have claimed 
to provide quantitative analysis of a fingerprint (Jacob et al., 2008, Goucher et al., 2009, 
Kuwayama et al., 2013) by washing the fingerprint off a substrate, evaporating to dryness 
and reconstituting in a solution containing a known concentration of internal standard. This 
approach does not consider the unknown mass of the fingerprint and is laborious compared 
with the high throughput (2 minutes per sample) analysis of DESI.  
DESI analysis were carried out at the National Physical Laboratory (NPL), Teddington using 
an Omni Spray 2D Ion Source (Prosolia, Indiana, IN, US) with a LTQ Orbitrap Mass 
Spectrometer (Thermo Scientific, Bremen, Germany). The DESI angle of collection was 
fixed at 10° and enforced by the permanent bend on the inlet capillary (sniffer). The sniffer 
was in contact with the sample. The sprayer and sniffer were aligned and kept at a constant 
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distance of 4 mm from each other. Table 6-1 describes the geometry arrangement used for 
the DESI analysis at NPL.  
Table 6-1 – Default parameters for DESI analysis at NPL. 
Parameter Setting 
Spray head angle (relative to the substrate (α)) 55° 
Collection angle (β) 10° 
Sprayer to surface distance (d1) 1-1.5 mm 
Sniffer to surface distance (d2) 0 mm 
Sprayer to sniffer distance (d3) 4 mm 
 
6.2.1. Development of a standard and optimisation of the method 
To evaluate the quantitative capacity of DESI, it was first necessary to produce a suitable 
standard. While a safe drug storage facility was being installed at Surrey, substitutes for 
illicit drugs were tested. 
A solution containing a mixture of paracetamol (Sigma Aldrich, Dorset), metronidazole 
(Sigma Aldrich, Dorset) and ibuprofen (Sigma Aldrich, Dorset) at a concentration of 1.0 
mg/mL each was prepared in 75:25 methanol (Fischer Scientific, Leicestershire):water 
(18MΩ, MilliQ). The resulting solution was pipetted (5 µL) onto a cavity glass slide and 
allowed to air dry, which caused the visible uneven precipitation of the analytes on the 
surface. Any attempt of quantification from these standards using the DESI method would 
have resulted in poor repeatability and difficulty in evaluating the limit of detection (LOD).  
To overcome the problem of analyte precipitation, gelatin (Sigma Aldrich, Dorset) films 
spiked with metronidazole were prepared and tested with DESI. A gelatin solution (30 
mg/mL of gelatin powder in water) was spiked with metronidazole (Sigma Aldrich, Dorset) 
at concentrations ranging from 0-1 mg/mL. The resulting solutions were transferred (2 mL) 
to a petri dish and placed under vacuum (1000 mBar) for 5 hours to form films. Films were 
cut into squares of approximately 1x1.5 cm and taped to a glass slide using double-sided 
tape. The DESI solvent consisted of 90:10 methanol (MeOH):water (H2O) with 0.1% formic 
acid (FA), sprayed at a 2.5 μL/min flow rate and with an applied voltage of 5 kV. All data 
was acquired in Orbitrap mode for 2 minutes.  Unless otherwise stated, the geometry of the 
DESI system was kept the same throughout the measurements and is described in Table 6-1.  
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Table 6-2 shows the average intensities (n=3) for metronidazole in the gelatin standards 
prepared as described above. Protonated metronidazole [M+H]+ has a monoisotopic mass of 
172.0722 and was detected with a mass accuracy of -2.95 ppm. There was an increase in 
intensity with increasing concentration (with the exception of standard of concentration 0.8 
mg/mL). However, the important observation is the acceptable variability of the three 
repeated measurements (spot analysis of the same gelatin film in three different areas) as 
shown by the relative standard deviations (RSD %), which demonstrated good spatial 
homogeneity of the sample. 
Table 6-2 - Average (n=3) ion intensity and RSD% of metronidazole measured in gelatin 
standards of concentrations 0.1 to 1.0 mg/mL; analyses were carried out using a 2D Omni 
Spray 2D Ion Source coupled with a LTQ Orbitrap Mass Spectrometer at the National Physical 
Laboratory (NPL). Electrospray consisted of a mixture of 90:10 MeOH/H2O (0.1% formic 
acid) with a flow rate of 2.5 μl/min and a 5 kV bias. 
Concentration of Metronidazole (mg/mL) Average (n=3) RSD% 
0.1 46019 8% 
0.5 51046 6% 
0.5 55524 8% 
0.8 54981 3% 
1.0 69126 2% 
 
One of the known drawbacks of DESI is the difficulty in obtaining repeatable results due to 
factors associated with both the sample removal and ionisation (Ifa et al., 2008b, Green et 
al., 2010). Changes in atmospheric conditions during analysis, instabilities in the 
electrospray and differences in the rate of sample removal from the surface due to solvent 
incorporation can cause the signal to vary as a function of time. Consequently, quantification 
using DESI is challenging, especially when the internal standard cannot be easily integrated 
with the sample (Ifa et al., 2010) – e.g. fingerprint samples. The addition of an internal 
standard at a fixed concentration has been shown to improve quantification with DESI by 
correcting for inefficiencies in analyte extraction (Ifa et al., 2008b). In the experiment 
described above, no internal standard was added to the gelatin films and this could be the 
cause of the lack of linearity of the results. However, DESI has been used to quantify drugs 
(clozapine) in animal tissues by the application of an internal standard (IS) – loxapine, a 
structural analogue of clozapine – to the tissue sample (Vismeh et al., 2012). Similarly, 
García-Reyes et al. (2009) employed DESI for the trace analysis of agrochemicals in food 
using matrix-matched standards and isotopically labelled internal standards. The quantitative 
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results were, in both cases, corroborated by liquid chromatography-mass spectrometry 
analysis (LC-MS) analysis that confirmed the DESI results and alluded to the similarities 
between DESI and direct infusion ESI. Ifa et al. (2008) looked at the quantitation of 
propranolol in a polytetrafluoroethylene (PTFE) substrate and how the repeatability of the 
results varied between the use of a structural analogue (atenolol) vs the use of an isotopically 
labelled internal standard (propranolol-D7). The latter yielded good accuracy (±7%) and 
precision (13%).  
Once the safe storage facility was made available at Surrey, the experiments described 
previously were repeated, this time using cocaine, benzoylecgonine (BZE) and ecgonine 
methyl ester (EME). Additionally, creatinine was added as an internal standard for these 
experiments for the reasons discussed above. Although creatinine is not a structural analogue 
or an isotopically labelled form of the analytes, reports in the literature demonstrated that 
normalising either lorazepam and lorazepam glucuronide to creatinine, which is known to 
be excreted in sweat, helped reduce the variability arising from the variable amount of 
fingerprint residue deposited (Goucher et al., 2009).  
Using the same process for gelatin standard preparation as described previously, films 
containing a mixture of cocaine, benzoylecgonine (BZE) and ecgonine methyl ester (EME) 
at 250 ng/mL and creatinine at 500 ng/mL were analysed with DESI at NPL, with the intent 
of optimising the solvent composition to increase the sensitivity to the analytes of interest. 
The spray solvent flow was kept at 2.5 μL/min with an applied voltage of 5 kV. Table 6-3 
describes the different spray solvents mixtures tested. 
Table 6-3 – Composition of spray solvents tested for the detection of cocaine, BZE and EME in 
gelatin thin films using DESI, at NPL. Flow rate was kept constant at 2.5 μL/min with an 
applied voltage of 5 kV. 
Solvent 
Methanol 
(MeOH) 
Water  
(H2O) 
Acetonitrile 
(ACN) 
Additives 
1 90% 10% - 0.1% Formic Acid (FA) 
2 50% 50% - 0.1% Formic Acid 
3 100% - - 0.1% Formic Acid 
4 - 100% - 0.1% Formic Acid 
5 50% 50% - 
0.1% Ammonium Hydroxide 
154 mM NaCl 
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6 100% - - 0.1% 7M Ammonium Acetate 
7 - 10% 90% 0.1% Formic Acid 
 
The detection of creatinine ([M+H]+, monoisotopic mass 114.0658) was highly dependent 
on the spray solvent used (see Table 6-4), with Solvents 3 and 7 yielding the highest peak 
intensities for creatinine (with a mass accuracy lower than +/- 10 ppm). Although Solvent 7 
produced high peak intensities, one of the three replicate measurements is considerably 
higher, perhaps due to the encounter of a “sweet spot” (area of analysis with a relatively 
high concentration of the analyte).  
Table 6-4 - Average measured peak intensity for protonated creatinine ([M+H]+) obtained 
using different DESI spray solvent compositions. Refer to Table 6-3 for descriptions of the 
composition of solvents 1-7. 
Solvent Replicate Measured Peak Intensity 
1 
1 819 
2 615 
3 714 
2 
1 190 
2 133 
3 111 
3 
1 18796 
2 35263 
3 30811 
4 
1 148 
2 0 
3 158 
5 
1 0 
2 0 
3 0 
6 
1 113 
2 0 
3 0 
7 
1 4500 
2 9082 
3 64024 
 
The detection of the analytes of interest (cocaine, BZE and EME – see Section 9.2 – 
Appendix II for monoisotopic masses) was also found to vary with the different spray 
compositions. Cocaine and EME were consistently detected in all gelatin films analysed 
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irrespective of the spray solvent being used. BZE was not detected when Solvent 5 was 
employed and the measured peak intensities were generally lower than for the other two 
analytes (see Table 6-5). For cocaine and EME, Solvents 3 and 7 yielded the highest peak 
intensities but out of the two, Solvent 3 gave the lowest relative standard deviation (18% and 
15% for cocaine and EME, respectively). BZE, similarly to the other analytes, was found at 
higher peak intensities for Solvents 3 and 7 although the RSD% were high for all spray 
solvents due to the low measured peak intensities/ 
Table 6-5 – Average peak intensities (n=3) for cocaine, BZE and EME in gelatin films analysed 
with DESI using different spray solvent compositions. Refer to Table 6-3 for descriptions of 
the composition of sprays 1-7. 
 Cocaine Benzoylecgonine Ecgonine Methyl Ester 
Solvent 
Average Peak 
Intensity (n=3) 
RSD% 
Average Peak 
Intensity (n=3) 
RSD% 
Average Peak 
Intensity (n=3) 
RSD% 
1 59032 49% 38 173% 2870 101% 
2 2695 148% 38 173% 9797 166% 
3 531831 18% 963 70% 35668 15% 
4 76357 105% 41 173% 152153 114% 
5 1410 51% 0 N/A 1319 110% 
6 22946 17% 72 173% 13462 5% 
7 490564 83% 2353 156% 42961 69% 
 
The results presented above suggest that the variability encountered with the DESI results, 
which may be the result of the poor repeatability of the technique or the quality of the 
samples, make it very challenging to make any conclusions regarding the choice of best 
solvent. However, when both repeatability and analyte signal are taken into consideration, 
Solvent 3 – 100% MeOH ( with 0.1% FA) stands out as the most appropriate solvent for the 
desorption of cocaine, BZE and EME from gelatin films. Of course, a gelatin film may be 
not representative of a fingerprint matrix, but attempts for method optimisation were needed 
in order to develop and assess the quantitative power of the method. 
6.2.2. Quantitative potential of DESI 
Using the knowledge acquired from the gelatin standards, the same DESI experimental 
conditions were applied to the analysis of standards prepared using sweat collected from 
gym users after a gym class by running a 2 mL vial up the chest several times. Sweat 
collected from gym users was pooled and spiked with cocaine, BZE and EME at 
concentrations ranging from 0.0-500 ng/mL with a fixed creatinine concentration of 500 
ng/mL. Each standard was spotted in triplicate on a glass slide (10 µL for each replicate) and 
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analysed using a DESI The solvent composition was 100% MeOH (0.1% FA), with a flow 
rate of 2.5 µL/min and a 5 kV bias . Data was acquired in Orbitrap mode for 2 minutes. 
Geometric parameters are described in Table 6-1. 
The measured peak intensity for the analytes of interest (Section 9.2 – Appendix II) and IS 
(creatinine – m/z 114.0667) were extracted and a mass accuracy of +/- 10ppm for the 
corresponding mass spectrum peak was accepted. Peak height intensity normalisation was 
carried out using Equation 6-1, where 𝑃(𝐴𝑛𝑎𝑙𝑦𝑡𝑒) corresponds to the measured intensity 
for each of the analytes in one single measurement and 𝑃(𝐼𝑛𝑡𝑒𝑟𝑛𝑎𝑙 𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑) corresponds 
to the measured intensity of the internal standard - creatinine - in the same spectrum. 
Normalised intensities were blank corrected by subtraction of the average normalised blank 
peak intensity. Results are shown in Table 6-6. 
𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑠𝑒𝑑 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 =  
𝑃(𝐴𝑛𝑎𝑙𝑦𝑡𝑒)
𝑃(𝐼𝑛𝑡𝑒𝑟𝑛𝑎𝑙 𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑)
 
Equation 6-1 – Equation used for peak intensity normalisation. 
The limit of detection (LOD) was calculated using Equation 6-2, where ?̅?𝑏𝑙𝑎𝑛𝑘 is the average 
of the normalised peak intensities in the blank and 𝜎𝑏𝑙𝑎𝑛𝑘 is the standard deviation of same 
the normalised signals measured in the blank. 
𝐿𝑖𝑚𝑖𝑡 𝑜𝑓 𝑑𝑒𝑡𝑒𝑐𝑡𝑖𝑜𝑛 =  ?̅?𝑏𝑙𝑎𝑛𝑘 + (3 ∙ 𝜎𝑏𝑙𝑎𝑛𝑘) 
Equation 6-2 – Limit of detection (LOD) calculation. 
The limit of detection (LOD) – in normalised peak intensity - was calculated to be 0.42, 0.03 
and 0.86 for cocaine, BZE and EME, respectively. In the case of cocaine, only standards 4-
8 (100, 250 and 500ng/mL) were above the limit of detection. For BZE, only the highest 
concentration standard (500ng/mL) was above the limit of detection. As for EME, the 
average peak intensity in the blank measurements was calculated to be 1.59 (normalised 
peak intensity), which is above the LOD and above all the standards with the exception of 
the standard of concentration 500ng/mL. The high response in the blank may be the result 
of carry-over effects from previous analysis. The correlation between the concentration and 
response is not linear, as the response did not increase linearly with the increasing 
concentration. This may be the result of the presence of “sweet spots” (uneven precipitation 
of analytes during sample drying).  
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As previously explained, peak intensity normalisation to creatinine may help account for the 
unknown mass of fingerprint being sampled. Table 6-6 shows the average peak intensity and 
RSD (showing the inter-variability) for cocaine, BZE and EME in sweat at different 
concentrations with (peak intensity) and without normalisation to creatinine (normalised 
peak intensity). Cells highlighted in green indicate that the RSD is lower when normalisation 
to creatinine was applied. Creatinine normalisation generally reduced the variability of both 
cocaine and EME but the sensitivity of the method is still not sufficiently competitive in 
comparison to current drug testing method offered by commercial providers (LGC, 2014, 
Claritest, 2015). 
Table 6-6 - Average (n=3) and relative standard deviation (RSD) calculated for cocaine, BZE 
and EME at different concentrations in natural sweat collected from gym users with 
(normalised peak intensity) and without normalisation (peak intensity) to creatinine. Cells 
highlighted in green indicated that the RSD% after normalisation to creatinine was lower than 
when no normalisation was applied. 
Cocaine 
Concentration 
(ng/mL) 
Normalised Peak Intensity Peak Intensity 
Average  RSD Average  RSD 
0.5 0.0000 N/D 0.00 N/A 
1 0.0288 N/D 338.67 105% 
5 0.0485 N/D 515.04 118% 
10 0.0227 N/D 236.90 88% 
50 0.0955 N/D 1436.23 16% 
100 0.6493 7% 11957.87 37% 
250 1.6117 6% 37610.03 30% 
500 4.3665 10% 91510.10 53% 
BZE 
Concentration 
(ng/mL) 
Normalised Peak Intensity Peak Intensity 
Average  RSD Average  RSD 
0.5 0.0122 N/D 101.24 173% 
1 0.0101 N/D 114.10 173% 
5 0.0164 N/D 100.16 173% 
10 0.0074 N/D 98.61 173% 
50 0.0000 N/D 0.00 N/D 
100 0.0096 N/D 214.62 87% 
250 0.0000 N/D 0.00 N/D 
500 0.0525 46% 949.39 33% 
EME 
Concentration 
(ng/mL) 
Normalised Peak Intensity Peak Intensity 
Average  RSD Average  RSD 
0.5 0.7124 N/D 3978.69 32% 
1 0.7938 N/D 7770.50 17% 
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5 1.0656 17% 9611.71 23% 
10 1.0064 22% 11224.17 7% 
50 0.9339 6% 14326.90 10% 
100 1.0763 29% 18586.44 18% 
250 1.4420 14% 32893.96 18% 
500 2.7432 6% 56664.87 46% 
 
The lack of matrix matched standards, the natural variability of the fingerprint composition 
and the difficulty in obtaining repeatable results using DESI makes quantitation challenging. 
However, as previously mentioned, DESI has been shown to be sensitive and reliable enough 
to qualitatively detect cocaine and respective metabolites in fingerprints attained from drug 
users (Bailey et al., 2015). The previous section shows how the use of an internal standard 
helps reduce the variability of the DESI technique. The next step was to explore the 
possibility of using creatinine and other compounds in a fingerprint to correct for the amount 
of sample that is deposited. This of course, assumes that fingerprints are spatially uniform. 
Creatinine has been explored as a potential normalising factor that can account for the 
variability in the amount of fingerprint collected on any given substrate. To study this 
possibility further, DESI was used to analyse fingerprints collected from two donors (3 
fingerprint samples from each donor) using the data from Bailey et al. (2015). Fingerprints 
were collected from individuals seeking treatment for drug dependency (a favourable ethical 
opinion for sample collection and analysis was received from the National Research Ethics 
Service (NRES) – REC reference: 14/LO/0346). Fingerprint samples were collected as 
presented on glass slides with an applied pressured between 800-1200g (measured using 
kitchen scales). Each fingerprint was analysed in three different areas. Data was acquired in 
Orbitrap mode with the highest resolution setting of 100,000 (at m/z 400). The composition 
of the spray solvent was 90:10 MeOH:H2O (with 0.1% FA) delivered with a flow rate of 1.5 
µL/min and a 5.0 kV bias.  
Cocaine and EME were consistently identified in all areas/samples, and BZE was detected 
in 17 out of 18 areas analysed. Tandem MS measurements were also taken to confirm the 
peak assignment for cocaine (304>182), BZE (290>168) and EME (200>182) – see Figure 
6-1. These results were corroborated by gas chromatography-mass spectrometry (GC-MS) 
analysis of oral fluid samples at LGC Forensics, Teddington, Middlesex.  
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Figure 6-1 – MS/MS spectra for (A) cocaine, (B) BZE and (C) EME detected in natural 
fingerprints collected from individuals seeking treatment at a drug rehabilitation clinic and 
analysed using DESI. 
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Full scan data was subsequently interrogated for the presence of endogenous substances (for 
a full list, see Section 9.10 – Appendix X). The substances with the highest peak intensities 
(those above 200 counts) were used to normalise the peak intensities of cocaine, BZE and 
EME as per Equation 6-1 – Equation used for peak intensity normalisation., where peak 
intensity of the internal standard - 𝑃(𝐼𝑛𝑡𝑒𝑟𝑛𝑎𝑙 𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑) - was replaced with the peak 
intensity for each of the selected endogenous substances. The peaks of interest were not 
present in the blank measurements. 
Table 6-7 shows the RSD% for the intra- and inter- variability of the measurements for 
Donors 1 and 2 when the peak intensity of cocaine, BZE and EME were normalised to lysine, 
phenylalanine, valine, isoleucine/leucine and riboflavin. Cells highlighted in green indicate 
that normalisation resulted in a decrease in the RSD% when compared to the raw data. 
Normalisation to any of the selected endogenous compounds did not systematically improve 
the intra- and inter-variability for the analytes. Judging by the measured peak intensities, 
cocaine had high intra- and inter-variability (>30%) and this may be a result of it being 
contact residue rather than an excreted drug. It could be expected that contact residues would 
be less spatially homogenous than excreted residues, although this has never been proven. 
The RSD% for BZE (>27%) follows a similar pattern to that of cocaine but it could have 
been the result of poor counting statistics, given that the measured peak intensities for BZE 
were lower than for the other two analytes. EME had the lowest variability (>4-62%), which 
suggests a more homogenous spatial distribution over the area of the samples. The 
uncertainty due to counting statistics was calculated using Equation 6-3 where n is the 
measured peak intensity for any given analyte detected. All of the analytes of interest apart 
from BZE (cocaine, EME, isoleucine/leucine, lysine, valine, phenylalanine and riboflavin) 
had an uncertainty below 15%. The uncertainties for BZE on all areas analysed were 
calculated to be between 22-108% which are likely to account for the variability shown in 
Table 6-7. 
𝑈𝑛𝑐𝑒𝑟𝑡𝑎𝑖𝑛𝑡𝑦 𝑑𝑢𝑒 𝑡𝑜 𝑡ℎ𝑒 𝑐𝑜𝑢𝑛𝑡𝑖𝑛𝑔 𝑠𝑡𝑎𝑡𝑖𝑠𝑡𝑖𝑐𝑠 (%) =  
√𝑛
𝑛
×100 
Equation 6-3 – Certainty of the counting statistics where n = the measured peak intensity for 
a given analyte. 
The results obtained using DESI for the analysis of fingerprints sample revealed difficulty 
in taking from dried liquids, due to drying patterns. The use of a gel containing an internal 
standard allowed the precision of cocaine, BZE and EME to be achieved at an accepted level. 
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The sensitivity to these analytes in gels was unacceptable for drug testing (which required 
<10 ng/mL for each analyte) even after optimisation.  However, it is questionable how 
representative a gel matrix is of a fingerprint. When the technique was applied to real 
fingerprints, the sensitivity appeared good enough, but the inter- and intra-sample variability 
were high even after normalisation to endogenous compound. This infers that the analytes 
are not co-located. 
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Table 6-7 - Relative standard deviation (RSD) for the intra- (within the same fingerprint sample, n=3) and inter-variability (for all areas and samples 
analysed) of the EME signal using different endogenous substances for peak intensity normalisation for Donor 1. Cells highlighted in green indicate 
that normalisation resulted in a decrease of the relative standard deviation % when compared to no normalisation applied. 
  
Donor 1 Donor 2 
Intra-
variability 
Left Thumb 
Intra-
variability 
Right Index 
Intra-
variability 
Right Ring 
Inter-
variability 
Intra-
variability 
Left Thumb 
Intra-
variability 
Right Index 
Intra-
variability 
Right Ring 
Inter-
variability 
Cocaine 
No normalisation 65% 64% 67% 30% 30% 113% 42% 123% 
Lysine 61% 67% 71% 29% 29% 109% 59% 119% 
Phenylalanine 65% 64% 67% 30% 30% 113% 42% 123% 
Valine 63% 62% 70% 34% 34% 107% 56% 118% 
Isoleucine/Leucine 63% 65% 66% 33% 33% 104% 62% 113% 
Riboflavin 67% 59% 61% 34% 34% 172% 50% 296% 
BZE 
No normalisation 121% 69% 37% 72% 72% 33% 61% 61% 
Lysine 125% 71% 30% 72% 72% 27% 60% 55% 
Phenylalanine 124% 73% 28% 69% 69% 40% 55% 56% 
Valine 124% 67% 36% 75% 75% 38% 60% 59% 
Isoleucine/Leucine 124% 69% 35% 75% 75% 33% 66% 61% 
Riboflavin 120% 66% 38% 76% 76% 167% 62% 264% 
EME 
No normalisation 28% 33% 62% 4% 4% 22% 21% 22% 
Lysine 23% 33% 79% 5% 5% 15% 5% 10% 
Phenylalanine 21% 37% 79% 7% 7% 0% 5% 15% 
Valine 25% 34% 65% 9% 9% 14% 8% 13% 
Isoleucine/Leucine 25% 34% 65% 5% 5% 9% 10% 16% 
Riboflavin 30% 35% 63% 6% 6% 169% 13% 276% 
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6.3. Liquid Assisted Surface Analysis (LESA) 
A recent publication described the application of LESA to the analysis of urine, oral fluid 
and fingerprints. This showed the potential for this technique for drug testing using different 
matrices (Bailey et al., 2016). This thesis uses this data to evaluate the suitability for drug 
detection in fingerprints were carried out using the Advion TriVersa Nanomate (Advion, 
Ithaca, NY, US) for LESA analysis, coupled with a LTQ Orbitrap Velos mass spectrometer 
(Thermo Scientific, Bremen, Germany). The TriVersa Nanomate was controlled by the 
LESA Points software.  The LESA method used was briefly optimised for the different 
matrices as shown in Table 6-8. The solvent composition was 70:30 MeOH:H2O (MeOH - 
Fischer Scientific, Leicestershire, UK and water purified by an ELGA Option 3 system, 
Marlow, UK) with 0.1% formic acid (Sigma Aldrich, Dorset, UK). Samples were introduced 
into the mass spectrometer at a flow rate of approximately 80 nL/min with a gas pressure of 
0.3 psi, a tip voltage of 1.4 kV and a capillary temperature of 250 °C. Data was collected in 
Orbitrap mode at a resolution of 100,000 (m/z 400) and the Automatic Gain Control (AGC) 
of 106 ions was set. Collision induced dissociation (CID) experiments were carried out in 
the linear ion trap using nitrogen gas with a normalised collision energy of 30%. 
Fingerprint, oral fluid and urine samples were collected from individuals seeking treatment 
at a drug rehabilitation clinic. This study received a favourable opinion from the National 
Research Ethics Service (NRES) (REC reference: 14/LO/0346). Fingerprints were collected 
as presented from onto glass microscope slides with an applied pressure between 800g and 
1200g. Two oral fluid samples were collected using a QualtisalTM (Allere Toxicology, UK) 
collection device; one sample was sent to LGC Forensics (Teddington, Middlesex, UK) for 
immunoassay screening and the second sample was kept for LESA analysis. The oral fluid 
collection kit includes a collection pad that is submersed in a buffer after sample collection 
to preserve the sample. Urine was collected using an LGC Forensics collection kit. Samples 
were stored in a fridge at 2-5 °C. Before analysis, oral fluid and urine samples were pipetted 
(0.2 µL) in triplicate onto separate clean glass microscope slides. Fingerprint samples were 
allowed to cool down to room temperature before analysis – three replicate measurements 
were taken for one single fingerprint in three different locations.   
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Table 6-8 – Optimised LESA methods for the analysis of natural fingerprints, oral fluid and 
urine.  
 Fingerprint Oral Fluid Urine 
Solvent composition 70% MeOH/30% H2O/0.1% FA 
Solvent volume (µL) 3 0.7 0.7 
Dispense (µL) 2 0.5 0.5 
Delay (s) 3 2 2 
Aspirate (µL) 3 0.8 0.8 
Dispensation height (mm) 0.4 0.4 0.4 
Aspiration height (mm) 0.2 0.2 0.2 
Delivery time (min) 3 3 3 
Gas pressure (psi) 0.3 0.3 0.3 
Voltage (kV) 1.4 1.4 1.4 
Fill time (ms) 43 9 3 
 
Data was extracted using Xcalibur 2.10 software (Thermo Scientific) into Microsoft Office 
ExcelTM for data processing. The detection of cocaine and respective metabolites in 
fingerprints, oral fluid and urine was achieved in full scan mode and in tandem MS mode 
for confirmatory purposes. Table 6-9 shows the results obtained for LESA analysis of oral 
fluid, urine and fingerprints and the LGC Forensics results for the oral fluid screening. 
Table 6-9 – Summary of the monoisotopic masses and CID transition for the drugs of abuse 
and metabolites detected in a fingerprint, oral fluid and urine using LESA; results obtained 
from the LESA analyses of fingerprints, oral fluid and urine and LGC oral fluid screening test 
are also shown. √ = positive 
Analyte 
LGC Oral Fluid 
Screening Result 
LESA Results 
Fingerprint Oral Fluid Urine 
Cocaine 
√ 
√ √ √ 
BZE √ √ √ 
EME √ √ √ 
 
The oral fluid samples analysed by LGC Forensics screened positive for both cocaine which 
corroborated the LESA results for oral fluid where cocaine, BZE and EME were also 
detected. LESA analyses of the urine sample revealed the presence of cocaine, BZE, EME. 
Fingerprint analyses showed the presence of cocaine, BZE, EME which positively correlates 
with the LGC oral fluid screening test. The peak assignments were further confirmed by 
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tandem MS measurements where the parent ions fragment into the characteristic fragment 
peaks (see Section 9.9 – Appendix X). 
A list of 51 substances (see Section 9.11 – Appendix XI), taken from a list of substance 
detected in fingerprints in a review by Girod et al. (2012), were searched for in all three 
matrices. A mass accuracy of +/- 10ppm from the theoretical mass was accepted and a 
threshold of three times the peak intensity of the blank measurement was set. Out of the 51 
substances listed, 38 were detected in all three areas analysed using LESA; 15 out of 18 
amino acids, 16 out of 22 fatty acids and 7 miscellaneous substances out of 11 as shown in 
Table 6-10. This shows the potential differences in the spatial uniformity of a fingerprint. 
The number of substances detected from one single fingerprint was remarkable and it 
highlights the sensitivity of LESA compared to chromatography approaches and the 
possibility of using this technique for fingerprint ageing studies. Some of these, such as the 
amino acids and fatty acids, were also present in oral fluid and urine samples.  
Table 6-10 - Compounds detected in a single fingerprint using LESA. List taken from Girod et 
al. (2012). x = detected with peak intensities above 3x the blank signal; √ = detected; N/D = not 
detected. Cells highlighted in green indicate that these substances were chosen for 
drug/metabolite peak intensity normalisation. 
  Right Little Finger  
Substance Area 1 Area 2 Area 3 
Miscellaneous 
Uric Acid √ N/D N/D 
Urea √ √ √ 
Phenol √ √ √ 
Lactic Acid √ √ √ 
Cholesterol ([M-H]+) √ N/D √ 
Creatinine √ √ √ 
Squalene √ √ N/D 
Glucose √ √ √ 
Riboflavin N/D √ √ 
Alpha-Tocopherol √ √ √ 
 Delta-Tocopherol  √ √ √ 
Amino Acids 
Glycine N/D √ N/D 
Histidine √ √ √ 
Serine √ √ √ 
Alanine √ √ √ 
Isoleucine/Leucine √ √ √ 
Threonine √ √ √ 
Arginine √ √ √ 
Tyrosine √ √ √ 
Asparagine √ √ √ 
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Lysine √ √ √ 
Valine √ √ √ 
Aspartic Acid √ √ √ 
Methionine N/D N/D √ 
Taurine N/D N/D √ 
Citrulline √ √ √ 
Ornithine √ √ √ 
Glutamic Acid √ √ √ 
Phenylalanine √ √ √ 
Fatty Acids 
Octanoic acids (8:0)  √ √ √ 
Nonanoic acid (9:0)  √ √ √ 
Decanoic acid (10:0)  √ √ √ 
Dodecanoic acid (12:0)  √ √ √ 
Tridecanoic acid (13:0)  √ N/D √ 
Myristoleic acid (14:1)  √ √ √ 
Myristic acid (14:0)  √ √ √ 
Pentadecenoic acid (15:1) √ √ √ 
Pentadecanoic acid (15:0) √ √ √ 
Palmitoleic acid (16:1)  √ √ √ 
Palmitic acid (16:0)  √ √ √ 
Margaric acid (17:0)  √ √ √ 
Heptadecenoic acid (17:1) √ √ √ 
Linoleic acid (18:2)  √ √ √ 
Oleic acid (18:1)  √ √ √ 
Stearic acid (18:0)  √ √ √ 
Nonadecanoic acid (19:0)  √ √ √ 
Eicosanoic acid (20:0)  √ N/D √ 
Heneicosanoic acid (21:0)  N/D N/D √ 
Docosanoic acid (22:0)  N/D N/D √ 
Tricosanoic acid (23:0)  N/D N/D N/D 
Tetracosanoic acid (24:0) N/D N/D √ 
 
LESA, being a surface mass spectrometry method, presents similar drawbacks to DESI 
regarding the requirement for spatially uniform standards. Standards of concentrations 
between 0.5 – 500 ng/mL of cocaine in artificial sweat were spotted (0.2 µL) onto glass 
slides in order to construct a calibration curve, but the analytes were not systematically 
detected in the replicate measurements, presumably due to precipitation of the analytes upon 
drying. This prevented any quantitative parameters from being determined. 
As was previously explored with DESI, the use of an internal standard may help for the 
unknown fingerprint mass. Normalisation of the analyte signals to endogenous substances 
simultaneously detected in the fingerprint may help reduce the variability encountered over 
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the three areas analysed with LESA. From the list presented in Table 6-10, the top ten 
compounds with the highest peak intensities were chosen (highlighted in green). 
Normalisation was calculated as per Equation 6-1. This calculation was applied to each drug 
and metabolite signal detected in each of the three spots analysed. An average was taken and 
the relative standard deviation (RSD) was calculated. The uncertainty due to counting 
statistics (Equation 6-3) was calculated by taking the number of counts in the peak of each 
of the selected endogenous substances, cocaine, BZE and EME and it was consistently under 
2%. This suggests that the RSD% seen for the intra-variability of the sample is due to the 
spatial inhomogeneity and not due to poor counting statistics.  
Table 6-11 shows the calculated RSD% of the un-normalised data versus the RSD% for the 
data normalised to the different endogenous substances selected. Cocaine presented the 
lowest variability and normalisation of cocaine to serine lowered the RSD% from 22% to 
1% but the same effect was not seen for BZE. These conclusions are consistent with the ones 
previously taken for DESI data where, irrespectively of the substance chosen, the variability 
of the peak intensity for the drug or metabolite could not be systematically corrected.  
Table 6-11 – Average (n=3) and relative standard deviations (%) for the normalisation of the 
peak intensities for drugs/metabolites to different endogenous substances detected in a single 
fingerprint.  
  
Cocaine BZE EME 
Average 
(n=3) RSD 
Averag
e (n=3) RSD 
Average 
(n=3) RSD 
No 
Normalisation 407533.15 22% 4295.00 33% 3220.24 118% 
Creatinine 0.42 15% 0.00 34% 0.00 110% 
Leucine 3.25 10% 0.04 39% 0.02 105% 
Serine 3.90 1% 0.04 44% 0.03 99% 
Valine 6.45 7% 0.07 47% 0.04 95% 
Histidine 11.96 16% 0.14 54% 0.08 89% 
Arginine 11.88 12% 0.14 50% 0.08 91% 
Oleic Acid 18.96 20% 0.21 53% 0.13 106% 
Palmitoleic 
Acid 30.23 21% 0.30 54% 0.16 86% 
Palmitic Acid 24.38 7% 0.27 43% 0.17 105% 
Myristic Acid 26.94 40% 0.27 26% 0.24 121% 
 
It would appear that LESA is good tool for chemical profiling of fingerprints as it enabled 
the detection of drugs of abuse, metabolites and an extensive list of commonly found 
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endogenous substances. The sensitivity shown to the endogenously secreted compounds 
supports the prospective use of the technique for fingerprint ageing studies. Regarding the 
application to drug testing, LESA was demonstrated to be a good candidate due to the lack 
of sample preparation and chromatographic separation compared with LC or GC-MS 
approaches. The sample throughput of LESA however, is slower than for DESI, because of 
the need to register the position on the sample prior to analysis, followed by the robot routine, 
which takes several minutes. Additionally, this preliminary study failed to provide 
quantitative data.  
6.4. Summary 
In this chapter, the mass spectrometry techniques explored – desorption electrospray 
ionisation (DESI) and liquid extraction surface analysis (LESA) mass spectrometry - enabled 
the detection of drugs and metabolites from a single fingerprint. The quantitation potential 
of each of these techniques was also tested and each of the techniques offered their own 
drawbacks. For DESI and LESA analyses, the use of standard solutions was found to be 
unsuitable due to the uneven precipitation of the standards over the substrate. Gelatin films 
were tested as a possible drug dispersion medium with DESI and although the dispersion of 
the analytes (cocaine, BZE and EME) over the area of analysis was improved over the use 
of solutions, the standards were not matrix matched to fingerprint.  
No direct comparison of these two techniques and paper spray (Section 3.2) could be made 
at the time due to the different samples used and the different mass spectrometers employed. 
The key advantages and limitations of the techniques for fingerprint testing are outlined in 
Table 6-12. At the time, paper spray was chosen for further investigation due to the ease of 
set up, rapidity of analysis, convenience of sample collection (on paper) and ability to 
provide preliminary quantitative data, even with the QToF mass spectrometer that was 
readily available at Surrey. 
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Table 6-12 – Comparison of the key features of DESI, LESA and Paper Spray mass spectrometry 
methods. 
 DESI LESA Paper Spray 
Age 
First reported in 2004 (Takáts 
et al., 2004) 
First reported in 2010 
(Kertesz et al., 2010) 
First reported in 2010 
(Liu et al., 2010) 
Cost 
£50k for a 2D source, although 
possible to be built in-house for 
£2k 
£50-60k for the LESA 
head plus £10 per 
sample to cover the 
consumption of the 
nanospray emitters 
Commercially available 
but focused towards 
dried blood spots 
analysis. Can be built in-
house for £50. 
Sample 
Throughput 
2 minutes 7 minutes 2 minutes 
Imaging 
capability? 
Yes (100µm spatial resolution) 
Yes, but very large spot 
area (<1 mm) 
No 
Advantages 
• Bailey et al. (2015) 
demonstrated that DESI can 
detect cocaine and respective 
metabolites in latent 
fingerprints. 
 
• Bailey et al. (2016) 
showed that LESA 
enabled the detection 
of drugs and 
metabolites as well as 
other endogenous 
substances in 
fingerprints 
 
• Section 4 (Chapter 3) 
demonstrates that 
paper spray could be 
used for the 
detection of drugs of 
abuse and 
endogenous 
substance in natural 
fingerprints using an 
inferior QToF mass 
spectrometer. 
• Consumes entire 
fingerprint, 
increasing the 
sensitivity of the 
method 
Disadvantages 
• Calibration curve standards 
preparation is difficult 
(analytes must be 
encapsulated in a gel matrix, 
which is not matrix matched 
to fingerprint samples) 
 
• It was not possible to 
generate a calibration 
curve from artificial 
sweat or gels because 
the LESA did not 
reproducibly pick up 
sample 
• No imaging 
capability 
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7. Conclusions and Future Work 
7.1. Conclusions 
The detection of drugs of abuse in fingerprints has been explored by several different research 
groups using different types of analytical techniques (see Section 1.3.3). The aim of this 
research was to develop a method for the detection of drugs of abuse and metabolites in latent 
fingerprints using ambient ionisation mass spectrometry (AIMS). This aim was achieved 
through the optimisation of the paper spray method and the subsequent application to 
fingerprint samples.  
Chapter 3 describes the steps taken to enhance the sensitivity of the analysis to the detection of 
cocaine, benzoylecgonine (BZE) and ecgonine methyl ester (EME). The paper spray source 
was built at the University of Surrey and several optimisation steps were taken; from the mass 
spectrometer settings (see Table 3-5), to the mass spectrometer inlet (see Section 3.4) and 
finally the paper spray method (see Section 3.6). For the latter, parameters such as spray solvent 
composition, volume of spray solvent, applied voltage and paper treatment were investigated 
to increase the sensitivity of the method towards the analytes of interest. This optimisation work 
was performed using standards of cocaine, BZE and EME prepared in artificial sweat to mimic 
the matrix effects of the finger residue. However, later comparison of the matrix effects of 
fingerprints versus acetonitrile (the solvent in which certified reference materials are available) 
and the artificial sweat suggested that the latter caused ionisation suppression effects that were 
not seen with fingerprint samples (see Section 3.6). The mass spectrometer method was 
developed to include full scan measurements (that can be used quantitatively) and tandem MS 
(MS/MS) scan of each analyte (for qualitative identification). Using the optimised paper spray 
method and calibration standards prepared in acetonitrile, the limits of detection (LOD) were 
calculated to be 1 ng/mL, 2 ng/mL and 31 ng/mL for cocaine, BZE and EME, respectively. For 
cocaine, the calculated limits of detection are comparable to the sensitivity of a paper spray 
method for the detection of drugs of abuse in dried blood spots reported by Espy et al. (2014) 
of 0.05 ng/mL. Similarly, Groeneveld et al. (2015) reported limits of detection of 10 ng/mL, 
100 ng/mL and 100 ng/mL for cocaine, BZE and EME, respectively using matrix-assisted laser 
desorption ionisation (MALDI), and therefore the paper spray method would appear more 
sensitive. 
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Chapter 4 describes the observation of the effect of different sample collection procedures on 
the qualitative identification of cocaine and respective metabolites. Results suggest that 
washing the hands with soap, instead of wiping the fingertips, is more efficient at removing 
traces of the analytes. However, very little is detected in the samples when the hands are washed 
with soap. Out of the 159 successfully analysed fingerprint samples, 99% of the samples tested 
positive for either cocaine, EME or BZE. All the fingerprint results were corroborated by oral 
fluid analysis, with the exception of one donor who tested negative for cocaine in their oral 
fluid but positive in the corresponding fingerprint samples, although the participant admitted to 
having taken cocaine. This might be the result of the different detection windows of the two 
matrices.  
Quantification of the drugs and metabolites detected in fingerprint samples was not possible 
due to the high degree of variability encountered with this type of samples, which can result 
from uneven excretion of the analytes from each finger or from the collection procedure, which 
results in the collection of different amounts of finger residues.  
Section 4.3 describes the analysis of fingerprint samples collected from the general population 
(n=80). Out of the 80 samples, 78 tested negative for cocaine, BZE and EME. The detection of 
cocaine and EME in one of the samples could not be explained (the other sample collected from 
the same participant tested negative) but it could be the result of cross-contamination from the 
lab or a true false-positive result, generated from contact with cocaine. Thus, the false-positive 
rate of the paper spray method developed was found to be less than 3% based on a single 
fingerprint. In the ambit of these experiments and to observe whether cocaine can be picked up 
and detected in fingerprints from contact with currency, fingerprint samples were collected 
from two cashiers and from two other participants that were asked to handle a £20 bank note, 
before and after wiping the fingertips. Cocaine was only detected in the two fingerprint samples 
collected from the one of the donors who handled a bank note, showing how day-to-day 
activities can lead to contamination of the fingers and consequently highlighting the importance 
of a robust hand cleaning procedure. 
Section 4.4 described a set of experiments whereby participants were asked to touch powdered 
cocaine (that also contained traces of BZE and EME) with their fingertips before depositing 
samples with and without a hand cleaning process (wiping the fingertips or washing the hands 
with soap). The results corroborated the findings described above where wiping the fingertips 
is less effective at removing cocaine and EME than washing the hands with soap. Nonetheless, 
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cocaine could not be systematically removed by any of the two procedures. Simultaneously, the 
effect of secondary transfer was tested by asking a participant to touch the powder and 
immediately shake hands with two other participants. Cocaine and EME were found to be 
transferred through the handshake. However, washing the hands with soap did enable the 
removal of the metabolite and, to some extent, of the parent drug (see Section 4.4).  
Other illicit substances and respective metabolites (opiates and methadone) were also detected 
in fingerprint samples collected from individuals seeking treatment for drug abuse. The 
detection rate was much smaller than for cocaine because of the absence of any optimisation 
steps for these analytes, but the results demonstrate the wide applicability of a paper spray mass 
spectrometry method than can detect several analytes simultaneously. However, further work 
needs to be carried out to ensure that the sensitivity to these substances is acceptable.  
One of the advantages of fingerprints over other biological matrices is the ability to identify the 
donor through the comparison and matching of the fingerprint ridge detail. Two fingerprint 
visualisation procedures often used in forensic casework – ninhydrin and silver nitrate – were 
tested for their ability to develop the fingerprint ridge detail on the paper spray substrate. Both 
enabled the successful visualisation of the ridge detail. However, the presence of these 
substances caused loss of sensitivity to the analytes of interest when tested with standards. 
Silver nitrate was also tested on fingerprint samples collected from individuals attending a 
rehabilitation clinic. Qualitatively, the presence of the drug and metabolite could be confirmed. 
However, quantitatively, the number of detected ions suggested that the presence of silver 
nitrate caused loss of sensitivity to the signals measured in full scan mode for the analytes of 
interest.   
Lastly, Chapter 6 describes the evaluation of two other mass spectrometry techniques – 
desorption electrospray ionisation (DESI) and liquid extraction surface analysis (LESA) - for 
their ability to chemically analyse finger residues and for their quantitative potential. Both 
techniques enabled the detection of cocaine and respective metabolites. However, the 
quantitative potential was still poorer than that of paper spray.   
Through this research, it has been demonstrated that: 
•  99% of 159 fingerprint samples (16 donors, one failed spray) analysed tested positive 
for cocaine and this was matched by a positive oral fluid in 15/16 donors, with the 
remaining donor reportedly taking cocaine 
166 
 
• False-positive rate, calculated from the detection of cocaine in fingerprint samples 
collected from the general population, was found to be <2.5% 
• Paper spray can be used as a high throughput method (~2 minutes) for drug testing using 
a single fingerprint (qualitatively) 
• Quantification of cocaine in fingerprints is difficult to achieve due to high variability of 
the sample 
• The fingerprint collection procedure must include a hand cleaning process to ensure that 
contact residues are minimised 
• Chemical developers may be used for visualisation of the fingerprint pattern and still 
enable the qualitative detection of cocaine and respective metabolites 
The paper spray method developed for the detection of cocaine, BZE and EME in fingerprints 
showed great potential. However, the implementation of the method in a legal framework will 
require further investigation of the sample collection procedure and stability of the analytes on 
the substrate after collection.  These two parameters may be key to ensure that the test is as 
accurate as blood analysis, which uses stabilisers to guarantee the permanency of the matrix 
(LGC, 2014). Nonetheless, the false-positive and the true-positive rates (above) of the 
development method were shown to be acceptable. Consequently, the process may be used as 
a non-quantitative confirmation test for other fingerprint based drug tests such as the Intelligent 
Fingerprinting immunoassay test (Intelligent Fingerprinting: How It Works, 2014). 
7.2. Future Work 
The research described showed the possibility of paper spray as a screening drug test using a 
single fingerprint. However, because this is a novel area, further studies on this type of sample 
and its validity as a drug testing matrix are required. 
Chapter 4 describes the development of a paper method for the detection of cocaine, BZE and 
EME and although the LOD calculated is comparable to other reports in the literature and cut-
off limits for other matrices, it can be improved. The use of a higher resolution mass 
spectrometer, such as an Orbitrap, may help improve the sensitivity of the method and the peak 
resolution, namely for EME and BZE. The discovery of a fingerprint biomarker that is excreted 
at a continuous rate and is systematically present in fingerprint samples may aid the 
development of a fully quantitative method by enabling the normalisation of the drug signals 
to the “amount” of fingerprint deposited on the substrate. Regarding the paper spray set-up, the 
automation of the substrate preparation and paper alignment on the source will increase the 
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sample turnaround time, the precision and repeatability of the method and the elimination of 
failed sprays (the result of poorly shaped tip of the paper). 
Very little is known about the stability of fingerprint samples and more importantly, the stability 
of drugs of abuse and respective metabolites in this matrix. Reports in the literature investigated 
the potential for parent drug metabolism/hydrolysis/breakdown on the skin. However, to this 
date, none have focused on the skin from the hands or feet, which only accommodate eccrine 
sweat pores. Such experiments can be carried out in a similar fashion to those described in 
Section 4.4, which focussed on contact residue and secondary transfer scenarios but using BZE 
and EME free cocaine powder.  Further research into fingerprint ageing will also contribute 
towards a better understanding of cocaine hydrolysis on the skin and/or analysis substrate. 
The fingerprint sampling procedure was explored as part of this PhD and it was shown that the 
complete removal of cocaine from the fingertips was not achieved, irrespective of the technique. 
The removal of contact residues is critical as some occupations, namely healthcare 
professionals and cashiers can encounter contaminated substances and/or patients. Whilst no 
positive samples came from cashiers, two of the samples of the background population were 
positive. Without an appropriate hand cleaning procedure, test results can be positive but not 
necessarily true positives (i.e. the result of drug administration and subsequent excretion 
through the sweat pores). Several other hand cleaning methods, or combination of methods, can 
be employed. Examples include alcohol wipes/hand rub and a combination of wipes and hand 
washing with soap. Upon removal of contact residues, the stimulation of sweat is key to ensure 
that enough sample is being collected and that it is representative. Nitrile gloves were used as 
part of this research, but a more in-depth study on the effect of sweating into gloves over not 
wearing gloves or any other sweat inducing processes, must be explored. Alternatively, the final 
protocol can utilise two samples per donor and both samples must contain at least one of the 
substances for the result to be considered positive. The application of this protocol to the 
background population presented above would result on a 0% false-positive rate.  
Lastly, ninhydrin and silver nitrate were tested as possible fingerprint pattern visualisation 
chemicals. However, the presence of these substances was found to have a negative impact on 
the detection of cocaine, BZE and EME in full scan mode. The application of silver nitrate to 
fingerprint samples collected from individuals at a rehabilitation clinic still enabled the 
detection of cocaine in all 20 samples analysed. Several other techniques can be used on porous 
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substrates – 1,8-diazafluoren-9-one (DFO) and indandione. Both of these are routinely used by 
police forces in casework (Home Office, 2013). 
This research showed the potential of using a single fingerprint for drug testing through the use 
of ambient mass spectrometry. However, this exploratory work focussed primarily on cocaine 
and respective metabolites although other substances were also detected (Section 4.5). A more 
in-depth exploration of other substances such as opiates, methadone, benzodiazepines and 
amphetamines would enhance the value of the test and maybe and possibly substitute/support 
immunoassays as screening tests.   
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9. Appendices 
9.1. Appendix I 
Overlay of spectra at m/z 133 (ornithine, monoisotopic mass 133.0977) obtained for (A) spiked 
sweat standard analysed with 90:10 ACN:H2O, (B) spiked sweat standard analysed with 70:30 
MeOH:H2O, (C) blank sweat standard analysed with 90:10 ACN:H2O, (D) blank sweat standard 
analysed with 70:30 MeOH:H2O, (E) blank paper analysed with 90:10 ACN:H2O and (F) blank 
paper analysed with 70:30 MeOH:H2O. Mass accuracy was calculated for the peak with the 
nearest mass to that of the analyte to interest. 
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Overlay of spectra at m/z 156 (histidine, monoisotopic mass 156.0773) obtained for (A) spiked 
sweat standard analysed with 90:10 ACN:H2O, (B) spiked sweat standard analysed with 70:30 
MeOH:H2O, (C) blank sweat standard analysed with 90:10 ACN:H2O, (D) blank sweat standard 
analysed with 70:30 MeOH:H2O, (E) blank paper analysed with 90:10 ACN:H2O and (F) blank 
paper analysed with 70:30 MeOH:H2O. Mass accuracy was calculated for the peak with the 
nearest mass to that of the analyte to interest. 
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Overlay of spectra at m/z 175 (arginine, monoisotopic mass 175.1195) obtained for (A) spiked 
sweat standard analysed with 90:10 ACN:H2O, (B) spiked sweat standard analysed with 70:30 
MeOH:H2O, (C) blank sweat standard analysed with 90:10 ACN:H2O, (D) blank sweat standard 
analysed with 70:30 MeOH:H2O, (E) blank paper analysed with 90:10 ACN:H2O and (F) blank 
paper analysed with 70:30 MeOH:H2O. Mass accuracy was calculated for the peak with the 
nearest mass to that of the analyte to interest. 
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9.2. Appendix II 
Monoisotopic mass for the protonated parent ion and fragments of cocaine, cocaine-D3, BZE, 
BZE-D3, EME and EME-D3. 
Parent Ion 
Protonated Monoisotopic 
Mass (u) 
Fragment Monoisotopic 
Mass (u) 
Cocaine  
(COC) 
304.15 182.12 
Cocaine-D3  
(COC-D3) 
307.17 185.14 
Benzoylecgonine 
(BZE) 
290.14 168.10 
Benzoylecgonine-D3 
(BZE-D3) 
293.16 171.12 
Ecgonine Methyl Ester 
(EME) 
200.13 182.12 
Ecgonine Methyl Ester-D3 
(EME-D3) 
203.15 185.14 
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9.3. Appendix III 
Ratio of A/IS for cocaine and BZE detected in fingerprint samples collected from Donors 4 and 7 
after wiping fingertips with alcohol free wipes or washing the hands with soap, wearing gloves 
for 10 minutes and depositing samples with a pressure between 800-1200 g for 10 seconds. 
Internal standard was present in every sample at 50 ng/mL. 
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9.4. Appendix IV 
Ratio of A/IS for BZE and EME detected in natural fingerprint samples collected from Donors 8 
to 12 after wiping fingertips with alcohol free wipes, wearing gloves for 10 minutes and 
depositing samples with a pressure between 800-1200 g. Internal standard was present in every 
sample at 50 ng/mL. 
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9.5. Appendix V 
Ratio of A/IS for (A) cocaine, (B) BZE and (C) EME in artificial sweat and acetonitrile over a 72 
hour time period. 
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9.6. Appendix VI 
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9.7. Appendix VII 
Analyte to internal standard ratio for cocaine, BZE and EME detected in fingerprint samples 
collected under four different scenarios of contact residue and secondary transfer. 
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9.8. Appendix VIII 
Oral fluid and fingerprint results obtained for Donors 1 to 16 analysed with the optimised paper spray method for methadone, diamorphine and 
respective metabolites. √ = detected; N/D = not detected. 
Drugs & 
Metabolites 
Oral Fluid 
Results  
Fingerprint Results  
Right 
Little  
Right 
Ring 
Right 
Middle 
Right 
Index 
Right 
Thumb 
Left 
Little  
Left 
Ring 
Left 
Middle 
Left 
Index 
Left 
Thumb 
  Donor 1 
Methadone  >160.0 ng/mL √ √ √ √ √ √ √ √ √ √ 
EDDP - √ √ N/D √ √ √ N/D √ √ √ 
EMDP - √ √ N/D √ N/D √ N/D √ √ √ 
Diamorphine - - - - - - - - - - - 
6-MAM Negative - - - - - - - - - - 
Morphine Negative - - - - - - - - - - 
Codeine Negative - - - - - - - - - - 
  Donor 2 
Methadone  >160.0 ng/mL √ √ √ √ √ √ √ √ √ √ 
EDDP - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
EMDP - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Diamorphine - N/D v N/D √ √ N/D √ √ √ √ 
6-MAM >32.0 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D √ N/D 
Morphine >320.0 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Codeine 174 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
  Donor 3 
Methadone  76.8 ng/mL N/D √ √ √ √ √ √ √ √ √ 
EDDP - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
EMDP - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
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Diamorphine - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
6-MAM Negative - - - - - - - - - - 
Morphine Negative - - - - - - - - - - 
Codeine Negative - - - - - - - - - - 
  Donor 4 
Methadone  >160.0 ng/mL N/D √ √ N/D √ N/D √ √ N/D √ 
EDDP - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
EMDP - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Diamorphine - N/D N/D √ √ √ √ √ √ √ √ 
6-MAM >32.0 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Morphine >320.0 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Codeine 254 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
  Donor 5 
Methadone  >160.0 ng/mL √ √ √ √ √ N/D N/D N/D √ √ 
EDDP - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
EMDP - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Diamorphine - N/D N/D N/D √ N/D N/D N/D N/D √ √ 
6-MAM Negative N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Morphine >320.0 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Codeine 149 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
  Donor 6 
Methadone  71.1 ng/mL N/D √ √ N/D N/D N/D N/D N/D √ N/D 
EDDP - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
EMDP - N/D √ √ N/D N/D N/D N/D N/D √ N/D 
Diamorphine - N/D √ N/D √ N/D N/D N/D N/D √ N/D 
6-MAM >32.0 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Morphine >320.0 ng/mL N/D √ √ N/D N/D N/D N/D N/D N/D N/D 
Codeine 91.0 ng/mL N/D √ √ N/D N/D N/D N/D N/D N/D N/D 
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  Donor 7 
Methadone  >160.0 ng/mL √ √ √ √ √ N/D √ √ √ √ 
EDDP - N/D N/D N/D N/D N/D N/D N/D √ N/D N/D 
EMDP - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Diamorphine - - - - - - - - - - - 
6-MAM Negative - - - - - - - - - - 
Morphine Negative - - - - - - - - - - 
Codeine Negative - - - - - - - - - - 
  Donor 8 
Methadone  >160.0 ng/mL √ N/D √ N/D √ N/D √ √ √ √ 
EDDP - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
EMDP - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Diamorphine - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
6-MAM >32.0 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Morphine >320.0 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Codeine 270 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
  Donor 9 
Methadone  Negative - - - - - - - - - - 
EDDP - - - - - - - - - - - 
EMDP - - - - - - - - - - - 
Diamorphine - - - - - - - - - - - 
6-MAM Negative - - - - - - - - - - 
Morphine Negative                     
Codeine 270 ng/mL - - - - - - - - - - 
  Donor 10 
Methadone  Negative - - - - - - - - - - 
EDDP - - - - - - - - - - - 
EMDP - - - - - - - - - - - 
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Diamorphine - N/D N/D N/D N/D N/D N/D √ N/D N/D N/D 
6-MAM >32.0 ng/mL √ N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Morphine 297 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Codeine 49 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
  Donor 11 
Methadone  Negative - - - - - - - - - - 
EDDP - - - - - - - - - - - 
EMDP - - - - - - - - - - - 
Diamorphine - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
6-MAM >32.0 ng/mL N/D N/D N/D √ √ N/D N/D √ √ √ 
Morphine Negative N/D N/D N/D N/D N/D N/D N/D √ √ √ 
Codeine >320.0 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
  Donor 12 
Methadone  >160.0 ng/mL √ N/D √ √ N/D √ √ √ √ √ 
EDDP - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
EMDP - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Diamorphine - N/D N/D N/D N/D N/D √ N/D N/D √ N/D 
6-MAM >32.0 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Morphine >320.0 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Codeine 214 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
  Donor 29 
Methadone  >160.0 ng/mL √ √ √ N/D √ N/D N/D N/D N/D N/D 
EDDP - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
EMDP - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Diamorphine - √ √ √ N/D √ N/D N/D N/D N/D N/D 
6-MAM 53.6 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Morphine 
Negative (6.46 
ng/mL) 
N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
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Codeine 46.0 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
  Donor 30 
Methadone  >160.0 ng/mL √ √ √ √ √ √ √ √ N/D √ 
EDDP - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
EMDP - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Diamorphine - N/D N/D N/D N/D N/D √ √ √ √ N/D 
6-MAM 20.3 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Morphine 77.3 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Codeine 48.6 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
  Donor 31 
Methadone  Negative - - - - - - - - - - 
EDDP - - - - - - - - - - - 
EMDP - - - - - - - - - - - 
Diamorphine - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
6-MAM 14.5 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Morphine 57.8 ng/mL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Codeine Negative N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
  Donor 32 
Methadone  >160.0 ng/mL √ √ √ √ √ N/D N/D N/D N/D N/D 
EDDP - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
EMDP - N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Diamorphine - - - - - - - - - - - 
6-MAM Negative - - - - - - - - - - 
Morphine Negative - - - - - - - - - - 
Codeine Negative - - - - - - - - - - 
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9.9. Appendix IX 
Measured peak intensity (full scan) for Donor 29 and 32 for cocaine measured from fingerprint 
samples collected from individuals at a drug rehabilitation centre with and without the presence 
of silver nitrate (BZE and EME were not detected in these samples). 
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9.10. Appendix X 
Collision induced dissociation (CID) spectra of (A) BZE, (B) EME and (C) cocaine detected on a 
single fingerprint using LESA. 
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9.11. Appendix XI 
List of endogenous substances commonly detected in fingerprint samples (Girod et al., 2012). 
  Analyte (Chemical Formula) Monoisotopic Mass (M+H) 
Miscellaneous 
Uric Acid 169.03617 
Urea 61.04019 
Phenol 95.04969 
Lactic Acid 91.03952 
Cholesterol ([M-H]+) 369.352118 
Creatinine 114.06674 
Squalene 411.39909 
Glucose 181.07122 
Riboflavin 377.14611 
Alpha-Tocopherol 431.38907 
 Delta-Tocopherol  403.35779 
Amino Acids 
Glycine 76.03985 
Histidine 156.07730 
Serine 106.05042 
Alanine 90.05550 
Isoleucine/Leucine 132.10245 
Threonine 120.06607 
Arginine 175.11950 
Tyrosine 182.08172 
Asparagine 133.06132 
Lysine 147.11335 
Valine 118.08680 
Aspartic Acid 134.04533 
Methionine 150.05888 
Taurine 126.02249 
Citrulline 176.10352 
Ornithine 133.09770 
Glutamic Acid 148.06098 
Phenylalanine 166.08680 
Fatty Acids 
Octanoic acids (8:0)  145.12304 
Nonanoic acid (9:0)  159.13868 
Decanoic acid (10:0)  173.15433 
Dodecanoic acid (12:0)  201.18563 
Tridecanoic acid (13:0)  215.20128 
Myristoleic acid (14:1)  227.20128 
Myristic acid (14:0)  229.21692 
Pentadecenoic acid (15:1) 241.21692 
Pentadecanoic acid (15:0) 243.23257 
Palmitoleic acid (16:1)  255.23258 
Palmitic acid (16:0)  257.24823 
Margaric acid (17:0)  271.26389 
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Heptadecenoic acid (17:1) 269.24823 
Linoleic acid (18:2)  281.24823 
Oleic acid (18:1)  283.26389 
Stearic acid (18:0)  285.27952 
Nonadecanoic acid (19:0)  299.29517 
Eicosanoic acid (20:0)  313.31083 
Heneicosanoic acid (21:0)  327.32648 
Docosanoic acid (22:0)  341.34213 
Tricosanoic acid (23:0)  355.35779 
Tetracosanoic acid (24:0) 369.37342 
 
